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 ABSTRACT 
        
 
Haem d1 is a modified tetrapyrrole unique to the periplasmic enzyme nitrite reductase 
where it acts in catalysing the reduction of nitrite (NO2-) to nitric oxide (NO), as part 
of denitrification. As with all modified tetrapyrroles, haem d1 shares a common 
biosynthetic pathway starting from 5-aminolaevulinic acid (ALA), up to the formation 
of uroporphyrinogen III (UIII).  UIII is the branch point from which the pathway 
diverges to form the various metallo-prosthetic groups including vitamin B12.  
The precise mechanism of transformation from UIII to haem d1 is unknown. 
Examination of both structures shows a requirement of methylation at C2 and C7; 
decarboxylation of acetate side chains at C12 and C18; loss of propionic side chains at 
C3 and C8 with subsequent oxidation at C3 and C8; dehydrogenation of C17 
propionate side chain gives the acrylate substituent and ferrochelation. Of particular 
interest is the addition of oxygen to the macrocycle under anaerobic conditions.  Only 
one other intermediate, compound 800, has been isolated thus far but it is unknown 
how it is part of the pathway. Genetic studies have implicated seven nir genes, called 
nirF, nirD, nirL, nirG, nirH, nirJ and nirE, are required for haem d1 biogenesis.  
Here, experiments and data show for the first time that it proceeds from UIII to 
precorrin-2 using the enzyme NirE.  This study is the first to experimentally show the 
production of precorrin-2 as part of the pathway using anaerobic enzyme assays. 
This thesis illustrates the intense work that has focused on cloning the genes 
individually and as multigene constructs in an attempt to characterise the proteins 
overproduced. Heterologous expression in Escherichia coli has been successful as 
well as the development of a homologous expression system in Pseudomonas 
aeruginosa. The data represented shows the various aspects entailed in the 
optimisation of overproduction and the stabilisation of the Nir proteins. It also 
documents the first concerted attempt to take the operon and engineer strains to make 
haem d1 both in vivo and in vitro, using the Link and Lock method to clone the nir 
genes consecutively into a plasmid. This thesis therefore provides a foundation for 
understanding the molecular biology and biochemistry of haem d1 synthesis for the 
future.     
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CHAPTER 1 
        
 
 
An Introduction to Tetrapyrroles,  
their Synthesis in Pseudomonads  
and the Enigma that is Haem d1 
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1. Introduction 
1.1. Modified tetrapyrroles 
Molecules such as chlorophyll, haem, vitamin B12, factor F430, sirohaem and haem 
d1 pertain to a family of compounds termed modified tetrapyrroles. They are utilised 
in nature as the prosthetic groups of different enzymes that are part of fundamental 
processes. Each modified tetrapyrrole fulfils important diverse chemical and 
biological functions facilitated by the central metal ion moiety and its peripheral 
groups. These properties also give them distinct colours such as the red of 
haemoglobin and green in chlorophyll and are thus referred to as being “the 
pigments of life”.   
As the name suggests tetrapyrroles are macrocyclic structures composed for four 
pyrrole units, each being a pentagonal ring structure to form the basic porphyrin 
framework. All tetrapyrroles share a common biosynthetic pathway up to the 
formation of uroporphyrinogen III (UIII), the first macrocyclic intermediate, as 
depicted in Figure 1.1.  From this point onwards the pathway diverges to form the 
various tetrapyrrole derivatives through unique modification of peripheral groups 
and chelation of a different metal ion at its core. 
For brevity, the synthesis of UIII will be discussed in detail later. Starting from 5 -
aminolaevulinic acid (ALA), two molecules of ALA condense to form 
porphobilinogen (PBG), catalysed by ALA dehydratase. Four PBG molecules then 
condense to form a linear tetrapyrrole, hydroxymethylbilane (HMB), also called pre-
uroporphyrinogen, in the presence of PBG deaminase. This compound then cyclises 
to form UIII, the precursor to various modified tetrapyrroles, as summarised in 
Figure 1.2.  
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Figure 1.1: The structure of Uroporphyrinogen III (UIII). 
UIII is the first macrocyclic intermediate and a key branch point molecule in the 
pathway to various tetrapyrroles. Decarboxylation of its acetate groups directs flux 
toward haem and chlorophyll synthesis whereas methylation of the macrocycle 
initiates synthesis toward sirohaem, vitamin B12, and haem d1. The systematic 
numbering of the tetrapyrrole carbons is shown in blue and the pyrrole groups are 
labelled, alphabetically, in red. A= CH2CO2H , P = CH2CH2CO2H. 
 
 
 
         
 
Figure 1.2: Summary of Tetrapyrrole biosynthesis: a branched pathway from 
Uroporphyrinogen III (UIII). 
This illustrates the shared pathway from ALA to UIII of all modified tetrapyrroles. 
UIII acts as a precursor to form haem, chlorophyll, vitamin B12, sirohaem, 
coenzyme F430 and haem d1. UIII via protoporphyrin IX yields haem and 
chlorophyll. The formation of sirohaem requires the conversion of UIII to precorrin 
2 (PC2), then sirohydrochlorin (SHC) and chelation. Vitamin B12 is formed from 
PC-2 directly. The transformation of PC-2 to yield factor F430 and Haem d1 remain 
as yet to be elucidated. For brevity, the pathway to each of these has not been shown 
in detail but one must appreciate the complicated steps required in the 
transformation of UIII to each modified tetrapyrrole. A = CH2CO2H, P = 
CH2CH2CO2H. 
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Figure 1.2: Summary of Tetrapyrrole biosynthesis: a branched pathway from Uroporphyrinogen III (UIII).
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1.1.1. Chlorophyll and Bacteriochlorophylls 
Chlorophylls and bacteriochlorophylls are characteristically green (or purple) 
compounds that are essential for the conversion of solar energy to chemical energy 
as part of photosynthesis. They all share the same macrocyclic ring, possessing an 
additional fifth ring (ring E) formed by cyclisation of a propionic acid side chain and 
a centrally chelated Mg2+. 
 
Chlorophylls can be divided in to three primary classes of chlorophylls, a, b and c. 
Higher plants and green algae contain a small proportion of chlorophyll b but mostly 
chlorophyll a, the most ubiquitous and well characterized form (Figure 1.3).  
Chlorophyll c is found in eukaryotic algae but do not contain chlorophyll b (Beale 
1990).  
 
Bacteriochlorophylls are synthesised by purple and green sulfur bacteria of which 
there are six classes, a, b, c, d, e and g. Bacteriochlorophyll a, the most common 
(Figure 1.3), and b are purple pigments produced by photosynthetic bacteria (e.g. 
Rhodobacter sphaeroides (Bchl a). Bacteriochlorophyll c, d and e are pigments of 
green and brown sulfur bacteria (e.g. Prosthecochloris aestuarii (BChl c), and 
bacteriochlorophyll g has been found in Heliobacterium chlorum (Smith 1991). 
 
The biosynthesis of all chlorophylls and bacteriochlorophylls is a shared pathway of 
which chlorophyll a is well studied. It has been shown to share the same pathway as 
haem (Figure 1.5), up to the formation of protoporphyrin IX (PPIX), after which 
Mg2+ is inserted into PPIX by a trimeric ATP-dependent enzyme, ChlH, ChlD and 
ChlI (or BchH, BchD and BchI for bacteriochlorophyll synthesis). BchE catalyses 
the addition of the extra ring (ring E), and the phytol group is subsequently attached 
(Beale 1990). 
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Figure 1.3: The structures of Chlorophyll a and Bacteriochlorophyll a   
Chlorophyll a and bacteriochlorophyll a, are green in colour and are depicted below 
along with the additional ring, E. The formation of each from UIII has required 
decarboxylation at C2, C7, C12 and C18 to produce methyl groups, whilst C3 and 
C8 have undergone oxidation to form vinyl and alkyl groups respectively. Chelation 
of Mg2+ occurs, and finally phytol group is attached to the propionate group at C17.  
 
     
  
            Chlorophyll a            Bacteriochlorophyll a 
 
 
Figure 1.4: The structure of Haem b 
Haem b is red in colour giving haemoglobin its distinctive pigmentation; the entire 
pathway from UIII to haem b is shown in Figure 1.5. 
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1.1.2. Haem 
One of the most colourful molecules found in nature is the haem molecule. Each 
exhibits unique properties based on the modifications of its peripheral groups with a 
ferrous ion at its core. Five classes of haem, differing only in their side chains, are 
synthesised in nature: a, b, c, d and o. Each type of haem acts as the prosthetic group 
of vital enzymes and proteins required in fundamental and regulatory processes 
nature. Typically, haems a, b and c are red whilst haems d and o are green. (Chang 
1994) 
 
Haem a is found in cytochrome oxidases catalysing the terminal reaction of the 
respiratory chain. The b-type haems (Figure 1.4), are the most well known and 
include protohaem as found in haemoglobin, cytochromes b and P450. Haem c is 
found in cytochrome c proteins. Haem d and o are associated with terminal 
cytochrome oxidases mediating the reduction of oxygen to water (Beale 1990; 
Chang 1994). Haem d and Haem dl exhibit unique properties not shared by b-type 
haems due to the addition of oxygen to the tetrapyrrole macrocycle thus altering 
their π-orbital system. Of these haem dl mediates the reduction of nitrite to nitric 
oxide as well as the four electron reduction of oxygen to water (Silvestrini, 
Falcinelli et al. 1994). Haem dl will be discussed in greater detail later. 
 
Haem biosynthesis is mediated under both aerobic and anaerobic conditions, of 
which the aerobic pathway has been more extensively characterized, as outlined in 
Figure 1.5.  The anaerobic pathways involved in haem biosynthesis are much less 
well characterized as in the case of haem dl.  An alternative haem pathway has been 
shown to exist in the sulfate reducing anaerobe Desulfovibrio vulgaris. In this 
bacterium protohaem (haem b), is synthesised by the methylation of UIII (C2, C7) 
to form PC-2, which is then decarboxylated (C12, C18) and dealkylated (C2, C7), 
yielding coproporphyrinogen III, an intermediate in the haem b biosynthetic 
pathway (Ishida, Yu et al. 1998). Thus, there is evidence for the employment of 
different pathways that share similar intermediates but employ different enzymes. 
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Figure 1.5: The haem b biosynthetic pathway  
The formation of this modified tetrapyrrole from UIII requires decarboxylation of 
the acetic acid side chains to produce methyl groups at C2, C7, C12 and C18, by 
UIII decarboxylase yielding coproporphyrinogen III, and the release of four CO2 
molecules. Subsequently, the propionate groups at C3 and C8 are reduced to vinyl 
groups by coproporphyrinogen III oxidase to give protoporphyrinogen IX and the 
release of two CO2 molecules. The macrocyclic ring undergoes a six-electron 
oxidation to form protoporphyrin IX, inducing a change in the entire ring structure 
as shown in red. Up to this point the pathway for haem and chlorophyll are 
undifferentiated, chelation of Mg2+ directs flux towards the production of 
chlorophyll whereas chelation of Fe2+ completes haem biosynthesis.  
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1.1.3. Sirohaem 
Sirohaem (Figure 1.6) is an isobacteriochlorin. It is the prosthetic group of nitrite 
and sulfite reductases, which convert nitrite to ammonia and sulfite to sulfide 
respectively, in a six-electron reduction step. Both these reductases depend on the 
sirohaem moiety to assist in this reaction (Murphy, Siegel et al. 1974; Crane, Siegel 
et al. 1995). The absence of sirohaem from sulfite reductase therefore leads to the 
failure to reduce sulfite and phenotypically presents as a cysteine auxotrophy since it 
is sulfide that reacts with 0-acetylserine to form cysteine (Figure 1.7) (Kredich 
1987). 
 
Sirohaem, being a much less complicated cofactor, requires significantly fewer 
steps for synthesis than does cobalamin. From UIII, two SAM dependent 
methylations generate PC-2, via PC-1 (Woodcock and Warren 1996), by 
methylation at C2 then C7. PC-2 is then dehydrogenated in a nicotinamide adenine 
dinucleotide (NAD+) dependent manner to give sirohydrochlorin (SHC), which is 
then chelated with a ferrous ion to complete the synthesis of sirohaem.  
 
For a simple pathway, there are many similar enzymes that catalyse the formation 
of sirohaem, as summarized in Figure 1.8. In B. subtilis and B. megetarium, three 
monofunctional enzymes, SirA, SirC and SirB, catalyse the methylation, reduction 
and ferrochelation, respectively (Leech, Raux-Deery et al. 2002; Raux, Leech et al. 
2003). In yeast, S. cerevisiae the transformation of UIII into sirohaem is performed 
by only two enzymes; The SAM-dependent methylation of UIII is catalysed by a 
single enzyme (Met1p) but dehydrogenation and chelation steps are catalysed by a 
bi-functional enzyme, Met8p (Hansen, Muldbjerg et al. 1997; Raux, McVeigh et al. 
1999). It is notable that in some bacteria, only a single enzyme performs the 
conversion of UIII into sirohaem. In S. enterica and in E. coli a tri-functional 
enzyme, CysG, is utilized. Studies of CysG reveal that it is composed of 2 distinct 
catalytic domains, CysGA and CysGB (Spencer, Stolowich et al. 1993; Warren, Bolt 
et al. 1994; Stroupe, Leech et al. 2003). CysGA confers SAM dependent 
methylation activity transforming UIII to PC-2 and has high levels of sequence 
similarity to MET1p and SirA, which function independently (Warren, Bolt et al. 
1994; Raux, McVeigh et al. 1999). CysGB is comprised of the catalytic region 
responsible for NAD+ dependent dehydrogenation and ferrochelation. MET8p and 
SirC also display similarity to CysGB, but SirB has no sequence identity with 
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CysGB, suggesting CysG is somewhat unique in that the gene fusion event that 
created this trifunctional enzyme (Warren, Roessner et al. 1990; Warren, Bolt et al. 
1994). 
 
 
Figure 1.6: The structure of Sirohaem 
A = CH2CO2H, P = CH2CH2CO2H. 
 
 
 
 
 
Figure 1.7: The role of Sirohaem in cysteine biosynthesis 
The biosynthesis of cysteine from serine requires sulphide, produced by the 
sirohaem containing sulphite reductase, since it is sulphide that reacts with 0- 
acetylserine to form cysteine. The absence of sirohaem from sulphite reductase leads 
to failure to reduce sulphite and phenotypically presents as a cysteine auxotrophy  
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Figure 1.8: Diversity in the biosynthetic pathway of the transformation of Uroporphyrinogen III into Sirohaem in different organisms 
Depending on the organism, the conversion of UIII to Sirohaem is performed by different enzymes.  E. coli and S. enterica generate sirohaem using a 
single multifunctional enzyme (CysG) with 2 domains (CysGA and CysGB), shown in green. S. cerevisiae utilises a 2-step process (pink). B. 
megaterium and B. subtilis utilises a 3-step pathway, with SirA, SirB, SirC, shown in orange. The changes in each structure along the pathway are 
highlighted in red.    A= CH2CO2H P = CH2CH2CO2H. 
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1.1.4. Coenzyme F430 
 
Coenzyme F430 is the prosthetic group of methyl coenzyme M reductase, which 
catalyses the final step of methane formation unique to methanogenic bacteria such 
as Methanobacterium thermoautotrophicum. It is a nickel-containing yellow-
pigmented modified tetrapyrrole (Figure 1.9). The crystal structure of methyl CoM 
reductase has been resolved to 1.45 Å, and shown to contain two molecules of 
coenzyme F430. The role of coenzyme F430 in the formation of global methane has 
been well described (Ermler, Grabarse et al. 1997; Shima, Goubeaud et al. 1997) 
Despite the important role that coenzyme F430 plays in nature, very little is known 
about the synthesis of this nickel containing tetrapyrrole. Other previous work 
suggests that it is synthesised from SHC and one intermediate, 15,17(3)-seco-F430-
17 (3)-acid has been reported (Pfaltz, Kobelt et al. 1987). 
 
 
 
Figure 1.9: The structure of Coenzyme F430 
The synthesis of this molecule remains to be solved. It has two additional rings 
attached to the tetrapyrrole macrocycle, mediated by closure of the side chains. A Ni 
ion is centrally chelated to the molecule. 
 
 
 
 
 
 
 
 
Ni++
CH3 CH3
HN
NN
N
H HN
H
H2NOC
HOOC O
H
O
HOOC
COOH
COOH
COOH
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 13 
13 
1.1.5. Vitamin B12 
Vitamin B12 is one of the most important and complicated of tetrapyrroles found in 
nature. The resolution of the x-ray crystal structure of cyanocobalamin by Dorothy 
Hodgkin revealed its great complexity (Hodgkin, Pickworth et al. 1955). A cobalt 
ion is centrally ligated to the contracted macrocycle of the tetrapyrrole (rings A and 
D are bonded together), the cobalt is further bound to a modified base on the lower 
axial ligand (a dimethyl benzimidazole) and also an upper axial ligand, shown as X 
in Figure 1.10.  
 
The upper axial ligand imposes different functions to the vitamin B12 molecule. The 
presence of an upper axial cyano group is an artefact of the extraction procedure. In 
biological systems there are two principle forms, adenosyl cobalamin and methyl 
cobalamin, in which the former is used to catalyse rearrangement or reductase 
reactions and the latter methyltransferase reactions (Warren, Raux et al. 2002). 
 
The complexity in its structure is also indicative of its intricate requirement for 
approximately thirty genes for the de novo synthesis of this molecule. Vitamin B12 
synthesis is uniquely restricted to few organisms, and no known eukaryote possesses 
the ability to make cobalamin. However, eukaryotes that require cobalamin rely on 
eubacteria and archeabacteria as sources and some have evolved to have intricate 
uptake systems (Seetharam and Alpers 1982).  
 
There are two distinct alternative routes towards the synthesis of vitamin B12 in 
bacteria and archea. These are differentiated by the requirement of oxygen and the 
absence of oxygen, termed the aerobic and anaerobic pathways. The pathway from 
ALA to PC-2 is the same in both routes. The aerobic pathway incorporates 
molecular oxygen in to the macrocycle as a prerequisite to ring contraction and 
cobalt is inserted late in the pathway. The aerobic route has been extensively studied 
in Ps. denitrificans, with the isolation of intermediates and the genes required 
(Debussche, Thibaut et al. 1993; Blanche 1995). The anaerobic route is characterised 
by the early insertion of cobalt at the PC-2 stage and the oxygen independent ring 
contraction. The anaerobic route is the more ancient to its aerobic counterpart 
(Santander, Roessner et al. 1997) and has been studied in S. enterica (Raux, Lanois 
et al. 1996), B. megatarium (Raux, Lanois et al. 1998; Raux, Lanois et al. 1998; 
Raux, Schubert et al. 1998) but is incomplete. Genes from organisms that make 
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cobalamin aerobically are referred to as cob and those that make cobalamin 
anaerobically are denoted the prefix cbi. 
 
 
 
Figure 1.10: The structure of Vitamin B12  
The structure of this molecule is of a complex nature. Depending upon the function, 
X can be a methyl group, a cyano group or a 5’deoxyadenosine, bestowing the 
macrocycle with different properties. 
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1.2. Haem d1  
Haem d1 is a modified tetrapyrrole with a characteristic green colour and a centrally 
chelated iron moiety. It has many unique features that have made it a source of great 
interest for over 20 years.  
 
It is uniquely found as the prosthetic group of periplasmic bacterial dissimilatory 
nitrite reductase, also known as cytochrome cd1, catalysing the dissimilatory 
reduction of nitrite (NO2-) to nitric oxide (NO), as part of denitrification. This occurs 
in all denitrifying bacteria during anaerobic respiration. Thus, haem d1 is also 
synthesised under anaerobic conditions. On a global scale, this is a crucial step in all 
denitrifying bacteria as part of the global nitrogen cycle, where denitrification is the 
committing step responsible for the return of fixed terrestrial nitrogen to the 
atmosphere on a substantial scale (Averill 1996; Zumft 1997). 
 
The structure of haem d1 has posed more questions in recent history than it answers. 
The green colour of haem d1 lead many to assume that it possessed a chlorin core 
structure. In 1984, Timkovich et al first proposed a porphyrindione 
(dioxoisobacteriochlorin) structure (Timkovich, Cork et al. 1984; Timkovich, Cork 
et al. 1984a) and after much debate, spectroscopic analysis and chemical synthesis 
(Chang 1985; Chang and Wu 1986), the structure was proven to be that of a 
porphyrindione (Chang, Timkovich et al. 1986b). 
 
Haem d1 differs from other haems and tetrapyrrole derivatives in that its synthesis is 
mediated via a completely separate branch of the tetrapyrrole biosynthetic pathway 
from UIII (Figure 1.2). Furthermore, it is a dioxoisobacteriochlorin, as opposed to a 
porphyrin, characterised by the presence of two oxo groups at C3 and C8, methyl 
groups at C2 and C7 and an acrylate in the C17 peripheral group as depicted in 
Figure 1.11.  
 
In comparison to haem b, haem d1 differs in that two pyrrole units are more saturated 
and the presence of two keto (oxo) groups at C3 and C8 alters the π-orbital 
configuration around the macrocycle; further saturation is observed with an acrylate 
in the C17 peripheral group. Such features give haem d1 unique properties not shared 
by other haems. In particular, the presence of the oxo groups acts to pull down the π-
stack to bring the redox potential of haem d1 closer to the parent porphyrin and thus 
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more positive than those of other porphyrin haems (Chang, Hanson et al. 1981). It 
has recently been resolved to be + 175mV in Paracoccus pantotrophus, by way of 
shifting the c-haem to – 60mV (Zajicek, Cartron et al. 2006). This redox property is 
advantageous for the ease of substrate reduction that haem d1 partakes in (Section 
1.2.1). Furthermore, the oxo groups make the macrocycle harder to oxidise. 
 
A link to the tetrapyrrole pathway was established by the stereoselective synthesis of 
haem d1 which showed the absolute configuration at C2 and C7 matched the 2R, 7R 
configuration also seen in PC-2, sirohydrochlorin (SHC), and vitamin B12 
(Micklefield 1993; Micklefield 1997). The introduction of [13C-methyl] methionine 
to the growth medium of Ps. aeruginosa showed that the methyl groups at C2 and 
C7 are derived from S-adenosyl-L-methionine (SAM) (Yap-Bondoc, Bondoc et al. 
1990). This is in a similar fashion to vitamin B12, sirohaem and coenzyme F430, 
thereby connecting haem d1 synthesis to UIII and PC-2 in the tetrapyrrole pathway. 
 
Figure 1.11: The structure of Haem d1 
The structure of haem d1 is characterised by the presence of two oxo groups at C3 
and C8, methyl groups at C2 and C7, and an acrylate in the C17 peripheral group 
and a centrally chelated iron. 
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1.2.1.  Haem d1 in cytochrome cd1 
Haem d1 is the prosthetic group of periplasmic bacterial dissimilatory nitrite 
reductase or cytochrome cd1. It has also previously been referred to as cytochrome 
oxidase due to its catalysis of oxygen to water (Horio, Higashi et al. 1961; 
Silvestrini, Falcinelli et al. 1994). 
 
Cytochrome cd1 is a soluble homodimeric enzyme of 120 kDa. It is a bifunctional 
enzyme that catalyses both the one electron reduction of nitrite to nitric oxide (1) 
and the in vitro four electron reduction of oxygen to water (2) 
  NO2¯ + 2H+ + e¯   NO + 2H2O    (1)  
  O2 + 4H+ + 4e¯    2H2O            (2) 
As the name suggests, each equivalent monomer of 60kDa contains a covalently 
bound c-type haem via two Cys residues, and a non-covalently bound haem d1 
(Kuronen and Ellfolk 1972; Gudat, Singh et al. 1973; Averill 1996). There exists a 
wealth of experimental evidence suggesting that the haem d1 iron moiety provides 
the active centre for nitrite reduction and oxygen reduction, and haem c is the site of 
electron entry from donors such as azurin, pseudoazurin and cytochrome c551 
(Silvestrini, Tordi et al. 1990; Fulop, Moir et al. 1995; Baker, Saunders et al. 1997; 
Williams, Fulop et al. 1997; George, Allen et al. 2000; Pearson, Page et al. 2003; 
Ferguson 2009). 
The 3D crystal structures of cytochrome cd1 have been determined from Pa. 
pantotrophus (previously Thiosphaera pantotropha) (Fulop, Moir et al. 1995), 
(Figure 1.12), and Ps. aeruginosa (Nurizzo, Silvestrini et al. 1997). The monomers 
consist of two structural domains: an N-terminal α-helical c-domain and a C-
terminal ß-propeller d1 domain, where the d1 haem is held within an eight bladed ß-
propeller structure (Figure 1.13) (Baker, Saunders et al. 1997). In spite of similar 
architecture, the structure of the haem binding sites differs significantly in the two 
enzymes from each organism (Cheesman, Ferguson et al. 1997). In the oxidised Pa. 
pantotropha cytochrome cd1, His17 and His69 provide the axial iron ligands for 
haem c; His200 is a fifth axial iron ligand for haem d1. An unusual feature of 
cytochrome cd1 is that the main chain of the c domain extrudes into the d1 domain, 
providing Tyr25 as the sixth axial iron ligand for haem d1 (Fulop, Moir et al. 1995). 
Reduction, allows Tyr25 to be released and allow substrate binding to haem d1; 
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concomitantly, a refolding of the c domain takes place, resulting in a switch of one 
haem c iron ligand from His17 to Met106 (Williams, Fulop et al. 1997). In the 
oxidised Ps. aeruginosa and Ps. stutzeri protein, His51 and Met88 provide the axial 
iron ligands for haem c and His182 provides the fifth axial iron ligand for haem d1. 
The hydroxide ion, hydrogen bonded to Tyr10, is a sixth axial iron ligand for haem 
d1 (Cheesman, Ferguson et al. 1997). Interestingly, no ligand exchange has been 
observed in Ps. aeruginosa cytochrome cd1, but a conformational change has been 
observed on binding of the substrate (Nurizzo, Silvestrini et al. 1997; Nurizzo, 
Cutruzzola et al. 1998; Nurizzo, Cutruzzola et al. 1999). Mutational analysis has 
implicated the requirement of His327 and His369 in the activity of the enzyme 
(Cutruzzola, Brown et al. 2001). 
Thus, although both sources of cytochrome cd1 share a similar function they have 
different haem ligands. Clearly, the presence of a tetrapyrrole as intricate the d1 
haem within this single enzyme with different ligands has evolved for a specific 
purpose and poses a catalytic advantage in the reduction of nitrite to nitric oxide. 
 
Figure 1.12 Cytochrome cd1 structure  
Ribbon representation of Pa. pantotrophus cytochrome cd1 homodimeric structure. 
Colour codes: chain A = orange; chain B = violet.  The haem c and haem d1 domains 
with the bound structures are indicated. Adapted from (Fulop, Moir et al. 1995). 
 
 
   
 
 
 
 
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 19 
19 
 
Figure 1.13: ß-propeller d1 domain structure 
Cytochrome cd1 β-propeller d1 domain (residues 135-624) shows the location of the 
d1 haem held non-covalently within the centre of the pocket. It is an eight bladed β-
propeller structure. Adapted from (Fulop, Moir et al. 1995). 
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1.2.2. Denitrification  
Denitrification is an important chemical transformation in the global nitrogen cycle 
converting nitrate, NO3-, to nitrogen gas, N2, in four sequential steps. It is the only 
process substantially returning fixed terrestrial nitrogen to the atmosphere being 
sustained by bacteria, to complete the nitrogen cycle. Moreover, denitrification 
contributes to the greenhouse effect (Lashof 1990; Hernandez-Ramirez, Brouder et 
al. 2009) and has been linked to the destruction of the ozone layer (Waibel, Peter et 
al. 1999), both being key environmental issues. 
Denitrification is the anaerobic use by facultative bacteria, of nitrogen oxide species 
as alternative terminal electron acceptors during respiration in the place of O2, for 
the generation of the electrochemical gradient across the cytoplasmic membrane 
(Ye, Averill et al. 1994; Berks, Ferguson et al. 1995b). The most detailed 
chromosomal map of a denitrifying bacterium is that of Ps. aeruginosa (Holloway, 
Romling et al. 1994), of which those for anaerobic respiration and denitrification are 
mapped (Vollack, Xie et al. 1998).  Much work has focused on the identification of 
denitrifying genes in Ps. aeruginosa, Ps. stutzeri, Ps. fluoresens and Pa. 
denitrificans and has been reviewed (Averill 1996; Zumft 1997; Baker, Ferguson et 
al. 1998; Philippot 2002). Denitrification also extends beyond bacteria to archea, and 
is found in halophilic and hyperthermophilic archea (Philippot 2002). 
The process of denitrification is the reduction of nitrate (NO3-) to nitrite (NO2-), 
catalysed by nitrate reductase; NO2- to nitric oxide (NO), by nitrite reductase; NO to 
nitrous oxide (N2O) by nitric oxide reductase, and then N2, by nitrous oxide 
reductase. The genes encoding these functions for nitrate respiration (nar), nitrite 
respiration (nir), NO respiration (nor), and N2O respiration (nos) are assembled in 
clusters in Ps. stutzeri (Jungst, Braun et al. 1991; Braun and Zumft 1992), Ps. 
aeruginosa (Arai, Igarashi et al. 1995) and Pa. denitrificans (de Boer, Reijnders et 
al. 1994; Berks, Page et al. 1995; de Boer, van der Oost et al. 1996). The reduction 
of the nitrogen oxide species (red) at each step is shown below; the enzymes (blue), 
each utilise a metal cofactor contributing in the reaction. 
 
                                  NITRATE                                   NITRITE                              NITRIC OXIDE                      NITROUS OXIDE                                                 
                                     REDUCTASE                             REDUCTASE                             REDUCTASE                             REDUCTASE                        
NITRATE                    NITRITE                 NITRIC OXIDE             NITROUS OXIDE            NITROGEN   
                               
 
NO3- NO2- NO* N2 N2O 
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1.2.3. The denitrification enzyme system 
The first step is catalysed by dissimilatory nitrate reductase (NaR), where a 
molybdenum cofactor provides the active site, to convert NO3- to NO2- (Hille 1996). 
The reduction of NO2- to NO is performed by dissimilatory nitrite reductase (NiR), 
where haem d1 is the active centre for the reaction. This is considered to be the 
committing step as it leads to a very reactive intermediate NO radical, possessing 
distinct chemical radical species properties that essentially are detrimental to the 
host, thus the process of denitrification has been committed. The presence of nitric 
oxide as a free intermediate has been a point of controversy, but the evidence for NO 
as an obligatory intermediate is now conclusive (Zumft 1993; Ye, Averill et al. 
1994). Nitric oxide reductase (NoR) removes NO by converting it to N2O with the 
aid of two b type haems. Finally, N2 is formed by the reduction of N2O by nitrous 
oxide reductase (NoS), a multicopper enzyme.  
Since these reactions are sequential it lends to the theory that they are performed in 
proximity to each other to facilitate sequential reactions with minimal toxicity. The 
organisation of these enzymes, particularly in gram-negative bacteria, such as 
Pseudomonads (facultative anaerobes) and Paracoccus (aerobe) has been well 
studied (Zumft 1997). The combined evidence as determined by cell fractionation, 
antibody labelling and electron microscopy (Coyne, Arunakumari et al. 1990; 
Korner and Mayer 1992; Zumft 1997) has been depicted in Figure 1.14. This model 
applies to Ps. aeruginosa, Ps. stutzeri and Paracoccus genus. 
The first enzyme NaR, is situated in the cytoplasmic membrane with the active site 
exposed towards the cytoplasmic side (Carlson, Ferguson et al. 1982; Bell, 
Richardson et al. 1990), whereby the presence of NiR in the periplasmic space 
necessitates first the transport of NO3- across the periplasm and cytoplasmic 
membrane, to be reduced to NO2-; Then its transportation to the periplasmic space 
which is postulated to be performed by a NO3-/NO2- antiporter. 
NiR studied from Ps. stutzeri and Ps. fluoresens and NoS from Ps. stutzeri, have 
been shown to reside in the periplasmic space by immunochemical location (Coyne, 
Arunakumari et al. 1990; Korner and Mayer 1992; Zumft 1997). NiR in particular 
has been shown to be strongly associated with the cytoplasmic membrane of Ps. 
aeruginosa (Yamanaka 1992).  
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NoR has been localised to the inner membrane, whereby the reaction of NO to N2O 
occurs on the periplasmic side (Bell, Richardson et al. 1990). This may have evolved 
as an evolutionary function so as to protect the cytoplasmic contents from radical 
/oxidative stress, as both NO and NO2- are toxic to the cell. 
 
Figure 1.14: Topology of the denitrification system in all denitrifying bacteria. 
Initially, the transport of NO3- through the periplasmic space and the cell membrane 
(1) is required for NaR, embedded in the membrane to reduce NO3- to NO2- on the 
cytoplasmic side (2). Nitrite then needs to be transported to the periplasmic space 
(3), probably via a NO3-/NO2- antiporter (AP), to be reduced to NO by NiR (4). NO, 
a species detrimental to the host, is converted to N2O in the periplasm by the 
membrane enzyme NoR (5). Finally, N2O is converted to N2 in the periplasm by 
NoS (6). Adapted from (Averill 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7
 
  NiR 
 
  NoS 
 
NoR NaR
 
AP 
 
NO3
NO2
N2O 
NO*
N2
NO2NO2
NO2
NO3
NO3
NO2 NO* N2O N2
GLOBAL N2
1 
2
3 
4
5
6 
   
   
 P
ER
IP
L
A
SM
 
 C
Y
T
O
PL
A
SM
IC
 
 M
EM
B
R
A
N
E 
C
Y
TO
PL
A
SM
 
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 23 
23 
1.3. The biosynthesis of Haem d1 
1.3.1. Synthesis of 5-aminolaevulinic acid (ALA) 
The first committed precursor in the biosynthesis of all tetrapyrroles is the synthesis 
of 5-aminolaevulinic acid (ALA). ALA is synthesised by one of two routes. In 
animals and photosynthetic bacteria (except higher plants and algae), succinyl 
coenzyme A and glycine condense to form ALA in a reaction catalysed by ALA 
synthase (HemA) with the loss of the carbonyl carbon of glycine (decarboxylation). 
This is known as the C-4 pathway, also called the Shemin route mediated by the 
hemA gene and requires pyridoxal phosphate as a co-factor (Figure 1.15). (Shemin 
1946; Shemin 1989). Higher plants, algae, cyanobacteria and several other 
photosynthetic and non-photosynthetic bacteria and archea produce ALA by the C-5 
pathway, a multi-enzyme pathway that requires glutamyl-tRNA (tRNAGlu) (Schon, 
Krupp et al. 1986; Kannangara, Gough et al. 1988).  
 
In Ps. aeruginosa and Ps. stutzeri the Shemin pathway is shown to not be operative 
in the synthesis of ALA but the C-5 pathway is employed (Matthews 1993; 
Hungerer, Troup et al. 1995a; Hungerer, Troup et al. 1995b).  Here, ALA is 
synthesised from the intact carbon skeleton of glutamate by a multi-enzyme 
pathway. Binding tRNAGlu with ATP-dependant glutamyl-tRNAGlu synthetase 
activates Glutamate at the α-carboxyl. An NADPH-dependent reductase (HemA) 
converts glutamyl-tRNAGlu to glutamate 1-semialdehyde, which is then transformed 
by glutamate 1-semialdehyde (GSA) aminotransferase (HemL) into ALA (Figure 
1.16) (Huang and Wang 1986; Kannangara, Gough et al. 1988; Hennig, Grimm et al. 
1997).  
 
In Ps. aeruginosa and Ps. stutzeri the genes are mapped for hemA (Hungerer, Troup 
et al. 1995a) and hemL (Hungerer, Troup et al. 1995b), which are required for the 
synthesis of ALA. In Pa. denitrificans hemA has also been identified (Page and 
Ferguson 1994). Both hemA and hemL transcription is increased during 
denitrification in response to low oxygen and the presence of nitrate (Hungerer, 
Troup et al. 1995a; Hungerer, Troup et al. 1995b). 
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Figure 1.15: Biosynthesis of ALA via the C-4 Shemin route  
Succinyl CoA and glycine condense to form ALA with a decarboxylation reaction. 
The reaction is catalysed by ALA synthase (HemA) and requires pyridoxal 
phosphate (PAP). 
  
 
 
 
Figure 1.16: Biosynthesis of ALA via the C-5 route 
ALA is formed from glutamate by this pathway. Glutamate binds tRNAGlu with 
glutamyl-tRNAGlu synthetase and NADPH-dependent reductase (HemA) converts 
glutamyl-tRNAGlu to glutamate 1-semialdehyde, which is then transformed by 
glutamate 1-semialdehyde (GSA) aminotransferase (HemL) into ALA. 
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1.3.2. Synthesis of the first macrocyclic intermediate, uroporphyrinogen III 
(UIII) from 5-aminolaevulinic acid (ALA) 
The transformation of ALA to UIII is common to all organisms. The genes encoding 
the enzymes required for this transformation have been discovered in a number of 
denitrifying bacteria as prerequisite to tetrapyrrole biosynthesis. The genes necessary 
are hemB, hemC and hemD that encode for the enzymes ALA dehydratase, 
porphobilinogen (PBG) deaminase and UIII synthase respectively (Figure 1.17). All 
hemB, hemC and hemD have been identified in Ps. aeruginosa.  
 
Firstly, HemB (ALA dehydratase) catalyses the condensation of two molecules of 
ALA to form PBG, the first pyrrole structure. Next, HemC (PBG deaminase), 
catalyses the head to tail polymerisation of four molecules of PBG, leading to the 
generation of an open linear tetrapyrrole molecule named either 
hydroxymethylbilane (HMB) or preuroporphyrinogen. UIII is subsequently 
synthesised from preuroporphyrinogen by HemD (UIII synthase), which closes the 
tetrapyrrole to form the macrocyclic ring after inversion of ring D (Figure 1.17) 
(Warren and Scott 1990).  
 
UIII is the last common intermediate from which the pathway branches to form the 
various modified tetrapyrroles. Each tetrapyrrole differs in its conjugation state, ring 
structure and chelated metal through the unique modification of the macrocycle from 
UIII. Enzymes specific to each pathway enable this and therefore bestow a wide 
range of structures and functions and unique properties. Decarboxylation of its 
acetate groups directs flux toward haem and chlorophyll synthesis whereas 
methylation of the macrocycle initiates synthesis toward a separate branch for 
sirohaem, vitamin B12, and haem d1 synthesis. A brief summary of the pathways 
deviating from UIII is shown in Figure 1.18. 
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Figure 1.17: The biosynthetic conversion of ALA to UIII 
ALA is converted to UIII via 3 enzymatic steps. Two molecules of ALA condense to 
form PBG in a reaction catalysed by the Zn/Mg-dependent enzyme ALA 
dehydratase (ALAD) encoded for by hemB. Four molecules of PBG then polymerise 
forming the linear tetrapyrrole, pre-UIII or HMB (releasing ammonia). This 
reaction, catalysed by HemC, inverts the terminal ring forming the type III 
stereoisomer. The tetrapyrrole macrocycle is circularised by the closure of the 
tetrapyrrole ring, forming UIII. A = CH2CO2H, P = CH2CH2CO2H  
 
 
Figure 1.18: Summary of the tetrapyrrole pathway from UIII  
 
 
 
 
 
 
 
UROPORPHYRINOGEN III 
 
      COPROPORPHYRINOGEN III   PRECORRIN-2 
                                                                               Co2+                            Ni 2+    
 
     PROTOPORPHYRIN IX                             Vit B12                              Coenzyme F430     
               Fe2+           Mg2+                                            Fe2+     
 
      HAEM         CHLOROPHYLL                     SIROHAEM    HAEM d1 
ALA dehydratase
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 27 
27 
1.3.3. The methylation of uroporphyrinogen III (UIII) and the formation of 
precorrin-2 (PC-2) 
Sirohaem, vitamin B12, and F430 all require the methylation of UIII as part of their 
synthesis to form PC-2, also known as dihydrosirohydrochlorin. This reaction is 
catalysed by an enzyme specific to the process called S-adenosyl-L-methionine 
uroporphyrinogen III methyltransferase (SUMT). SUMT refers to a group of 
enzymes that have each evolved for a specific tetrapyrrole pathway but catalyse the 
same reaction. 
As reflected in their name, all SUMT enzymes utilise S-adenosyl-L-methionine 
(SAM) as the methyl donor to insert two methyl groups onto the UIII macrocycle. 
This is executed by the subsequent methylation of UIII at the base of the acetate side 
chains at positions C2 and C7 to yield PC-2. This has been shown to occur via a 
mono-methylated intermediate Precorrin-1 concomitant with the release of the 
product S-adenosyl-L-homocysteine (SAH). Precorrin-1 is in turn methylated to 
produce the bis-methylated PC-2 (Figure 1.19) (Warren, Stolowich et al. 1990). 
 
Figure 1.19: The transformation of UIII to PC-2 via PC-1 
Analysis reveals that the transformation from UIII to PC-2 involves two SAM 
dependent methylations, firstly at C2 and then C7, catalysed by SUMT enzymes. 
This is achieved via a mono-methylated intermediate Precorrin-1 (PC-1) with the 
release of S-adenosyl-L-homocysteine (SAH), which is in turn methylated to 
produce the bis-methylated PC-2. A = CH2CO2H, P = CH2CH2CO2H. 
 
There exist a plethora of SUMT enzymes that have been discovered in different 
organisms and plants that perform this transformation. The most well known and 
well studied is CobA. 
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1.3.3.1. CobA in the vitamin B12 pathway 
The first SUMT to be characterised was CobA from Ps. denitrificans (Blanche, 
Debussche et al. 1989). It is a SUMT responsible for the C2 and C7 corrin ring 
methylations in the conversion of UIII into PC-2, in the vitamin B12 pathway. PC-2 
represents the point at which the aerobic and anaerobic pathways diverge in their 
separate routes to cobalamin.  Both pathways differ in the timing of metal insertion, 
method of the ring contraction and mechanism of carbon extrusion. The aerobic 
pathway is characterised by the requirement of molecular oxygen for the ring 
contraction (CobG) and subsequent release of acetic acid. The insertion of cobalt 
occurs late in this pathway and requires an ATP-dependent trimeric enzyme 
(CobNST). The anaerobic pathway, in contrast, inserts cobalt very early in the 
pathway (CbiK or CbiX) using considerably smaller, monomeric enzymes. It has no 
requirement for oxygen and less is known of the anaerobic pathway but is well 
reviewed (Warren, Raux et al. 2002; Frank, Brindley et al. 2005; Warren 2006). 
 
Ps. denitrificans CobA is a homodimer with a subunit mass of 29kDa and a low 
catalytic efficiency (38/h) (Blanche, Debussche et al. 1989). The structure of this 
enzyme has been resolved to 2.7 Ǻ with the product, SAH, still bound in the crystal 
(Figure 1.20) (Vevodova, Graham et al. 2004).  
 
Figure 1.20: The structure of CobA from Ps. denitrificans 
The homodimeric structure of CobA. Two domains are shown with the SAH ligand 
bound in the center of the proposed substrate-binding site. Each unit has five-
stranded β-sheets with five associated a-helices, and are made up of β-α repeating 
motifs.(Vevodova, Graham et al. 2004) 
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 29 
29 
1.3.3.2. CysGA in E. coli and S. enterica in the sirohaem pathway  
Sirohaem requires significantly fewer steps for synthesis than does cobalamin. From 
UIII, two SAM dependent methylations at C2 then C7 generate PC-2, via PC-1 
(Woodcock and Warren 1996). PC-2 is then dehydrogenated in a NAD+ dependent 
manner to give sirohydrochlorin (SHC), which is subsequently chelated with a 
ferrous ion to complete the synthesis of sirohaem.  Sirohaem synthase or CysG is a 
unique multifunctional enzyme encompassing all these properties to transform UIII 
into sirohaem in E. coli and S. enterica (Peakman, Crouzet et al. 1990; Warren, 
Roessner et al. 1990; Wu, Siegel et al. 1991). 
 
E. coli CysG is a 457 amino acid protein which can be described in terms of two 
functional domains; CysGA the C-terminal catalytic domain (amino acids 202-457-
29KDa), which confers the transmethylase activity, and CysGB, the N-terminal 
catalytic domain (amino acids 1-201) which performs the dehydrogenation of SHC 
and ferrochelation reactions (Peakman, Crouzet et al. 1990; Warren, Roessner et al. 
1990; Spencer, Stolowich et al. 1993; Warren, Bolt et al. 1994)  
 
E. coli and S. enterica CysG have 90% similarity to each other at the primary 
structure level. Similar to CysG from E. coli, S. enterica CysG can be described as 
having two functional domains; CysGB (amino acids 1-214) conferring 
dehydrogenation and ferrochelatase activity and CysGA that mediates 
transmethylase activity (amino acids 215-457) (Warren, Bolt et al. 1994). The 
structure of CysG from S. enterica has been resolved to 2.2 Å (Figure 1.21) 
(Stroupe, Leech et al. 2003). Resolving the structure of the CysGA domain revealed 
a resemblance to the structure of CbiF, a cobalt precorrin-4 methyltransferase 
enzyme from B. megatarium of the cobalamin pathway (Schubert, Wilson et al. 
1998). Again, the structure was of a homodimer with two equivalent domains. 
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Figure 1.21: The structure of CysG from S. enterica 
The homodimeric structure of CysG is shown here from a NAD+ co-crystal 
structure. Each subunit is blue or green, where CysGB at the top (IB) is more lightly 
coloured and CysGA at the bottom (IA) is darkly coloured. The NAD and SAH are 
shown as orange. The linker regions from the blue and green subunits are purple and 
yellow respectively (Stroupe, Leech et al. 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vina Parmar                                                   Chapter 1: Introduction to tetrapyrroles and haem d1: page 31 
31 
1.3.3.3. SirA in Bacilli in the sirohaem pathway 
In Bacilli there are three separate enzymes responsible for the conversion of UIII 
into sirohaem, a methyltransferase, dehydrogenase and a chelatase. This is in 
contrast to the fused multifunctional CysG. (Leech, Raux-Deery et al. 2002) B. 
subtilis uses three proteins that are in a distinct gene cluster, YInD, the SUMT, 
YlnF, the PC-2 dehydrogenase and YlnE, the SHC ferrochelatase (Johansson and 
Hederstedt 1999).      
In B. megatarium, the SUMT analogous to the P. denitrificans CobA was first 
identified in 1991 (Robin, Blanche et al. 1991). This SUMT of the sirohaem operon 
has since been renamed SirA and confirmed to be the UIII methyltransferase by 
mutation and complementation analysis as well as sequence analysis with other 
well-characterized SUMTs such as CobA and CysGA. (Leech, Raux-Deery et al. 
2002; Raux, Leech et al. 2003). The other enzymes needed to complete the synthesis 
of sirohaem in B. megaterium have also been identified; SirC, a PC-2 dehydrogenase 
and SirB, a ferrochelatase. Subsequently, the isofunctional B. subtilis enzymes are 
renamed: YlnD as SirA, YlnF as SirC and YlnE as SirB (Raux, Leech et al. 2003). 
 
1.3.3.4. Met1p in Saccharomyces cerevisiae in the sirohaem pathway 
In S. cerevisiae two genes have been identified for the transformation of UIII into 
sirohaem, MET1 and MET 8. Sirohaem is used exclusively in sulfite reduction, as 
this organism does not possess a nitrite reductase. (Hansen, Muldbjerg et al. 1997; 
Raux, McVeigh et al. 1999). MET1 encodes the SUMT, Met1p (~65kDa) that has 
593 amino acids, larger than the 457 amino acid CysG.  Sequence comparisons 
showed the C-terminus (amino acids 326-556) is similar to the domain of CysG 
conferring SUMT activity, CysGA.  MET8 encodes for the bifunctional enzyme 
Met8p (~32kDa), a NAD+-dependent PC-2 dehydrogenase and a ferrochelatase. The 
structure of Met8p was resolved to 2.2 Å in 2002 which also portrayed a 
homodimeric structure (Schubert, Raux et al. 2002).   
 
1.3.3.5. CorA in Methanobacterium ivanovii 
CorA is also a homodimer with a subunit mass of 29kDa found to have SUMT 
activity in M. ivanovii. In contrast to CobA from B. megaterium and Ps. 
denitrificans that exhibited low [UIII] substrate inhibition, CorA from M. ivanovii is 
inhibited by [UIII] of close to 20 μM. It is perceived that since methanogens require 
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such high levels of tetrapyrrole coenzyme F430 that inhibition does not occur at low 
UIII substrate concentrations, to allow greater flux through the pathway (Blanche, 
Robin et al. 1991). 
 
1.3.3.6. UPM1 from A. thaliana and ZmSUMT1 from maize  
Tetrapyrrole biosynthesis in plants is crucial to plant metabolism (Tanaka and 
Tanaka 2007). Higher plants such as A. thaliana synthesize the major tetrapyrroles 
chlorophyll, haem, and sirohaem. UIII is either methylated and iron is inserted to 
form sirohaem or it is oxidatively decarboxylated to form protoporphyrin IX. 
Insertion of Fe2+ into protoporphyrin IX leads to haem whereas insertion of Mg2+ is 
leads to the chlorophyll branch. (Vavilin and Vermaas 2002). Sirohaem is the 
cofactor for two chloroplast enzymes nitrite and sulphite reductases (Murphy, Siegel 
et al. 1974).  All tetrapyrroles are synthesized in the chloroplast, or plastids in non-
photosynthetic cells, with the exception that the last two steps of haem synthesis are 
also found in mitochondria (Smith and al 1999). 
 
UPM1p from A. thaliana has been isolated and identified as an SUMT as part of the 
sirohaem biosynthetic pathway and shown to be ~40kda conferring ~43% homology 
to E. coli CysGA. A sequence has been identified to resemble a transit peptide for 
localization to plastids. The protein produced by in vitro expression is able to enter 
isolated intact chloroplasts but not mitochondria. Sirohydrochlorin chelatase At-SirB 
is also localised in the plastids. The search for a sirohydrochlorin dehydrogenase 
continues to complete the sirohaem pathway in A. thaliana (Leustek, Smith et al. 
1997; Raux-Deery, Leech et al. 2005).  
 
Similarly, ZmSUMT1 from maize was isolated. The purified mature ZmSUMT1 
revealed a molecular mass of 52kDa using gel-filtration chromatography. It confers 
about 50 % homology to the E. coli CysGA. ZmSUMT1 was also shown to be 
transported to plastids, indicating the synthesis of sirohaem occurs in plastids too but 
further analysis is required to deduce how sirohaem is manufactured (Sakakibara, 
Takei et al. 1996; Fan, Wang et al. 2006).   
 
Clearly, the presence of different SUMT enzymes specific to each pathway is a 
highly evolved mechanism of regulation of tetrapyrrole biosynthesis, and therefore 
flux through these pathways. 
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1.3.4. The biosynthesis of haem d1 
As already mentioned, the synthesis of haem d1 proceeds from ALA via UIII as with 
all other tetrapyrroles. The precise mechanism of transformation from UIII to haem 
d1 poses a great challenge and is less well characterised. A distinct lack of 
information exists regarding the prerequisite intermediates for the formation of haem 
d1 and as to how the aforementioned atypical substituents are introduced into the 
macrocycle. Of particular interest is the incorporation of the oxygen onto the 
macrocycle under anaerobic conditions. As a direct result resolving the synthesis of 
haem d1 has attracted much interest, but no true intermediates have been isolated, 
but is very desirable. 
Examination of both structures reveal the transformation from UIII to haem d1 
necessitates methylation at C2 and C7; decarboxylation of the acetate side chains at 
C12 and C18; loss of the propionic side chains at C3 and C8 with subsequent 
oxidation at C3 and C8; dehydrogenation of the C17 propionate side chain to give 
the acrylate substituent and ferrochelation (Figure 1.23). 
Mutation and complementation analysis of the nir genes have implicated a 
requirement of seven nir genes for haem d1 biogenesis that are found as an operon, 
called nirE, nirJ, nirH, nirG, nirL, nirD and nirF. Mutational analysis in Ps. stutzeri 
revealed that if any one or all nir genes are defective it results in an inactive semi 
apoform of cytochrome cd1, lacking haem d1 but containing haem c (Palmedo, 
Seither et al. 1995). In Ps. aeruginosa mutational analysis as well as 
complementation, both implicated the same requirement of the seven nir genes for 
haem d1 biosynthesis (Kawasaki, Arai et al. 1995; Kawasaki, Arai et al. 1997).  
Reconstitution of cytochrome cd1 with native haem d1 has been shown to restore 
nitrite reductase activity in both Ps. stutzeri and Ps. aeruginosa by 82 % and 95 % 
respectively. While reconstitution with synthetic haem d1 has been shown to restore 
nitrite reductase activity to 77 % in Ps. stutzeri. Significantly, no other haem can 
substitute for haem d1, except for haem a but only 5 % activity is restored (Hill and 
Wharton 1978). Reconstitution with synthetic haem d1 lacking the oxo groups 
showed that removal of only one carbonyl resulted in complete loss of activity and 
removal of the acrylate resulted in a loss 60 % activity (Chang 1994). Clearly, the 
stereo specificity of the haem d1 macrocycle and its unique peripheral groups are 
relevant to the enzymes performance.  
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In Ps. stutzeri the genes for haem d1 biosynthesis are located over two loci, nirJEN 
and nirCFDLGH, which respectively lie upstream and downstream of the structural 
NiR gene nirS (Palmedo, Seither et al. 1995). In Ps. aeruginosa the same genes, 
nirCFDLGHJEN are found in one locus downstream of nirS and may encode the 
entire set of proteins required for the formation of haem d1 (Kawasaki, Arai et al. 
1995; Kawasaki, Arai et al. 1997). In Pa. denitrificans, the presence of nirECFD 
downstream of nirS has been well documented (Baker, Ferguson et al. 1998; 
Philippot 2002). It is further proposed that NirF and NirD are fused within this 
organism (de Boer, Reijnders et al. 1994; Palmedo, Seither et al. 1995). The nir 
operons are diagrammatically represented in Figure 1.22. 
 
Figure 1.22: The organisation of haem d1 genes within the operon.  
An illustration of the nir operon from Ps. aeruginosa, Ps. stutzeri and Pa. 
denitrificans. Block arrows show the direction of transcription and homologues are 
shown in the same colour. The genes have not been drawn to scale. Nir I and X are 
shown to be involved in transcriptional regulation of the operon. 
 
Ps. aeruginosa   
 
 
  Ps. stutzeri 
 
 
 
Pa. denitrificans 
 
 
 
 
The discovery of the genes required in the biosynthesis of haem d1 was significant. 
However, in the past ten years, very little has been revealed about the structure and 
function of the proteins that they encode, and indeed any intermediates they may 
synthesise. Comparative analysis to known proteins of some similarity gives little 
indication as to their structure and the reactions they may catalyse. Therefore 
resolving the structure of these proteins would be advantageous, especially in 
determining function and furthermore any intermediates they may catalyse in the 
haem d1 pathway. 
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1.3.4.1. NirE as a SUMT  
It is reported that the gene product of nirE encodes for a SUMT. This is supported 
by the similarity it shares with other methyltransferases that have been purified and 
characterised from different sources such as CobA and CysG (Blanche, Debussche 
et al. 1989; Blanche, Robin et al. 1991; Vevodova, Graham et al. 2004). nirE was 
first discovered in Pa. denitrificans, downstream of nirS (de Boer, Reijnders et al. 
1994). It has since been found in Ps. aeruginosa (Kawasaki, Arai et al. 1997; 
Vollack, Xie et al. 1998) and in Ps. stutzeri (Palmedo, Seither et al. 1995). 
 
Although sequence identity indicates that nirE encodes an S-adenosyl-L-methionine 
dependent uroporphyrinogen III methyltransferase, the activity of NirE has never 
been proven to transform UIII to PC-2. Only from mutational and complementation 
studies, has it been shown that nirE is essential for haem d1 as the lack of it perturbs 
biosynthesis (Palmedo, Seither et al. 1995; Kawasaki, Arai et al. 1997). The growth 
of Ps. aeruginosa on [13C] methionine, indicated methionine to be the source of the 
methyl groups at C2 and C7 and that C-methylation occurs as part of the route to 
haem d1 (Yap-Bondoc, Bondoc et al. 1990). The methylation of UIII to form PC-2 is 
common to the vitamin B12 and sirohaem pathways suggesting UIII is the pre-cursor 
haem d1, and that its synthesis is therefore likely to proceed via PC-2. However, the 
pathway from PC-2 remains unclear (Figure 1.23). 
 
Experiments using labelled ALA showed the origin of the haem d1 macrocycle, 
including the carbonyls at C3 and C8 is derived from ALA only, except for the C2 
and C7 methyl groups that are from SAM (Matthews 1993). The exact stereo-
specificity of the methyl groups on haem d1 was found to be exactly the same as 
vitamin B12, sirohaem and its intermediates, in the absolute configuration of 2R, 7R. 
This further substantiates a connection to the tetrapyrrole pathway implicating that 
methylation occurs as part of the haem d1 pathway (Micklefield 1997). 
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Figure 1.23: The transformation from UIII to form haem d1  
Analysis reveals that the transformation from UIII, is catalysed by NirE, and 
involves methylation at C2 and C7 (a), yielding PC-2. Further modifications include: 
(b) decarboxylation of the acetate side chains at C12 and C18; (c) loss of the 
propionic side chains at C3 and C8; (d) subsequent oxidation at C3 and C8; (e) 
dehydrogenation of the C17 propionate side chain to give the acrylate substituent; (f) 
ferrochelation. 
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1.3.4.2. The enigma of haem d1 biosynthesis. 
 Recent papers have reported many different hypotheses on the pathway for haem d1 
from UIII. Each is different and forms its own conclusions with a few similarities. 
One looks at a possible intermediate whilst another forms very different conclusions 
on the enzymes required to synthesise haem d1. 
 Only one putative intermediate thus far has been isolated (Youn, Liang et al. 2004). 
This species, termed Compound 800, shown in Figure 5.1 (page 171), after the 
unique mass of its methyl ester derivative, has not been constructively put into a 
possible sequence of events in the pathway to haem d1. They had initially assumed 
that NirFDLGH from Ps. stutzeri would be sufficient for haem d1 synthesis in the 
correct host such as E. coli and checked for haem d1 precursors assuming that E. coli 
CysG would be sufficient for SUMT activity, but it was to no avail. The addition of 
cell extract from E. coli containing overproduced CysG did not produce any new 
tetrapyrroles. Similarly, Ps. aeruginosa with the NirFDLGH plasmid had no effect 
on the level of haem d1 synthesis but a new tetrapyrrole, C800, was observed when 
cell extracts of Ps. aeruginosa with NirFDLGH and cell extract of SUMT from D. 
vulgaris were incubated anaerobically with SAM and UIII. Interestingly, there is no 
mention of the use of NirE as the SUMT, particularly as it has been well 
documented to be the preferred SUMT for this pathway and thus the use of D. 
vulgaris SUMT is debatable. NirJ has been omitted in these investigations, but it is 
clearly necessary for haem d1 biosynthesis. Manipulation of C800 with strong acid 
and heat converted it to haem d1, however these are non-physiological conditions 
and will not occur otherwise. Furthermore, the structure of C800 has atypical 
substituents such as epoxide and sulfoxide moieties that have not previously been 
found in any tetrapyrrole intermediate. Therefore, the presence of C800 is somewhat 
new but the ambiguity of this compound makes it very difficult to confirm if it is 
part of, or related to a true intermediate in the pathway. 
 
More recently, bioinformatic analysis in heliobacter (Heliobacillus mobilus and 
Heliophilium fasciatum) has been performed (Xiong, Bauer et al. 2007). The 
presence of a haem d1 like operon has been proposed, containing NirD, NirL and 
two forms of NirJ (NirJ1 and NirJ2) alongside genes for the production of UIII from 
ALA as well as CysGA and CysGB. The pathway for haem d1 has been proposed, 
however the acceptability of this hypothesis is debatable. Firstly not all of the 
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transformations from UIII to haem d1 can be explained by the presence of these 
enzymes. It has been hypothesised that CysGA acts as an SUMT to yield PC-2 and 
CysGB yields SHC, and that only NirJ is involved in decarboxylation and then 
CysGB is involved again in ferrochelation completing the synthesis of haem d1. This 
hypothesis does not take into account the formation of an acrylate at C17 nor the 
conversion of the propionates to oxo groups at C3 and C8. There are no enzymes 
with similarity to NirG and NirH in this bacterium; this is unusual since they occur 
in all nir operons characterised thus far. Furthermore, the presence of NirD and NirL 
has been eliminated from the pathway and stated to be involved only in 
transcriptional regulation and DNA binding. This does not take into account the 
previously demonstrated necessity of nirFDLGHJE in the pathway. If the genes 
required for haem d1 were present as hypothesised by Xiong (NirJ1 and NirJ2; 
CysGA and CysGB), the insertional mutations of nirD or nirL would have no effect 
on haem d1 synthesis, as a lack of any one of these would be complemented by nirG 
or nirH (Chapter 4). It can also be said that the transcription regulation of the nir 
operon is mediated upstream of the cluster by FNR-like transcriptional activators in 
Ps. aeruginosa (ANR (Sawers 1991)) and Pa. denitrificans (NNR, NirI, NirX 
(Saunders, Houben et al. 1999)), whose transcription is mediated by nitric oxide 
signalling (Van Spanning, Houben et al. 1999). Nitric oxide signalling has also been 
implicated in transcriptional control in Ps. aeruginosa and Ps. stutzeri (Arai, 
Kodama et al. 1999; Vollack and Zumft 2001). Thus the transcription of these genes 
is tightly regulated by ANR or NNR, which in turn are activated in response to 
anaerobic stimuli. Therefore, the inferences made by Xiong et al can be said to have 
no foundation in the d1 pathway as they are based on bioinformatic analysis and 
manipulation only. They are not experimentally derived. The pathway proposed in 
this case is more likely to be related to a primitive haem pathway observed in D. 
vulgaris and Methanosarcina barkeri, whereby UIII is methylated instead of 
decarboxylated (Ishida, Yu et al. 1998; Buchenau, Kahnt et al. 2006). In M. barkeri 
the late haem genes are missing, and it is presumed that an alternative pathway is 
utilised to make haem. Thus, it is likely to be the same in heliobacteria. Moreover, 
heliobacter contain bacteriochlorophyll and have no indication of a requiring an 
alternative respiratory nitrogen metabolism pathway such as one requiring haem d1.  
 
Therefore, the pathway to haem d1 still remains to be established and the isolation of 
any intermediates is highly sought-after. 
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1.4. Ps. aeruginosa as a candidate species  
Ps. aeruginosa is a gram-negative bacterium found in a large variety of habitats that 
include soil, marine as well as plant and animal tissue. Its ubiquitous nature has 
allowed it to evolve to possess a large spectrum of biochemical pathways and the 
metabolic versatility of which pseudomonads are renowned. Ps. aeruginosa is the 
most thoroughly characterised of the denitrifying bacteria as a result of the interest 
in it as an opportunistic pathogen, as well as a versatile soil bacterium.  Its ability to 
utilise and adapt regulatory systems has enabled it to thrive in many extreme 
environments, conferring resistance to many antibiotics and disinfectants. The 
genome has been fully sequenced revealing a large bacterial genome, 6.3 million 
base pairs, in comparison to other microorganisms that are near to 3 million base 
pairs. Clearly, its evolution as a complex bacterium is reflected in its diversity as 
well as genome size (Stover, Pham et al. 2000). 
 
Therefore, the reasons for studying haem d1 biosynthesis in Ps. aeruginosa are 
multiple, including it large size, ease of genetic manipulation and its inherent neat 
genetic organisation. In particular, the genes nirCFDLGHJEN are found in one locus 
being read in the same direction as oppose to Ps. stutzeri (Figure1.22). These may 
encode the entire set of proteins required for the formation of haem d1. It is 
documented to have a basal level of haem d1 in wild type Ps. aeruginosa at 0.7 nmol 
per gram wet weight (Youn, Liang et al. 2004). Indeed, the use of Ps. aeruginosa in 
this study is as a model organism for understanding not only how haem d1 is 
synthesised, but also how it is regulated and controlled in relation to other 
tetrapyrroles. Such studies could lead to the conception of new tetrapyrrole 
intermediates that may involve new and unique chemistry in the world of 
tetrapyrroles. 
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1.5.  Purpose of thesis 
From the review of literature, we can see a clear scarceness in the information 
available on the pathway from UIII to haem d1. There are no true characterised 
intermediates to date for the last 25 years, and only a methyl ester, C800 has been 
put forward. The genes necessary for the synthesis of haem d1 have been found, but 
little is known of the proteins they encode and their structures or mechanism of 
action. 
            
Thus, the purpose of the research conducted was to elucidate the pathway for the 
production of haem d1, including the characterisation of the enzymes and any 
intermediates. This thesis hoped to resolve some of the questions and challenges 
posed in this pathway. 
 
In this thesis, a number of different approaches are employed in the study of such a 
unique pathway. In Chapter 3, it was confirmed for the first time that NirE was a 
true SUMT and shown to be active by catalysing the transformation from UIII to 
PC-2, with the formulation of an anaerobic assay coupled to the formation of 
sirohydrochlorin. Chapter 4 shows the concerted effort required in the optimisation 
of overproduction and stabilisation of the remaining Nir proteins and the conception 
of a novel homologous system of expression in Ps. aeruginosa. The last chapter 
focuses on engineering both E. coli and Ps. aeruginosa to make haem d1 and thus, 
the expression of intermediates by use of Link and Lock cloning, to clone the nir 
genes consecutively into a plasmid. The accumulation of intermediates was also 
examined by analysis of activity of the Nir proteins towards PC-2 and SHC.  
 
Therefore, this thesis provides a suitable foundation for future work in the 
investigation of the haem d1 tetrapyrrole pathway, its enzymes and intermediates. 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals (source) 
Almost all chemicals such as antibiotics and tetrapyrroles were purchased from 
Sigma-Aldrich Ltd (Poole, UK) unless otherwise stated. Restriction enzymes were 
purchased from Promega (Madison, USA), except for AscI that was purchased from 
New England Biolabs (Hitchin, UK); pGEMT-Easy vector systems and the 
bacterial strain JM109 were also purchased from Promega (Madison, USA); pET14b 
and pETcoco cloning vectors were purchased from Novagen; Bacterial Agar, 
Tryptone and yeast extract were purchased from Oxiod Ltd (Basingstoke, UK); Hot 
star Taq DNA polymerase, MiniEluteTM Gel extraction Kit, QIAprep Spin 
Miniprep Kit and QIAquick Gel Extraction Kit from Qiagen GmbH (Germany); 
PD10 columns, Sephadex G-75, Sepharose S-200, DEAE Sephacel and chelating 
sepharose fast flow resin were from Amersham Biosciences (Amersham Pharmacia, 
UK); 50 x TAE Buffer was purchased from Eppendorf (Cambridge, UK) and IPTG 
from BDH (VWR international Ltd, Poole, UK). 
 
2.1.2. Bacterial Strains 
Bacterial Strains JM109, BL21 (subtypes) were purchased from Novagen (UK), 
Promega (USA) and SCS110 was provided by Stratagene (USA), except for those 
carrying the prefix ER. Those strains carrying the prefix ER were provided courtesy 
of Dr Evelyne Raux-Deery (University of Kent, Canterbury). The list of cloning 
strains used in this study can be found in Table 2.1. All other strains made with the 
desired plasmid in Ps. aeruginosa or in E. coli are listed in Table 2.2. 
 
2.1.3. Plasmids  
The vectors used in this study have been listed in Table 2.3 and the plasmids that 
were constructed as part of the research are listed in Table 2.4. The plasmids with a 
prefix pER were given by Dr Evelyne Raux-Deery (University of Kent, Canterbury).  
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Table 2.1: List of stock strains used in this study 
All genes in the bacterium are presumed to be in the wild type state, except for those 
listed, which are mutant alleles carried by that bacterium. Genes listed on the F′ 
episome represent wild type alleles unless specified otherwise. Strains are λ– unless 
specified otherwise. A description of genotype or phenotype incurred is detailed in 
the appendix. 
 
Strains Genotype / Phenotype Description 
Reference/
Source 
JM109 
 
endA1 recA1 gyrA96, thi 
hsdR17(rK-mk+) relA1 
supE44  (lac-proAB) [F, 
traD36 proAB 
lacIqZM15] 
 
Cloning strain used  for simple 
molecular biology applications 
Promega / 
(Hanahan 
1983; 
Hanahan 
1985) 
BL21(DE3) 
pLysS 
 
F-, ompT, hsdSB (rB-, mB-), 
dcm, gal, (DE3), pLysS, 
CmR  
 
 
Protein expression strain for plasmids 
utilising the T7 promoter system. 
Contains λ DE3 lysogen carrying gene 
for T7 RNA polymerase under control 
of the lacUV5 promoter. IPTG is 
induces expression of the T7 RNA 
polymerase.  
 
Novagen 
 
SCS110 
 
 
RpsL (Strr) thr leu endA 
thi-l galK galT ara tonA 
tsx dam dcm supE44 (lac-
proAB) [F, traD36 
lacIqZM15] 
 proAB, CmR 
 
An endA- derivative of the JM110 
strain. Used for preparing plasmid or 
phagemid DNA, free of Dam or Dcm 
methylation allowing restriction by 
one or more methylation-sensitive 
restriction enzymes. 
 
Stratagene 
BL21 Star 
(DE3) 
 
F- ompT hsdSB (rB-mB-) 
gal dcm rne131 (DE3) 
(CmR) 
 
 
Contains a mutation in the gene 
encoding RNaseE (rne131), one of the 
major sources of mRNA degradation. 
Improves stability of mRNA 
transcripts and increases protein 
expression yield from T7 promoter-
based vectors. Do not contain the lon 
protease or the outer membrane 
protease, OmpT, further reducing 
degradation of heterologous proteins 
expressed in the strains  
 
Invitrogen 
BL21star 
(DE3)pLysS 
F- ompT hsdSB (rB-mB-) 
gal dcm rne131 (DE3) 
pLysS (CmR) 
 
 
Same as BL21 Star (DE3) but 
BL21 Star (DE3) pLysS carries the 
pLysS plasmid which produces T7 
lysozyme  
 
Invitrogen 
AR3612 
(pCIQ) 
S. enterica (typhimurium)     
Leu+ SmR cysGA – 
MetE, Cmr 
 
Lacks CysGA activity, but retains 
CysGB activity. Met H B12 dependent 
and B12 deficient 
(Raux, 
Lanois et al. 
1996) 
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TUNER 
F– ompT hsdSB (rB– mB–) 
gal dcm lacY1(DE3) pLacI 
(CmR) 
 
lacZY deletion mutants of BL21, 
enabling adjustable levels of protein 
expression throughout all cells in a 
culture. The lac permease (lacY) 
mutation allows uniform entry of 
IPTG into all cells in population, 
producing a concentration-dependent, 
homogeneous level of induction. By 
adjusting the concentration of IPTG, 
expression can be finely regulated in 
pET vectors 
 
Invitrogen 
ER171 
 
cysG- 302a (pAR8068) 
pACYC184 lacIq 
 
E. coli cysG deleted strain  Dr E.Raux-Deery 
CysG- 247 JM101 pCIQ pTac cobA E. coli cysG deleted strain, with cobA from Ps. denitrificans 
Dr E.Raux-
Deery 
Pseudomonas 
aeruginosa 
 
PAO1 Ps. aeruginosa wt 
(Dunn and 
Holloway 
1971) 
 
 
Table 2.2: List of strains used as part of this study 
A library of strains containing the various single and multigene plasmids was 
compiled using strains from both Ps. aeruginosa (PAO wt) and E. coli and stored as 
glycerol stocks at –80 C (see Table 2.4 for plasmids). 
 
Strains   Genotype / Phenotype Description Reference/ Source 
VP01 BL21(DE3) pLysS (pVP14) Ps. aeruginosa NirF Histagged This study 
VP02 BL21(DE3) pLysS (pVP13) Ps. aeruginosa NirD Histagged This study 
VP03 BL21(DE3) pLysS (pVP09) Ps. aeruginosa NirL Histagged This study 
VP04 BL21(DE3) pLysS (pVP05) Ps. aeruginosa NirG Histagged This study 
VP05 BL21(DE3) pLysS (pVP06) Ps. aeruginosa NirH Histagged This study 
VP06 BL21(DE3) pLysS (pVP66) Ps. aeruginosa NirJ Histagged This study 
VP07 BL21(DE3) pLysS (pVP02) Ps. aeruginosa NirE Histagged This study 
VP08 
BL21(DE3) pLysS (pVP71) Ps. aeruginosa NirDL (NirD 
Histagged) 
This study 
VP09 
BL21(DE3) pLysS (pVP72) Ps. aeruginosa NirDLG (NirD 
Histagged) 
This study 
VP10 
BL21(DE3) pLysS (pVP73) Ps. aeruginosa NirDLGH (NirD 
Histagged) 
This study 
VP11 TUNER (pVP14)  Ps. aeruginosa NirF Histagged This study 
VP12 TUNER (pVP13) Ps. aeruginosa NirD Histagged This study 
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VP13 TUNER (pVP09) Ps. aeruginosa NirL Histagged This study 
VP14 TUNER (pVP05) Ps. aeruginosa NirG Histagged This study 
VP15 TUNER (pVP06) Ps. aeruginosa NirH Histagged This study 
VP16 TUNER (pVP66) Ps. aeruginosa NirJ Histagged This study 
VP17 TUNER (pVP02) Ps. aeruginosa NirE Histagged This study 
VP18 PAO1 (pVP19) Ps. aeruginosa NirF Histagged This study 
VP19 PAO1 (pVP21) Ps. aeruginosa NirD Histagged This study 
VP20 PAO1 (pVP47) Ps. aeruginosa NirL Histagged This study 
VP21 PAO1 (pVP23) Ps. aeruginosa NirG Histagged This study 
VP22 PAO1 (pVP48) Ps. aeruginosa NirH Histagged This study 
VP23 PAO1 (pVP78) Ps. aeruginosa NirJ Histagged This study 
VP24 PAO1 (pVP17) Ps. aeruginosa NirE Histagged This study 
VP25 PAO1 (pVP18) Ps. aeruginosa NirF  This study 
VP26 PAO1 (pVP20) Ps. aeruginosa NirD  This study 
VP27 PAO1 (pVP25) Ps. aeruginosa NirL  This study 
VP28 PAO1 (pVP22) Ps. aeruginosa NirG  This study 
VP29 PAO1 (pVP24) Ps. aeruginosa NirH  This study 
VP30 PAO1 (pVP77) Ps. aeruginosa NirJ  This study 
VP31 PAO1 (pVP16) Ps. aeruginosa NirE  This study 
VP32 
PAO1 (pVP33) Ps. aeruginosa NirE 
(Nde/Xba/BamHI primers) 
This study 
VP33 PAO1 (pVP50) Ps. aeruginosa NirEF This study 
VP34 PAO1 (pVP51) Ps. aeruginosa NirEFD This study 
VP35 PAO1 (pVP52) Ps. aeruginosa NirEFDL This study 
VP36 PAO1 (pVP53) Ps. aeruginosa NirEFDLG This study 
VP37 PAO1 (pVP54) Ps. aeruginosa NirEFDLGH This study 
VP38 PAO1 (pVP55) Ps. aeruginosa NirEFDLGHJ This study 
VP39 PAO1 (pVP58) Ps. aeruginosa NirF This study 
VP40 PAO1 (pVP59) Ps. aeruginosa NirFD This study 
VP41 PAO1 (pVP60) Ps. aeruginosa NirFDL This study 
VP42 PAO1 (pVP61) Ps. aeruginosa NirFDLG This study 
VP43 PAO1 (pVP62) Ps. aeruginosa NirFDLGH This study 
VP44 PAO1 (pVP63) Ps. aeruginosa NirFDLGHJ This study 
VP45 PAO1 (pVP65) Ps. aeruginosa NirFDLGHJE This study 
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VP46 
E. coli  JM109 (pVP33) Ps. aeruginosa NirE This study 
VP47 
E. coli  JM109 (pVP50) Ps. aeruginosa NirEF This study 
VP48 
E. coli  JM109 (pVP51) Ps. aeruginosa NirEFD This study 
VP49 
E. coli  JM109 (pVP52) Ps. aeruginosa NirEFDL This study 
VP50 
E. coli  JM109 (pVP53) Ps. aeruginosa NirEFDLG This study 
VP51 
E. coli  JM109 (pVP54) Ps. aeruginosa NirEFDLGH This study 
VP52 
E. coli  JM109 (pVP55) Ps. aeruginosa NirEFDLGHJ This study 
VP53 
PAO1 (pVP67) Ps. aeruginosa NirDL This study 
VP54 
PAO1 (pVP68) Ps. aeruginosa NirDLG This study 
VP55 PAO1 (pVP69) Ps. aeruginosa NirDLGH This study 
VP56 
PAO1 (pVP71) Ps. aeruginosa NirDL (NirD 
Histagged) 
This study 
VP57 
PAO1 (pVP72) Ps. aeruginosa NirDLG (NirD 
Histagged) 
This study 
VP58 
PAO1 (pVP73) Ps. aeruginosa NirDLGH (NirD 
Histagged) 
This study 
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Table 2.3: List of stock vectors used in the study 
Cloning vectors and plasmids obtained from laboratory members and companies. 
 
Vector Description Source 
pGEM-T Easy 
 
T-vector cloning system for PCR products; 
MCS contains 3’-T overhangs for ease of 
ligation. 
AmpR, T7, SP6 RNA polymerase promoters 
 
Promega 
pET14b 
 
Protein overproduction vector with N-
terminal His-tag. AmpR, T7 promoter, T7 
terminator 
 
Novagen 
pUCP-Nco 
 
NcoI (C/CATGG) in MCS downstream of 
promoter. AmpR, lac promoter 
 
Warren Lab (Ross 
Graham) (Cronin and 
McIntire 1999) 
pUCP-Nde 
 
NdeI (CA/TATG) in MCS downstream of 
promoter. AmpR, lac promoter 
 
Warren Lab (Ross 
Graham)(Cronin and 
McIntire 1999) 
 
pKK233.3 + 
haem d1 
operon 
 
nirF, nirD, nirL, nirG, nirH, nirJ, nirE 
cloned as part of operon. AmpR 
Donated by Evelyne 
Deery 
nirJ pET14b 
 
nirJ with N-terminal His-tag,  
AmpR, T7 promoter, T7 terminator 
 
Donated by Andrew 
Lawrence (mutation) 
cobApET14b 
 
cobA with N-terminal His-tag,  
AmpR, T7 promoter, T7 terminator 
 
Donated by Amanda 
Brindley 
pETcoco 
ABCD 
 
hemB, hemC, hemD, cobA with N-terminal 
His-tag. AmpR, T7 promoter, T7 terminator 
(for PC-2) 
 
Donated by Evelyne 
Deery 
pETcoco 
ABCDC 
 
hemB, hemC, hemD, cobA, sirC  with N-
terminal His-tag, AmpR, T7 promoter, T7 
terminator  (for UIII) 
 
Donated by Evelyne 
Deery 
pET14b BCDC 
 
hemB, hemC, hemD, sirC  with N-terminal 
His-tag. AmpR, T7 promoter, T7 terminator 
(for SHC no SUMT) 
 
Donated by Amanda 
Brindley 
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Table 2.4: List of plasmids constructed and used in this study 
Unless otherwise stated, all the genes were cloned from Pseudomonas aeruginosa,  
RBS refers to ribosome binding site. A total of 78 plasmids were contrasted as part 
of this study. 
 
Construct Gene Vector Description / Origin Mutation free 
Single gene construct: NdeI – BamHI Primers in pGEMT-Easy and pET14b 
pVP11 nirF pGEMT-E
PCR1 fragment to introduce 
NdeI and BamHI primer sites 
(clones with two gene 
orientations in plasmid) 
D1039N 
pVP12 nirF pET14b NdeI-BamHI fragment from pVP11 PCR1 D1039N 
pVP14 nirF pET14b 
PCR2 fragment NdeI and 
BamHI primer sites, direct 
cloning to vector 
Yes 
pVP07 nirD pGEMT-E PCR1 fragment to introduce NdeI and BamHI primer sites NdeI lost 
pVP10 nirD pET14b NdeI-BamHI fragment from pVP07 PCR1 NdeI lost 
pVP13 nirD pET14b 
PCR2 fragment NdeI and 
BamHI primer sites, direct 
cloning to vector 
Yes 
pVP08 nirL pGEMT-E PCR1 fragment to introduce NdeI and BamHI primer sites Yes 
pVP09 nirL pET14b NdeI-BamHI fragment from pVP08 PCR1 Yes 
pVP03 nirG pGEMT-E PCR1 fragment to introduce NdeI and BamHI primer sites  Yes 
pVP05 nirG pET14b NdeI-BamHI fragment from pVP03 PCR1 Yes 
pVP04 nirH pGEMT-E PCR1 fragment to introduce NdeI and BamHI primer sites Yes 
pVP06 nirH pET14b NdeI-BamHI fragment from pVP04 PCR1 Yes 
pVP01 nirE pGEMT-E
PCR1 fragment to introduce 
NdeI and BamHI primer sites 
(clones with two gene 
orientations in plasmid) 
Yes 
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pVP02 nirE pET14b NdeI-BamHI fragment from pVP01 PCR1 Yes 
pVP15 nirJ pET14b NdeI-BamHI primer sites courtesy of A Lawrence No 
pVP66 nirJ pET14b 
AscI and XhoI fragment from 
pKK Haem d1 plasmid, 
cloned into pVP15 
Yes 
Construct Gene Vector Description / Origin Mutation free 
Single gene construct: NdeI or NcoI – BamHI Primers in pUCPNde or 
pUCPNco 
pVP18 nirF 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP14 Yes 
pVP19 nirF 
pUCP-
Nco 
NcoI-BamHI fragment from 
pVP14 + histag Yes 
pVP20 nirD 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP13 Yes 
pVP21 nirD 
pUCP-
Nco 
NcoI-BamHI fragment from 
pVP13 + histag Yes 
pVP25 nirL 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP09 Yes 
pVP47 
 
nirL 
 
pUCP-
Nco 
NdeI-BamHI fragment from 
pVP09 + Vector and histag 
from pVP19 NdeI-BamHI 
prerestricted. 
Yes 
pVP22 nirG 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP05 Yes 
pVP23 nirG 
pUCP-
Nco 
NcoI-BamHI fragment from 
pVP05 + histag Yes 
pVP24 nirH 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP06 Yes 
pVP48 nirH 
pUCP-
Nco 
NdeI-BamHI fragment from 
pVP06 + Vector and histag 
from pVP19 NdeI-BamHI 
prerestricted. 
Yes 
pVP77 nirJ 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP66 Yes 
PVP78 nirJ 
pUCP-
Nco 
NcoI-BamHI fragment from 
pVP66 + histag Yes 
pVP16 nirE 
pUCP-
Nde 
NdeI-BamHI fragment from 
pVP02 Yes 
pVP17 nirE 
pUCP-
Nco 
NcoI-BamHI fragment from 
pVP02 + histag Yes 
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Construct Gene Vector Description / Origin Mutation free 
Multi-gene constructs (NdeI or NheI – RBS and XbaI - BamHI Primers) 
pVP27 nirF pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end (2 
orientations of gene) 
Yes  
pVP28 nirD pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
G1713A, 
NheI Lost 
pVP34 nirD pGEMT-E 
PCR2 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end (reverse 
orientation to PCR1) 
No stop 
codon 
pVP40 nirD pGEMT-E 
PCR3 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end  
N93S 
pVP41 nirD pUCPNde 
PCR1 NdeI -XbaI - BamHI 
fragment from pVP28 
G1713A, 
NheI Lost 
pVP42 nirD pUCPNco 
PCR2 NcoI -XbaI - BamHI 
fragment pVP34 
No stop 
codon 
pVP43 nirD pUCPNde 
pVP41 vector prerestricted 
with AvaI and BamHI + 
AvaI and BamHI fragment 
from pVP42 
Yes  
pVP29 nirL pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes  
pVP30 nirG pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
H14Y, 
V115A 
pVP35 nirG pGEMT-E 
PCR2 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Very poor 
reading 
PVP38 nirG pGEMT-E 
PCR3 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
A76V 
PVP39 nirG pGEMT-E 
PCR4 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes 
pVP31 nirH pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes 
pVP32 nirJ pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
R36H, 
Q119Q 
 
Vina Parmar                                                                        Chapter 2: Materials and Methods: page 51 
51 
Construct Gene Vector Description / Origin Mutation free 
pVP36 nirJ pGEMT-E 
PCR2 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
I62V 
 
pVP37 nirJ pGEMT-E 
AscI and XhoI fragment 
from pVP15, cloned into 
pVP32  
I62V 
(found in 
pVP15) 
pVP44 nirJ pGEMT-E 
PCR3 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
I4T 
 
pVP45 nirJ pGEMT-E 
PCR4 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes 
 
pVP46 nirJ pGEMT-E 
AscI and XhoI fragment 
from pKK Haem d1 
plasmid,cloned into pVP32  
Yes 
 
pVP26 nirE pGEMT-E 
PCR1 to RBS-NdeI sites 
at the 5’ end and XbaI - 
BamHI 3’ end 
D29D, 
NdeI lost 
pVP33 nirE pGEMT-E 
PCR2 to RBS-NdeI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes 
PVP64 nirE pGEMT-E 
PCR1 to RBS-NheI sites at 
the 5’ end and XbaI - 
BamHI 3’ end 
Yes 
pVP49 nirE pUCP-Nde 
NdeI - BamHI fragment 
from pVP33 Yes 
pVP50 nirEF pUCP-Nde 
NheI - BamHI fragment 
from pVP27, cloned into 
XbaI – BamHI of pVP49 
Yes 
pVP51 nirEFD pUCP-Nde 
NheI - BamHI fragment 
from pVP43, cloned into 
XbaI – BamHI of pVP50 
Yes 
pVP52 nirEFDL pUCP-Nde 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP51 
Yes 
pVP53 nirEFDLG 
pUCP-Nde 
NheI - BamHI fragment 
from pVP39, cloned into 
XbaI – BamHI of pVP52 
Yes 
pVP54 nirEFDLGH 
pUCP-Nde 
NheI - BamHI fragment 
from pVP31, cloned into 
XbaI – BamHI of pVP53 
Yes 
pVP55 nirEFDLGHJ 
pUCP-Nde 
NheI - BamHI fragment 
from pVP45, cloned into 
XbaI – BamHI of pVP54 
Yes 
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Construct Gene Vector Description / Origin Mutation free 
pVP58 nirF pUCP-Nde 
SalI - BamHI fragment 
from pVP27, cloned into 
SalI – BamHI of pVP18 
Yes 
pVP59 nirFD pUCP-Nde 
NheI - BamHI fragment 
from pVP43, cloned into 
XbaI – BamHI of pVP58 
Yes 
pVP60 nirFDL pUCP-Nde 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP59 
Yes 
pVP61 nirFDLG pUCP-Nde 
NheI - BamHI fragment 
from pVP39, cloned into 
XbaI – BamHI of pVP60 
Yes 
pVP62 nirFDLGH 
pUCP-Nde 
NheI - BamHI fragment 
from pVP31, cloned into 
XbaI – BamHI of pVP61 
Yes 
pVP63 nirFDLGHJ 
pUCP-Nde 
NheI - BamHI fragment 
from pVP45, cloned into 
XbaI – BamHI of pVP62 
Yes 
pVP65 nirFDLGHJE 
pUCP-Nde 
NheI - BamHI fragment 
from pVP33, cloned into 
XbaI – BamHI of pVP63 
Yes 
pVP67 nirDL pUCP-Nde 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP43 
Yes 
pVP68 nirDLG pUCP-Nde 
NheI - BamHI fragment 
from pVP39, cloned into 
XbaI – BamHI of pVP67 
Yes 
pVP69 nirDLGH pUCP-Nde 
NheI - BamHI fragment 
from pVP31, cloned into 
XbaI – BamHI of pVP68 
Yes 
pVP70 nirD 
pUCP-Nco 
(+ histag) 
AvaI - BamHI fragment 
from pVP29, cloned into 
AvaI - BamHI pVP21 
Yes 
pVP71 nirDL 
pUCP-Nco 
(+ histag) 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP70 
Yes 
pVP72 nirDLG 
pUCP-Nco 
(+ histag) 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP71 
Yes 
pVP73 nirDLGH 
pUCP-Nco 
(+ histag) 
NheI - BamHI fragment 
from pVP29, cloned into 
XbaI – BamHI of pVP72 
Yes 
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Construct Gene Vector Description / Origin Mutation free 
pVP74 nirDL pET14b 
NdeI - BamHI fragment 
from pVP71 Yes 
pVP75 nirDLG pET14b 
NdeI - BamHI fragment 
from pVP72 Yes 
pVP76 nirDLGH pET14b 
NdeI - BamHI fragment 
from pVP73 Yes 
pVP56 nirED pUCP-Nde 
NheI - BamHI fragment 
from pVP43, cloned into 
XbaI – BamHI of pVP49 
Yes  
PVP57 nirEG pUCP-Nde 
NheI - BamHI fragment 
from pVP39, cloned into 
XbaI – BamHI of pVP49 
Yes  
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2.1.4. Media and Solutions for bacterial work 
Luria Bertani (LB) Broth: 
NaCl    5 g  
Yeast     5 g 
Tryptone   10 g 
This was made up to 1L with distilled water and autoclaved before use. 
Super LB Broth: 
    NaCl    5 g 
    Yeast    20 g 
    Tryptone   32 g 
This was made up to 1L with distilled water and autoclaved before use. 
 
LB Agar: 
    Bacterio-Agar   15 g 
15 g of agar was added per litre of LB Broth and autoclaved before use. 
2TY Broth: 
Peptone   16 g   
 Yeast    10 g 
NaCl    5 g 
This was made up to 1L with distilled water and autoclaved before use.  
 
Minimal Media: 
The solutions made up as below, were all sterilised separately and mixed together to 
make 1L of minimal media or broth with or without the addition of 15 g bacto-agar. 
 
 Stock    Final Concentration    Volume 
   x 10 M9 Salts   x 1 M9 Salts    100 ml  
 20 % Glucose   0.02 %     20 ml  
 1M MgSO4        2 ml 
 0.1M CaCl2        1 ml 
 Cysteine (5 mg/ml)       10 ml 
 H2O (+/- 15 g bacto-agar)      900 ml 
 + Antibiotics as required   
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Antibiotics: 
To allow for plasmid isolation and cultivation of strains conferring antibiotic 
resistance, the following levels were used and stored at –20 C: 
    Ampicillin   100 mg/ml stock  
Dissolved in ddH2O and filter sterilised; used at a final concentration of 100 mg/l. 
 
    Chloramphenicol  34 mg/ml stock 
Dissolved in Analar ethanol, filter sterilised; used at a final concentration of 34 mg/l. 
 
    Carbenicillin   100 mg/ml stock 
Dissolved in ddH2O and filter sterilised; used at a final concentration of 500 mg/l in 
liquid cultures and 250 mg/l in plates. 
 
Magnesium Chloride Solution (0.1M) 
   MgCl2.6H2O (Mr = 203.3 g) 1.0 g 
Added to 50 mls dH2O and filter sterilised for preparation of competent cells. 
 
Calcium Chloride Solution (0.1M) 
   CaCl2. 2H2O (Mr = 147.0 g) 0.74 g 
Added to 50 mls dH2O and autoclaved for minimal media preparation or filter  
sterilised for preparation of competent cells. 
 
TG Salts   CaCl2    75 mM 
    MgCl2    6 mM 
    Glycerol   15 % 
 
Magnesium Sulphate Solution (1M) 
   MgSO4.7H2O (Mr = 246.48) 12.34 g 
Added to 50mls dH2O and autoclaved for minimal media preparation. 
 
X10 M9 Salts:  Na2HPO4   60 g 
KH2PO4   30 g 
NH4Cl    10 g 
NaCl    5 g 
All added to 1L of dH2O and autoclaved before use in minimal media preparation. 
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 20 % Glucose  
   Glucose (C6H12O6)   20 % w / v filter sterilised 
Dissolved in ddH2O, filter sterilised and stored at –20 C. 
  
IPTG Solution (1M): 
   IPTG     2.38 g 
Dissolved in 10 mls ddH2O and filter sterilised and used in culture at a final 
concentration of 0.4 mM. 
 
L-Methionine (10 mg/ml) 
   C5H11NO2S    0.1 g 
Dissolved in 10 mls ddH2O and filter sterilised; used at a final concentration of 10 
mg/l in liquid cultures. 
 
δ-Aminoleavulinic Acid (10 mg/ml) 
   C5H9NO3.HCl    0.1 g  
Dissolved in 10 mls ddH2O and filter sterilised; used at a final concentration of 10 
mg/l in liquid cultures. 
 
L-Cysteine (5 mg/ml) 
Dissolved in 10 mls ddH2O and filter sterilised; used at a final concentration of 10 
mg in complementation in 1L of media. 
 
Sodium Nitrate (1M)        
   NaNO3   84.99 g    
All added to 1L of dH2O and autoclaved before use in minimal media preparation. 
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2.1.5. Solutions for DNA work  
All solutions were made using Analar (ddH20) 
 
TE Buffer   Tris-HCl pH 8.0   10 mM 
 EDTA pH 8.0   1 mM 
 
 
6 x DNA Loading Buffer Bromophenol blue   0.25 % 
 Glycerol    50 % 
 TE Buffer    50 % 
 
 
TAE Buffer  Tris-Acetate   40 mM   
    EDTA pH8.3   1 mM 
 
 
One-Phor-All-Buffer (x10)  
    Tris Acetate pH7.5  100 mM  
    Magnesium Acetate  100 mM 
    Potassium Acetate  500 mM 
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2.1.6. Solutions for Protein work  
2.1.6.1. Solutions for metal chelate chromatography 
Shown below are formulations of buffers with Tris. Where needed Tris was replaced 
with the appropriate buffer. 
 
       Charge Buffer        NiSO4                             100 mM 
 
Binding Buffer   Tris-HCl pH 8.0  20 mM  
     NaCl    0.5 M 
Imidazole    5 mM  
 
Wash Buffer I (20 mM) Tris-HCl pH 8.0  20 mM 
                                          NaCl               0.5 M 
     Imidazole   20 mM 
Wash Buffer II (50 mM) Tris-HCl pH 8.0  20 mM 
                                         NaCl               0.5 M 
     Imidazole   50 mM  
 
Wash Buffer III (60 mM)  Tris-HCl pH 8.0  20 mM 
                                           NaCl               0.5 M 
      Imidazole   60 mM  
 
Elute Buffer (400 mM) Tris-HCl pH 8.0  20 mM 
                                          NaCl               0.5 M 
       Imidazole   400 mM  
 
Strip Buffer       EDTA                          100 mM 
               NaCl               0.5 M 
   Tris-HCl pH 8.0           20 mM 
 
      10 x His•tag cleavage buffer  
      Tris-HCl pH 8.4                     200 mM    
     NaCl               1.5 M 
        CaCl2               25 mM 
 
Vina Parmar                                                                        Chapter 2: Materials and Methods: page 59 
59 
Potassium Phosphate Buffer pH range: 5.8 - 8.0 
Stocks of 1M K2HPO4 and 1M KH2PO4 were made and added together to obtain the 
desired pH. E.g. 9.4 ml 1M K2HPO4 + 0.6 ml 1M KH2PO4 made to 100 ml with 
dH2O gives a solution of pH 8.0. For other pH values refer to Sambrook et al. 
 
Sodium Phosphate Buffer pH range: 5.8 – 8.0 
Stocks of 1M Na2HPO4 and 1M NaH2PO4 were made and added together to obtain 
the desired pH. E.g. 9.32 ml 1M Na2HPO4 + 6.8 ml 1M NaH2PO4 made to 100 ml 
with dH2O gives a solution of pH8.0. For other pH values refer to Sambrook et al. 
 
CHES (2-[N-Cyclohexylamino] ethane sulfonic acid) pH range: 8.6 - 10 
    C8H17NO3S   207.3 
Added to 1L of dH2O before use in protein stabilisation. Adjusted to desired pH. 
     
MES (2-[N-Morpholino] ethane sulfonic acid pH range: 5.5 – 6.7 
    C6H13NO4S   195.2 
Added to 1L of dH2O before use in protein stabilisation. Adjusted to desired pH  
 
HEPES pH range:  6.8 – 8.2 
    C8H17N2NaO4S  260.29 
Added to 1L of dH2O before use in protein stabilisation 
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2.1.6.2. Solutions for SDS-PAGE and Native gels 
Depending on the size of the protein and the resolution required, SDS-PAGE or 
Native gels were made up to the following specifications, the resolving gel being 
made first and then the stacking gel on top of this. 
 
Table 2.5: Composition of the running gels made to the desired concentration of 
acrylamide depending on the size of the protein 
 
Running Gels 
SDS-PAGE Gels Native Gels 
Composites (ml) 
8 % 10 % 12.5% 15 % 3 % 5 % 10 % 
dH2O 5.7 4.7 3.4 2.2 9.7 8.7 5.2 
30 % 
Acrylamide 
4.0 5.0 6.3 7.5 1.52 2.55 5.0 
1.5 M Tris pH 
8.8 
3.8 3.8 3.8 3.8 3.8 3.8 3.8 
10 % SDS 1.5 1.5 1.5 1.5 - - - 
10 % APS 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
TEMED 0.01 0.01 0.01 0.01 
 
0.01 0.01 0.01 
 
Table 2.6: Composition of the stacking gels made to the desired concentration 
Stacking Gels 
Composites (ml) SDS Gel: 5 % Native Gel: 5 % 
dH2O 3.4 4 
30 % Acrylamide 1.5 1.5 
1.5M Tris pH 6.8 1.9 1.9 
10 % SDS 0.75 - 
10 % APS 0.075 0.075 
TEMED 0.01 0.01 
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10 x Running Buffer   Tris-HCl   30 g/l 
     Glycine   144 g/l 
 
 SDS sample Buffer      0.5 M Tris-HCl pH 6.8 6.00 ml  
     Glycerol   4.80 ml 
     10 % SDS   9.60 ml 
     0.05 % bromophenol blue 1.20 ml 
     dH2O    24.0 ml 
     add 14 µl -Mercaptoethanol/ml 2 x SDS-Buffer 
 
Native sample Buffer      0.5 M Tris-HCl pH 6.8 1 ml  
     Glycerol   0.8 ml 
     0.05 % bromophenol blue 0.2 ml 
               dH2O    6 ml 
 
Denaturing Molecular Weight Marker Dalton VII 
Protein   Molecular Weight (kDa) 
Bovine serum albumin    66,000 
Ovalbumin     45,000 
G-3-P dehydrogenase    36,000 
 
Carbonic anhydrase    29,000 
Trypsinogen     24,000 
Trypsin inhibitor     20,100 
                                  
X-Lactalbumin     14,200 
 
High molecular marker:    
    Protein    Molecular Weight (kDa) 
myosin, rabbit muscle  205 
β-galactosidase  116 
phosphorylase 6    97.4 
bovine albumin (BSA)  66 
egg albumin   45 
carbonic anhydrase  29 
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MWM for native electrophoresis  
Protein    Molecular Weight (Da) 
Thyroglobulin    669,000 
Ferritin    440,000 
Catalase   232,000 
Lactate dehydrogenase  140,000 
Bovine serum albumin  66,000 
 
Coomassie blue stain  
     Trichloraccetic acid  250 ml 
Coomassie blue R250  0.6 g 
SDS    0.1 g 
    Tris-HCl   0.25 g 
Glycine   0.15 g 
    up to 500 ml 
 
2.1.6.3. Solutions for Western Blotting 
10 x Running Buffer:   Tris-HCl   30 g 
     Glycine   144 g 
up to 1000 ml with dH2O 
 
Transfer buffer:  Methanol   200 ml 
     10 x Running buffer  100 ml 
     up to 1000 ml dH2O 
 
PBS:    NaCl    140 mM 
     KCl    3 mM 
     Na2HPO4   10 mM 
     KH2PO4   2 mM 
 
Tris-NaCl buffer:  Trizma base pH 7.4  50 mM 
     NaCl    150 mM 
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Low Rainbow marker:  
Protein      Molecular weight (kDa) Colour 
Ovalbumin   45   Yellow 
Carbonic anhydrase  30   Orange 
Trypsin inhibitor   20.1   Blue 
Lysozyme   14.3  Magenta 
Aprotinin    6.5   Blue black 
Insulin (b) chain   3.5   Blue 
Insulin (a) chain   2.5   Blue 
 
 
High Rainbow marker:  
Protein      Molecular weight (kDa) Colour 
Myosin    220  Blue 
Phophorylase b    97  Orange 
Bovine serum albumin  66  Pink 
Ovalbumin    45   Yellow 
 
Carbonic anhydrase    30    Orange 
 
Trypsin inhibitor    20.1   Blue 
 
Lysozyme     14.3  Magenta 
 
                                 
Add an appropriate volume of your gel-loading buffer (up to 10 μl). Loading buffer 
should contain sufficient β-mercaptoethanol to give a final concentration of 5 % to 
ensure complete reduction of proteins. Samples may be loaded on to gel 
immediately, or can be stored temporarily on ice. Load 20 μl for full-size gels (16–
20 cm) and 5 μl for mini-gels. 
 
 
 
 
 
 
 
Vina Parmar                                                                        Chapter 2: Materials and Methods: page 64 
64 
2.1.6.4. Solutions for Gel Filtration Chromotography (FPLC) 
 
Column Buffers: 
 
HEPES Buffer pH  HEPES pH   50 mM 
                NaCl    150 mM 
 
 
    Tris Buffer pH8  Tris HCl pH 8.0  50 mM  
     NaCl    150 mM 
  
 
Washing Buffer  NaCl    2 M  
     Sodium Azide   0.2 % 
 
 
Storage Buffer   ddH2O        
     Sodium Azide   0.2 % 
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2.2. Molecular biology methods 
Protocols are based on the methods described by Sambrook et al (2002). 
 
2.2.1. Isolation of genomic DNA from PAO 
Ps. aeruginosa genomic DNA was kindly received from Dr Evelyne Raux-Deery  
(University of Kent), at a concentration of 0.02 mg/ml. Paracoccus denitrificans 
genomic DNA was kindly donated by Richard Zajicek (University of Oxford). 
 
2.2.2. Isolation of plasmid DNA 
Plasmid DNA was isolated from bacterial strains such as JM109 or SCS110, using 
the Qiagen QIAprep® Miniprep kit and the protocol for micro-centrifuges. Cultures 
were grown overnight in 5 ml LB and antibiotics where appropriate and then 
pelleted by centrifugation before isolation of the DNA. The DNA was eluted into a 
sterile tube and stored at –20 °C until further use.  
Table 2.7: Amino acids listed with their properties 
Stop codons include: UAA UAG UGA 
Amino Acid Abbreviations Codons  Group 
Alanine Ala A GCA GCC GCG GCU Small 
Cysteine Cys C UGC UGU Nucleophilic 
Aspartic Acid Asp D GAC GAU Acidic 
Glutamic Acid Glu E GAA GAG Acidic 
Phenylalanine Phe F UUC UUU Aromatic 
Glycine Gly G GGA GGC GGG GGU Small 
Histidine His H CAC CAU Basic 
Isoleucine Ile  I AUA AUC AUU Hydrophobic 
Lysine Lys K AAA AAG Basic 
Leucine Leu  L UUA UUG CUA CUC CUG CUU Hydrophobic 
Methionine Met M AUG Hydrophobic 
Asparagine Asn N AAC AAU Amide 
Proline Pro P CCA CCC CCG CCU Hydrophobic 
Glutamine Gln Q CAA CAG Amide 
Arginine Arg R AGA AGG CGA CGC CGG CGU Basic 
Serine Ser S AGC AGU UCA UCC UCG UCU Nucleophilic 
Threonine Thr T ACA ACC ACG ACU Nucleophilic 
Valine Val V GUA GUC GUG GUU Hydrophobic 
Tryptophan Trp W UGG Aromatic 
Tyrosine Tyr Y UAC UAU Aromatic 
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2.2.3. Restriction of DNA 
The amplified DNA was incubated for a minimum of 2 hours with the restriction 
enzymes in the corresponding buffers, at the temperature required by the restriction 
enzyme. The fragments were then separated on an agarose gel (Section 2.2.4.1) and 
if desired ligated as needed (Section 2.2.6). Please refer to the Promega restriction 
enzyme (RE) table for double digests. For the majority of double digests, OPAB 
buffer was sufficient. 
 
Typical restriction digests: 
Vector  5’ RE  3’RE  ddH2O       Total Vol: 
pGEMT-E     5 μl   1 μl   1 μl   3 μl   10 μl 
pET14b         15 μl   1 μl   1 μl   3 μl   20 μl 
pUCP19       4 / 5 μl   1 μl   1 μl   3 / 4 μl   10 μl 
 
2.2.4. Electrophoresis of DNA 
DNA fragments were separated, identified and purified by agarose gel 
electrophoresis (1 % w/v agarose in TAE buffer). Linear fragments of DNA migrate 
through the gel according to their molecular weight and charge. 
 
2.2.4.1. Agarose gel 
In this project 1 % agarose gels were sufficient to separate the DNA fragments 
according to the size of the fragments. Agarose (1 g) was dissolved in 1 x TAE 
Buffer (100 ml) with the addition of ethidium bromide. Ethidium bromide is a 
fluorescent dye that intercalates between the base pairs, allowing visualization of the 
DNA under UV light. DNA samples in 20 % DNA loading buffer were loaded into 
the molded gel wells and a voltage of 70 mV (at most 90 mV) was applied to 
separate the DNA. Hyperladder I (Section 2.2.4.3) was also applied to determine the 
size of the separated fragments. 
 
2.2.4.2. Visualisation and UV 
Ethidium bromide forms a complex with DNA and absorbs UV radiation (312 nm), 
and re-emits it at 590 nm in the red-orange wavelength range. This allows the DNA 
fragments to be visualized by placing the gel onto an UV transilluminator. A camera 
then photographed the gel through a red filter. 
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2.2.4.3. Hyperladder (Bioline) 
Molecular weight marker Hyperladder I (Bioline) 
Agarose gel  
10,000  bp    
8,000  bp   
6,000  bp   
5,000  bp   
4,000  bp   
3,000  bp   
2500 bp   
2000 bp 
1500 bp 
 
1000 bp 
800  bp 
600 bp 
400  bp 
200 bp 
 
 
 
2.2.5. Isolation and purification of a DNA fragment from an Agarose gel 
DNA bands of the correct size were carefully excised (separately) from an agarose 
gel using separate sterile scalpel blades. Each slice was then purified using the 
Qiagen QIAquick® gel extraction kit and QIAquick® gel extraction kit protocol for 
micro-centrifuges in QIAquick® spin Handbook.  The DNA was eluted into a sterile 
tube and stored at –20 °C until further use. 
 
2.2.6. Ligation of DNA fragments 
After restricton and purification of inserts or plasmid / vectors, DNA fragments were 
ligated together using T4 DNA Ligase in 1 x T4 DNA Ligase Buffer (Promega). The 
reaction was allowed to proceed usually at 4 °C overnight or at 16 °C for 2 hrs. For 
optimum results a ratio of 1:1.5 of insert to vector was used. 
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2.2.7. Competent cells and Transformation 
2.2.7.1. Preparation of E. coli Competent Cells 
An individual colony from an overnight plated culture of the desired bacterium was 
taken and used to inoculate 50 ml of LB and then incubated at 37 °C with aeration. 
The culture was grown to an OD600 of approximately 0.3. After standing the culture 
on ice for 10 min to cool the cells, the cells were harvested by centrifugation at 3000 
rpm for 10 min at 4 °C. The cell pellet was washed with 50 ml ice cold 0.1 M 
MgCl2, centrifuged again and resuspended in 25 ml ice cold 0.1 M CaCl2 and left on 
ice for 20 min to 1 hr. The cells were centrifuged again and the pellet was 
resuspended in 250 µl ice-cold 0.1 M CaCl2 / 15 % glycerol. The final bacterial 
suspension was dispensed into 1.5 ml eppendorfs in 20 µl aliquots and immediately 
frozen at –80 °C. 
 
2.2.7.2. Transformation of E. coli Competent Cells 
The method is based on the heat shock transformation protocol. Competent cells 
were defrosted on ice for 15 min before adding of 0.5 µl to 1.5 µl of miniprep or 
ligation mixture. After a further incubation on ice for 10 min, the cell-DNA mixture 
was heat shocked for 50 sec at 42 °C and cooled on ice for 2 min before adding of 
200 µl LB medium. The cell-DNA mixture was then incubated at 37 °C for 20 min 1 
hr to allow plasmid replication and for cells to confer antibiotic resistance that 
allows selection of the cells containing the plasmid when plated. The cells were then 
streaked out onto LB plates with appropriate antibiotics and incubated overnight at 
37 °C. 
 
2.2.7.3. Preparation of Ps. aeruginosa Competent cells 
The protocol described here is adapted from the method described by Chuanchuen, 
Narasaki et al. 2002.  Wild type Ps. aeruginosa cells were grown overnight at 37 °C 
from a single colony in 10 ml of LB. For harvesting, 1.5 ml aliquots of cells were 
transferred to pre-chilled microfuge tubes and the cells pelleted by centrifugation at 
13000-x g for 30 secs. The cell pellets were resuspended in 1 ml cold (4 °C) 0.1 M 
MgCl2 using a micropipette, centrifuged again at 13000 x g for 30 secs and the 
supernatant discarded. The pellets were then resuspended in 1 ml transformation 
salts with glycerol (TG Salts, see 2.1.4) and incubated on ice for 10 min. The cell 
pellets were centrifuged at 13000 x g for 30 sec and the supernatant decanted. The 
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resultant pellets were resuspended in 200 µl cold TG salt solution, divided into 100 
µl aliquots into prechilled eppendorfs and frozen at –80 °C for later use 
 
2.2.7.4. Transformation of Ps. aeruginosa Competent cells 
This method has also been adapted from the method described by (Chuanchuen, 
Narasaki et al. 2002).  Competent cells were defrosted ice for 15 min before the 
addition of 1.5 µl of miniprep. After a further incubation on ice for 15 min, the cell-
DNA mixture was heat shocked for either 50 sec at 42 °C or 2 min at 37 °C and then 
cooled on ice for 2 min before the addition of 500 µl LB medium. The cell-DNA 
mixture was then incubated at 37 °C for no less than 1 hr, with or without shaking, 
to allow plasmid replication and for the cells to confer antibiotic resistance that 
allows selection of the cells containing the plasmid when plated. The cells were then 
streaked out onto LB plates containing the appropriate antibiotics an incubated at 37 
°C for 36 - 48 hrs. 
 
2.2.7.5. Preparation of S. enterica AR3612 Competent cells 
S. enterica cysG metE (AR3612) cells were kindly provided by Dr Evelyne Raux-
Deery. These cells are deficient in CysGA activity but retain their CysGB activity as 
the host contains a gene having the same phenotype as cysGB (cbiK) (Raux, Lanois 
et al. 1996). Cells were streaked over night on LB media with chloramphenicol, and 
an individual colony was taken to inoculate 50 ml of LB with chloramphenicol 34 
mg/ml and incubated at 37 °C with aeration. The culture was grown to an OD600 of 
approximately 0.3. After standing the culture on ice for 10 min to cool the cells, the 
cells were harvested by centrifugation at 3000 rpm for 10 min at 4 °C. The cell pellet 
was washed with 50 ml ice cold 0.1 M MgCl2, centrifuged again and resuspended in 
25 ml ice cold 0.1 M CaCl2 and left on ice for 20 min to 1 hr. The cells were 
centrifuged again and the pellet was resuspended in 250 µl ice-cold 0.1 M CaCl2  / 
15 % glycerol. The final bacterial suspension was dispensed into 1.5 ml eppendorfs 
in 50 μl aliquots and immediately frozen at –80 °C. 
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2.2.7.6. Transformation of S. enterica AR3612 Competent cells 
Competent cells were defrosted ice for 15 min before the addition of 5 µl of 
miniprep as desired. After a further incubation on ice for 10 min, the cell-DNA 
mixture was heat shocked for 50 sec at 42 °C and then cooled on ice for 2 min 
before the addition of 200 µl LB medium. The cell-DNA mixture was incubated at 
37 °C for no less than 30 min to 1 hr allowing plasmid replication and for the cells to 
confer antibiotic resistance allowing selection of the cells when plated. The cells 
were then streaked out onto LB plates containing the appropriate antibiotics before 
incubating at 37 °C for 24 – 48 hrs until colonies are formed. 
 
2.2.7.7. S. enterica cysG complementation 
A S. enterica cysG metE (AR3612) strain is deficient in its ability to transform UIII 
into PC-2. Complementation studies were conducted by transforming 5 μl of the 
vector miniprep containing a plasmid of the gene or combination of genes into S. 
enterica cysG metE (AR3612) strain competent cells. The resultant colonies were 
then restreaked on to minimal media plates made with 50 μg/ml of both methionine 
and cysteine; with cysteine and without methionine; without cysteine and with 
methionine; without cysteine and methionine; plus ampicillin 100 mg/l and 
Chloramphenicol 34 mg/ml as appropriate. The plates were then incubated at 37 oC 
for 24 – 48 hrs, until bacterial colonies were evident in the plates.  
 
2.2.7.8. Glycerol stocks of strains 
Overnight bacterial cultures of all the various strains (Table 2.2), were grown in 5ml 
LB plus or minus the appropriate antibiotic, and prepared for storage by the addition 
of 15 % glycerol (volume/volume) to create a library of strains. The strains were 
stored at –80 °C. 
 
A typical stock would contain: 
  Overnight culture  850 µl 
100 % Glycerol   150 µl 
    1000 µl 
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2.2.8. Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) is the process of amplification of the DNA of the 
gene of interest.  PCR amplification involves the introduction of restrictable 
enzymes, which in turn allows cloning into pre-restricted plasmids or vectors. All 
PCR reactions were prepared on ice as below and performed in a Techne thermal 
cycler with cycles as indicated in Section 2.2.8.1. Following PCR, reaction products 
are separated by an agarose gel (Section 2.2.4.) and the band of correct size and 
interest is cut from the gel. The DNA of the gene of interest is then purified from the 
gel by gel extraction (Section 2.2.5). 
 
PCR Reaction mixture:      + Q Buffer     - Q Buffer 
  10 x PCR buffer (Promega)   5 µl   5 µl 
  5 x Q Buffer (Promega)   10 µl  10 µl 
  2mM dNTPs (Bioline)   5 µl  5 µl 
  Genomic DNA (0.02 mg/ml)   1 µl  1 µl 
  10µM 5’ Primer     2 µl  2 µl 
  10µM 3’ Primer    2 µl  2 µl 
  Sterile water     24.5 µl  34.5 µl 
  Hot Star Taq (Promega)   0.5 µl  0.5 µl 
                50 µl  50 µl 
2.2.8.1. PCR of nir genes 
All the nir genes were amplified by PCR using the respective designed primers 
(Table 2.8). 
 
2.2.8.1.1. NdeI and BamHI Primers 
 Stated are the reaction conditions for the genes cloned with the NdeI and BamHI 
primers, for single gene plasmids. 
 nirE: 1 cycle:  95 °C for 15 minutes 
 
       95 °C for 20 seconds 
35 cycles:  60 °C for 20 seconds 
       72 °C for 51 seconds 
 
   1 cycle:  72 °C for 10 minutes 
 
Vina Parmar                                                                        Chapter 2: Materials and Methods: page 72 
72 
 nirD,  nirL, nirG,  nirH: 
 
1 cycle:  95 °C for 15 minutes 
 
       95 °C for 20 seconds 
35 cycles:  60 °C for 20 seconds 
       72 °C for 35 seconds 
 
   1 cycle:  72 °C for 10 minutes 
 
 nirF 
1 cycle:  95 °C for 3 minutes 
 
       95 °C for 20 seconds 
35 cycles:  55 °C for 20 seconds 
       72 °C for 2 minutes 20 seconds 
 
   1 cycle:  72° C for 10 minutes 
 
 
2.2.8.1.2. NdeI or NheI, RBS and XbaI and BamHI Primers 
Below are the reaction conditions for the genes cloned with the ribosome-binding 
site (RBS) and NheI or NdeI primers at the 5’end and XbaI and BamHI primers at 
the 3’ end, for multiple gene plasmids. 
1 cycle:  95 °C for 3 minutes 
 
       95 °C for 20 seconds 
35 cycles:  55 °C for 20 seconds 
       72 °C for 2 minutes 20 seconds 
 
   1 cycle:  72°C for 10 minutes 
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2.2.8.2. Primers for PCR 
Table 2.8: Tabulation of all primers used in this study to clone the genes 
individually and for the Link and Lock method.   
PCR primers were designed for each of the genes from a database nucleotide 
sequence, Pubmed Acc # D84475, for genes from Ps.aeruginosa, unless otherwise 
indicated. 
NdeI = CATATG  BamHI = GGATCC      Stop = TAG/TAA/TGA 
XbaI = TCTAGA  SpeI = ACTAGT             NheI = GCTAGC 
RBS (ribosome binding site) in pET14b = AGGAG (A) 
 
Gene of Interest NdeI and BamHI Primers 
nirF (PAO) 5’- 3’ NdeI TGC ATA TGA ACC TGC GTC C 
nirF (PAO) 3’- 5’ BamHI TCG GAT CCT CCT AGA GTC CGA TGT GC 
nirD (PAO) 5’- 3’ NdeI TTC ATA TGG ACG ACC TCT CC 
nirD (PAO) 3’- 5’ BamHI GTG GAT CCT CAT CGG CTG GCC TCC AG 
nirL (PAO) 5’- 3’ NdeI TGC ATA TGA ACC CCG TCG AAC C 
nirL (PAO) 3’- 5’ BamHI TTG GAT CCT CAT CCA TGG CGG CGC TCC 
nirG (PAO) 5’- 3’ NdeI TGC ATA TGG ATG AGT TCG ACC 
nirG (PAO) 3’- 5’ BamHI TGG GAT CCG TCA GAG GGG GAA ATG C 
nirH (PAO) 5’- 3’ NdeI TCC ATA TGT CGG CCT GCA TTT CC 
nirH (PAO) 3’- 5’ BamHI GTG GAT CCT CAG CAT GGA CGT TCCTCC 
nirE (PAO) 5’- 3’ NdeI TGC ATA TGA ACA CTA CCG TGA TTC CG 
nirE (PAO) 3’- 5’ BamHI TCG GAT CCG ATC AGG CGC ATG CGA C 
Link and Lock Primers 
nirF (PAO) 5’- 3’ NheI-RBS 
TCA GCT AGC GAG GAG TTA TAT ATC ATG AAC 
CTG CGT CCC CTC 
nirF (PAO) 3’- 5’ XbaI-BamHI 
TAT GGA TCC AAA TCT AGA TCC TAG AGT CCG 
ATG TGC 
nirD (PAO) 5’- 3’ NheI-RBS 
ATC GCT AGC AGG AGA TCA CAG CTC ATG GAC 
GAC CTC TCC CGC 
nirD (PAO) 3’- 5’ XbaI-BamHI 
TAT GGA TCC AAA TCT AGA TCA TCG GCT GGC 
CTC CAG 
nirL (PAO) 5’- 3’ NheI-RBS 
GAT GCT AGC AGG AGA TCA CAC CAG ATG AAC 
CCC GTC GAA CC 
nirL (PAO) 3’- 5’ XbaI-BamHI 
GTA GGA TCC AAA TCT AGA TCA TCC ATG GCG 
GCG CTC C 
nirG (PAO) 5’- 3’ NheI-RBS 
TAT GCT AGC AGG AGA TCA CAG ATC ATG GAT 
GAG TTC GAC CGG 
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nirG (PAO) 3’- 5’ XbaI-BamHI 
GAA GGA TCC AGA TCT AGA GTC AGA GGG GGA 
AAT GCA G 
nirH (PAO) 5’- 3’ NheI-RBS 
CTA GCT AGC AGG AGA TCT CAG CTC ATG TCG 
GCC TGC ATT TCC 
nirH (PAO) 3’- 5’ XbaI-BamHI 
TCA GGA TCC TAA TCT AGA TCA GCA TGG ACG 
TTC CTC C 
nirJ (PAO) 5’- 3’ NheI-RBS 
TAT GCT AGC AGG AGA AGA TTG TCC ATG CTG 
AGG ATC AG 
nirJ (PAO) 3’- 5’ XbaI-BamHI 
TTA GGA TCC AAA TCT AGA CCT TAG ACG GCG 
TGC AGC 
nirE (PAO) 5’- 3’ NheI-RBS 
TCA GCT AGC GAG GAG TTA TAT ATC ATG AAC 
ACT ACC GTG ATT CCG 
nirE (PAO) 3’- 5’ XbaI-BamHI 
TAT GGA TCC AAA TCT AGA GAT CAG GCG CAT 
GCG AC 
nirJ (Pa. Pantotrophus) 5’- 3’ 
NdeI 
TAT CAT ATG TTC CGC CTG ACC C 
nirJ (Pa. Pantotrophus) ) 5’- 3’ 
NheI-RBS 
ATC GCT AGC  AGG AGA TCA CAG CTC ATG TTC 
CGC CTG ACC C 
nirJ (Pa. Pantotrophus) 
 3’- 5’ XbaI- SacI 
ATA GAG CTC AGA TCT AGA CTA AAG AAA GCG 
GTG GGC 
 
NdeI = CATATG BamHI = GGATCC      Stop = TAG/TAA/TGA 
XbaI = TCTAGA SpeI = ACTAGT             NheI = GCTAGC 
RBS in pET14b = AGGAG (A) 
 
2.2.9. T-Vector cloning of PCR products 
All PCR products of predicted size, having been isolated and purified from an 
agarose gel (Section 2.2.5) were cloned using the pGEM®-T Easy vector system 
from Promega (refer to the manual more in depth details or plasmid map in the 
appendix). Briefly, an ’A’- overhang generated on the DNA fragment during PCR 
can be ligated to the cohesive ’T’- overhang of pGEM-T Easy without the need for 
restriction prior to ligation Figure 2.1. The ligation mixture is then transformed in 
JM109 cells (Section 2.2.7.2) incubated overnight on IPTG / X-gal / Amp plates for 
blue/white selection. Colonies that were white were selected as they contained the 
plasmid with the gene of interest, due to the disruption of the β-galactosidase gene. 
Those that were blue were not selected, as they were re-ligated plasmid 
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Figure 2.1:  The promoter and multiple cloning sequences of pGEMT and 
pGEMT-Easy Vectors. 
The top strand of the sequence shown corresponds to the RNA synthesised by T7 
RNA polymerase. The bottom strand corresponds to the RNA synthesised by SP6 
RNA polymerase.  
        T7 Transcription Start 
 
5’. . . TGTAA TACGA CTCAC TATAG GGCGA ATTGG GCCCG ACGTC GCATG CTCCC GGCCG CCATG 
3’. . . ACATT ATGCT GAGTG ATATC CCGCT TAACC CGGGC TGCAG CGTAC GAGGG CCGGC GGTAC 
 
                T7 Promoter             Apa I          Aat II         Sph I                       BstZ I          Nco I  
 

GCGGC CGCGG GAATT CGATT3’               ATCAC TAGTG AATTC GCGGC CGCCT GCAGG TCGAC 
         (CLONED INSERT) 
CGCCG GCGCC CTTAA GCTA          3’TTAGTG ATCAC TTAAG CGCCG GCGGA CGTCC AGCTG 
 
     Not I                                                                                                                                  Not I 
                       Sac II     EcoR I                               Spe I         EcoR I           BstZ I               Pst  I          Sal I 
     
 
 
         SP6 Transcription Start 
 
 
CATAT GGGA GAGCT CCCAA CGCGT TGGAT GCATA GCTTG AGTAT TCTAT AGTGT CACCT AAAT . . . 3’

GTATA CCCT CTCGA GGGTT GCGCA ACCTA CGTAT CGAAC TCATA AGATA TCACA GTGGA TTTA . . . 5’ 
 
SP6 Promoter 
     Nde I                  Sac I                  Bst X I                  Nsi I 
 
 
 
2.2.10. Subcloning into pET14b:  
NdeI – BamHI for Protein Expression in pET14b 
The genes with primers designed to introduce NdeI (CATATG) and BamHI 
(GGATCC) at the 5’ and 3’ sites respectively, were all subcloned into pET14b, via 
pGEM-T® E vector containing the PCR product. The introduction of these sites 
allowed easy in frame cloning into pET14b, which contains a N-terminal histag 
sequence (CAT x 6) allowing the encoded protein to be produced as a N-terminal 
poly-histidine tagged fusion protein. This conveniently allows protein 
overproduction and recombinant protein affinity purification by metal chelate 
chromatography. For the full method refer to the Novagen pET system instruction 
manual (Novagen). To confirm the sequence of the gene was correct, all vectors 
were sent off for sequencing. 
The gene and plasmid were restricted to have complementary sites (Section 2.2.3) 
and ligated accordingly (Section 2.2.6) after isolating the fragment by agarose gel 
(Section 2.2.4.) and gel extraction (Section 2.2.5). 
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Figure 2.2:  The promoter and multiple cloning sites of pET14b 
The pET-14b vector carries an N-terminal HisTag sequence followed by a thrombin 
site and three cloning sites. The cloning / expression region of the coding strand 
transcribed by T7 RNA polymerase is shown below. 
 
 
T7 promoter primer 
 
T7 promoter 
 
AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAA 
 
 
  Bgl II                                                                                                                                                  Xba I 
 
                His-Tag 
GAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGCTCGAG 
                                   Met Gly Ser  Ser   His   His  His  His  His  His Ser  Ser Gly Leu Val Pro  Arg    Gly  Ser   His  Met Leu Glu  
 
 
         RBS                  Nco I                                                                                                                                   Thrombin                      Nde I    Xho I   
 
 
                                
                                                                                                            T7 terminator primer 
  
GATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGC 
Asp  Pro  Ala  Ala  Asn  Lys Ala  Arg  Lys Glu Ala  Glu  Leu  Ala Ala  Ala Thr  Ala Glu Gln End 
T7 
 
BamH I 
 
CTCTAAACGGGTCTTGAGGGGTTTTTTG 
 
      terminator 
 
 
 
2.2.11. Subcloning into pUCP Nde/Nco for Expression in Ps. aeruginosa 
Since Ps. aeruginosa does not recognise the T7 promoter, a new system was 
formulated to facilitate recombinant protein overproduction in Ps. aeruginosa. 
Various plasmids were screened for transformation efficiency in Ps. aeruginosa and 
suitable multiple cloning sites. The plasmid most compatible in both cases was 
pUCP19-Nde / Nco an Escherichia-Pseudomonas shuttle vector for recombinant 
protein over expression in Pseudomonas (Cronin and McIntire 1999). This vector, 
being under the control of a lac promoter, allows the genes to be over expressed and 
induced to over produce the proteins by the addition of IPTG.  A simplified map of 
the vector is shown in Figure 2.3, please refer to the paper for more detail (Cronin 
and McIntire 1999). 
 
The nir genes were individually subcloned from pET14b into pUCP19-NcoI (ampR 
carbR), using the pET14b restriction sites NcoI (CCATGG) BamHI (GGATCC). 
This allowed both the gene and the histag to be subcloned into pUCP19-NcoI and 
allowed recombinant protein overproduction in Ps. aeruginosa. The resultant 
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homologously expressed recombinant protein was then purified by metal chelate 
chromatography. 
 
Similarly, the genes were all subcloned using the NdeI (CATATG) and BamHI 
(GGATCC) restriction sites, into pUCP19-Nde (ampR carbR). This allowed 
expression of the various genes without encoding for a histag, subsequently 
producing a non-histagged recombinant protein in Ps. aeruginosa. 
 
 
Figure 2.3:  The promoter and multiple cloning sites of pUCP-Nde / pUCP-Nco 
Protein expression vectors pUCP-Nco and pUCP-Nde. The relative lengths and 
coding directions of the lacZα, β-lactamase (bla), and pRO1614-derived replication 
(rep) genes within the pUCP-Nde vector are indicated, together with the ColE I 
replication origin (ori) and unique restriction sites. The differences between the 
pUCP-Nde and pUCP-Nco vectors are four base pairs surrounding the lacZa 
translational start codon that places it within the context of, respectively, a NdeI or 
NcoI restriction enzyme cloning site (Cronin and McIntire 1999). 
 
                      Nru I 
 
 Eco RI                                                     rep 
  Sac I 
 Kpn I 
 Sma I 
 BamHI    
      lacZα                         bla                  
 Xba I 
 Sal I 
  Pst I 
  Sph I 
 Hind III                                                   ori 
 
  Nde I or Nco I 
                         Spe I       
     
            
  pUCP - Nde:    CAT GGT CAT ATG TGT 
 
  pUCP – Nco:   CAT GGC CAT GGC TGT 
                                 lacZα 
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2.2.12. Link and Lock construction of haem d1 operon 
 The Link and Lock Cloning strategy, as devised by Dr Evelyne Deery and Dr Helen 
McGoldrick, allows the consecutive cloning of genes into a plasmid in a specified 
order. It utilises the ability of restriction enzymes to restrict at different recognition 
sequences but generating the same sticky end overhangs, thus forming compatible 
cohesive ends. These when ligated, do not generate the same restriction sites and 
therefore can be re-used in introducing other genes, under the proviso that they do 
not occur naturally within the genes or plasmid.  In this way we utilise the ability of 
neoisoschizomer restriction enzymes to clone our operon. 
 
 In this study we used NheI (GCTAGC) and XbaI (TCTAGA) both forming 
compatible cohesive ends, which when ligated are no longer restrictable, see Figure 
2.4. These sites are not found within the nir genes or the plasmid, pUCPNde/Nco. 
Primers were designed for each of the genes nirE, nirJ, nirG, nirH, nirL, nirD and 
nirF, to introduce, NdeI (CATATG) and a ribosome binding site (AGGAG (A)) for 
the first gene (nirE or nirF) and then NheI (GCTAGC) sites and a ribosome binding 
sites (AGGAG (A)) at the 5` end for all other genes. XbaI (TCTAGA) and BamHI 
(GGATCC) restriction sites were introduced at the 3` termini of all the nir genes. 
Refer to Table 2.8 for a comprehensive list of primers. The introduction of these 
sites allowed link and lock cloning of the operon into the pUCPNde expression 
vector allowing the encoded proteins to be expressed both within E. coli (JM109) 
and wild type Ps. aeruginosa (PAO1).  
 
The first gene in the sequence, for example nirE, was cloned into the plasmid using 
NdeI at the 5’end and XbaI – BamHI at the 3’end. The next gene and all subsequent 
genes are then cloned with NheI at the 5’ end and XbaI – BamHI at the 3’ end. The 
plasmid is then restricted with XbaI and BamHI, and the gene to be consecutively 
cloned is restricted with NheI and BamHI. These are then ligated utilising the 
compatibility of XbaI and NheI, and BamHI to BamHI, to form a plasmid with two 
genes. Since ligated XbaI and NheI are no longer restrictable, they can be reused to 
consecutively clone genes into the plasmid in subsequent steps. This has been shown 
diagrammatically in Figure 2.5. 
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Figure 2.4:  XbaI and NheI; the formation of compatible cohesive ends 
XbaI and NheI are examples of neoschizomers with a clear advantage. Both 
recognize the same sequence but XbaI cleaves after the first T, while NheI cleaves 
after the first G generating the same overhang and compatible cohesive ends. These 
when ligated are no longer restrictable by XbaI and NheI, allowing their subsequent 
reuse. In this case only BfaI can recleave the same site. 
 
 
XbaI 5’....TCTAGA….3’    5’.…GCTAGC.…3’  NheI  
              3’…AGATCT.…5’    3’.…CGATCG.…5’ 
 
       restricted    
 
 
 
XbaI 5’....T      5’….CTAGC….3’  NheI 
             3’....AGATC….5’              G….5’ 
 
      Ligated together as they have compatable ends 
 
 
 
5’...TCTAGC…3’            
3’...AGATCG…5’ 
   
                  Original restriction sites are lost and can be re-used 
                              in consecutive cloning of genes into single plasmid. 
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Figure 2.5:  Diagrammatic representation of link and lock method of cloning 
 XbaI and NheI have been used to illustrate this but other combinations are possible. 
 
   NdeI    BamHI                                                         NdeI    XbaI-BamHI 
 
 
NdeI, BamHI restricted plasmid                                                      NdeI, BamHI restricted gene A fragment 
 
 
                 ligation 
          
    
                           
            NdeI    XbaI-BamHI 
            
    
pUCP -A 
    Restriction of plasmid with XbaI, BamHI 
         
               Ligation of NheI, BamHI restricted gene B to plasmid 
      NheI     XbaI-BamHI 
 
 
                                                    XbaI-NheI    
                                                           NdeI             XbaI- BamHI 
                                    
pUCP-AB  
    
XbaI from A joins to NheI from B 
and are no longer restrictable.    Restriction of plasmid with XbaI, BamHI 
This allows them to be re-used to      
cloned the next gene, C          
               Ligation of NheI, BamHI restricted gene C to plasmid 
      NheI     XbaI-BamHI 
 
 
          XbaI-NheI  XbaI-NheI     
  NdeI          XbaI- BamHI 
pUCP-ABC 
 
 
XbaI from B joins to NheI from C 
and are no longer restrictable.    Restriction of plasmid with XbaI, BamHI 
This allows them to be re-used to      
cloned the next gene, D         
               Ligation of NheI, BamHI restricted gene D to plasmid 
      NheI     XbaI-BamHI 
 
 
 
      XbaI-NheI    XbaI-NheI             
                                   NdeI            XbaI-NheI          XbaI- BamHI  
pUCP-ABCD 
 
 
 
 
In this manner we may continue to clone genes consecutively into the plasmid, to 
obtain operons in a single plasmid 
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2.2.13. Restriction analysis of nir genes in haem d1 operon 
To aid in the detection of each nir gene as it was consecutively cloned into the 
plasmid, restriction enzymes unique to each gene were identified for ease of 
restriction analysis. This has been summarised in Table 2.9. 
Table 2.9: Restriction enzymes unique to each nir gene and plasmid  
Each nir gene is shown relative to its position in the original operon, thus each 
restriction enzyme site is shown relative to it position in the gene, and not in the 
plasmid. The positions of restriction enzymes cutting once or twice in the plasmid 
are shown also. *  = in MCS 
 PUCPNde/Nco 
nirF 
391 – 
1569  
nirD 
1578 – 
2030 
nirL 
2027 – 
2551 
nirG 
2544 – 
2987  
nirH 
2962 - 
3477 
nirJ  
3471 - 
4634 
nirE 
4645 - 
5484 
AatII 424 / 3831 1256 X 2268 X 3206 X X 
AvaI 1626 842 / 868 / 1521 1794 X X X 
4313 / 
4605 X 
AscI X X X X X X 4605 X 
BamHI 1631 X X X X X X X 
EcoRI 1610 1411 X X X X X X 
HincII 844 / 1643* 861 / 1311 1847 2284 X X X 5016 
NarI 196 X 2139 2561 X 3276 X 
4715 / 
4979 / 
5318 / 
5441 
NcoI 1681 if pUCPNco X X 2542 X 3317 X X 
NdeI 1681 if pUCPNde X X X X X X X 
NheI X X X X X X X X 
NruI 1353 626 X X 2833 X X X 
PstI X X X X X X 4491 5132 
SalI X 859 X 2282 X X X 5014 
SpeI 2020 X X X X X X X 
XbaI 
 1637* X X X X X X X 
XhoI X X X X X X 4605 X 
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2.3. Biochemical Methods 
2.3.1 Protein assay (Bradford Assay) 
The Bradford assay allows the estimation of the quantity of protein in a solution.  
Briefly, a 5 µl of the sample aliquot of eluted protein was added to 5 µl of coomassie 
blue G250 dye (BioRad) and a 15 µl of dH2O.  The dye has absorbance maxima 
between 470 to 650 nm in the red cationic state, but in the presence of protein this 
shifts to the blue anionic form, having absorbance maxima of 590 to 620 nm. Thus, 
allowing the exact quantity of protein to be determined by observation at 595 nm, 
referring to a standard curve generated using bovine serum albumin at 5, 10, 15, 20 
and 25 µg.  
 
2.3.2 A280 protein concentration estimation 
Recording the optical density of the protein solution at 280 nm and the calculated 
extinction co-efficient for the protein, and then using the following equation, 
determined the concentration of protein in a solution (Layne 1957): 
                       A280 = concentration x extinction co-efficient 
Further, to obtain mg/ml: 
          mg / ml protein concentration = molecular mass x concentration 
The extinction co-efficients and molecular weights have been recorded in the 
appendix for ease of reference. 
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2.3.3 Standard cloning, growth and purification of histagged proteins 
Detailed information on growth parameters for each of the proteins overproduced 
can be found in the respective chapters. 
2.3.3.1 Protein overproduction in E. coli 
 To facilitate recombinant protein overproduction, the pET14b-nir gene plasmid 
constructs were individually transformed into E. coli BL21 (DE3) pLysS strains in 
which the T7 polymerase is induced by the addition of IPTG  (Novagen).  
 An overnight starter culture of 1 colony in 10 ml LB (plus ampicillin 100 mg/l and 
Chloramphenicol 34 mg/l) grown aerobically at 37 C, was used to inoculate 1L LB 
medium and grown at 37 C plus ampicillin 100 mg/l and Chloramphenicol 34 mg/l 
at the 37 ºC, until the OD600 reached approximately 0.6. IPTG was then added to a 
final concentration of 0.4 mM. Cultures were further incubated as appropriate at 37 
C or 16 C, before harvesting by centrifugation (10 000 x g, 4 C). The bacterial 
pellets were resuspended in the appropriate binding buffer (5 mM imidazole, 0.5 M 
NaCl, 20 mM buffer).  Proteins were purified as described in the pET system manual 
(Novagen) using metal chelate chromatography.  
2.3.3.2 Protein overproduction in Ps. aeruginosa 
 The appropriate pUCP – nir histidine tagged plasmid constructs were individually 
transformed into Ps. aeruginosa (wild type), in which the promoter, lac polymerase 
is induced by the addition of IPTG.  
An overnight starter culture of 1 colony in 10 ml LB (plus Carbenecillin 500 mg/l) 
grown aerobically at 37 C, was used to inoculate 1L LB medium and grown at 37 
C plus Carbenecillin 500 mg/l at the 37 ºC, until the OD578 reached approximately 
0.9. IPTG was then added to a final concentration of 1 mM. Cultures were further 
incubated as appropriate at 37 C or 16 C, before harvesting by centrifugation (10 
000 x g, 4 C). The bacterial pellets were resuspended in the appropriate binding 
buffer (5 mM imidazole, 0.5 M NaCl, 20 mM buffer).  Proteins were then purified in 
the same way, using metal chelate chromatography. The proteins were overproduced 
aerobically (shaking) and anaerobically (no shaking) covering the culture with sterile 
mineral oil and the addition of sterile sodium nitrate at a final concentration of 25 
mM. 
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2.3.3.3 Sonication of bacteria 
Prior to purification, the crude cell fractions were sonicated using a SonicsVibracell 
Ultrasonic processor, with an output between 20 and 30 watts. To the pellet, 1 
complete, mini, EDTA-free protease inhibitor cocktail tablet was added per litre to 
be sonicated to prevent protein degradation. These inhibit serine and cysteine 
proteases, and the absence of EDTA allows for the stability and function of metal 
dependant proteins. Sonication was performed in burst of 30 secs on and 30 sec off, 
approximately 6 times, or until the cells were sufficiently lysed.  The lysed cells 
were then centrifuged at 16,000 rpm for 20 min at 4 C. The resultant supernatants 
containing soluble protein were then subject to purification by metal chelate 
chromatography. 
 
2.3.3.4 Purification by Metal chelate chromatography 
The overproduced recombinant protein is fused to an N-terminal Histag. This allows 
us to purify the protein by exploiting the affinity that histidine has for chelating to 
metals such as Cu 2+, Zn2+, Fs3+, and Ni2+. Therefore, Chelating Sepharose fast flow 
resin, with immobilised Ni2+ will selectively bind and retain the recombinant protein 
whilst unbound proteins are washed away. The bound recombinant proteins are then 
isolated from the column by competition elution with imidazole. For a detailed 
methodology please refer to the Amersham Biosciences Chelating Sepharose Fast 
Flow instruction manual. 
Purification of the various proteins has been detailed individually in the appropriate 
chapters for brevity. To summarise columns containing ~5mls of resin were charged 
using 0.1M NiSO4 (15 ml) and equilibrated with the appropriate binding buffer for 
the protein (15 ml). The supernatant from the sonicated extract (Section 2.4.3.3) was 
then applied to the column and allowed to flow through. The columns were washed 
with binding buffer, and wash buffers of increasing imidazole concentration (50 mM 
then 100 mM). The proteins were eluted in 2 ml fractions using elution buffer (400 
mM imidazole), and stored on ice. The presence of protein in the fractions was 
detected by the BioRad protein assay (Section 2.3.1) and SDS-PAGE (Section 
2.3.4). 
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2.3.3.5 Histag Cleavage 
One unit of thrombin is required to cleave one milligram of protein. Therefore. The 
concentration of protein was estimated by A280, and an appropriate volume of 
thrombin was added to the protein solution and left overnight at 4 °C. Cleavage was 
checked by running both samples on a SDS-PAGE gel. 
 
2.3.3.6 Buffer Exchange / Desalting 
Purified protein was desalted or changed into a different buffer using pre-packed 
Sephadex G25, pD10 columns, details can be found in the manual (Amersham). The 
column is pre-equilibrated with 50 ml of the buffer into which the protein is to be 
exchanged, before adding 2.5 ml of the protein sample. The protein is then eluted 
into 3.5 ml of the new buffer 
 
2.3.3.7 Gel filtration / Fast protein liquid chromatography 
Where possible, to further remove protein aggregates and to estimate native 
molecular weight of the protein, a sufficiently concentrated solution of protein was 
loaded onto pre-packed high flow, high resolution Superdex 75 column (molecular 
mass range 5 x 102 to 7 x 104 or) or High Prep Sephadex 200 column, in conjunction 
with Äkta FPLC (all from Amersham). These were pre equilibrated with 1.5 - 2 
column volumes of column buffer as per the protein. The protein is then eluted at 0.5 
ml/min or 1.0 ml/min into 0.5 ml or 1 ml fractions with buffer as appropriate to the 
protein. Fractions were analysed by SDS-PAGE and the purest fractions pooled. The 
columns are then washed with wash buffer and stored in storage buffer. Details of all 
the buffers used can be found in Section 2.1.6.4. 
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2.3.4 Poly- Acrylamide Gel Electrophoresis (PAGE) of proteins 
The composition of all the buffers, solutions and stacking and running gels are 
detailed in Section 2.1.6.2. 
 
2.3.4.1 SDS-PAGE of proteins 
In order to visualise the purity and integrity of the resultant overproduced proteins, 
SDS-PAGE was performed according to the method outlined by Laemmli (Laemmli 
1970). This is widely used for the separation of proteins by molecular weight and 
charge. Gels typically consist of a resolving gel (pH 8.8) for protein separation and a 
stacking gel (pH 6.8) that focuses the proteins prior to entering the resolving gel. 
The final percentage of acrylamide was determined according to the molecular 
weight of the protein to be identified. Since all the proteins in this study were in the 
region of 19 to 46 kDa, a 12.5 % acrylamide gel was sufficient for resolution.    
Protein samples were denatured by addition of an equal volume of SDS buffer to the 
sample and boiling for 5 minutes.  Once the gel had polymerised, the gel plate 
sandwich was placed into an electrophoresis chamber (Atto Dual Mini Slab 
AE6450) flooded with SDS running buffer. Samples were loaded into the wells 
alongside a Dalton VII molecular weight marker, with known protein sizes as a 
standard. Electrophoresis was performed at a constant voltage of 200 V until the 
loading dye front (bromophenol blue) reached the end of the gel plate. The gels were 
removed carefully from the apparatus and stained with coomassie blue stain and de-
stained using water. They are then dried between two sheets of cellophane (BioRad), 
for convenient storage. 
 
2.3.4.2 Native-PAGE of proteins 
Native gels or non-denaturing gels were prepared as described in Section 2.1.6.2, 
with the exception of the non-denaturing nature of the loading sample buffer (no 
SDS) and the samples not being boiled. Thus in this type of separation we may 
anticipate the presence of multimeric unfolded states native to the protein. Compact 
conformations have a higher mobility through the gel whereas larger structures, like 
oligomers, have lower mobility. The samples are directly loaded onto the gel after 
adding the loading sample buffer. A native molecular weight marker is used as a 
standard. Electrophoresis is performed on the same apparatus at a constant voltage 
of 100 V. After electrophoresis, the gels are removed carefully from the apparatus 
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and stained with coomassie blue stain and de-stained using water. They are then 
dried between two sheets of cellophane (BioRad), for convenient storage. 
 
2.3.5 Western blotting of Histagged proteins 
The composition of all the buffers, solutions and stacking and running gels are 
detailed in Section 2.1.6.3. 
 
2.3.5.1 SDS-PAGE for Western blotting of proteins 
Gels and samples were prepared and run as in the same way as before as detailed in 
Section 2.3.4.1, except the electrophoresis was performed at a constant voltage of 
150 V and a pre stained high or low molecular weight marker was used instead of 
Dalton VII as a standard. 
 
2.3.5.2 Western blotting 
Proteins separated on a denaturing polyacrylamide gel were electrophoretically 
transferred onto a Hybond-P, hydrophobic polyvinylidene difluoride (PVDF) 
membrane (Hybond-P (Pharmacia)) membrane using the method outlined by 
(Towbin, Staehelin et al. 1979).  
 
The unstained SDS-PAGE gels, blotting paper, fibre pads were all pre-soaked in 
cold transfer buffer (20 % Methanol, 192 mM Glycine, 25 mM Tris). The PVDF 
transfer membrane (Hybond-P (Pharmacia)) was saturated in 100 % methanol, then 
water before soaking in transfer buffer.  
 
The blot was arranged as shown in Figure 2.5 ensuring no air bubbles were present, 
and placed in a BioRad gel cassette with an ice block, in ice-cold transfer buffer. 
The proteins were transferred to the membrane by passing 100 V for 1 h in to the 
cassette. After the transfer, the PVDF membranes were blocked for 2 hrs in 5 % 
non-fat milk in PBS (or overnight at 4 °C) to block non-specific sites, on a platform 
shaker (140 mM NaCl, 3 mM KCl, 10 mM Na2HPO4, 2 mMKH2PO4).  
 
 
 
 
 
Vina Parmar                                                                        Chapter 2: Materials and Methods: page 88 
88 
Figure 2.6: Assembly of the western blotting apparatus 
The Western blot must be assembled in the order here, starting from the black anode 
end assembling upwards. The membrane is closest to the anode, then the gel, 
ensuring there are no air bubbles and that the sandwich is placed in the tank facing 
the right way. The proteins are then transferred to the membrane at 100V for 1hr. 
 
          CATHODE 
  
          GAUZE 
            
          BLOTTING PAPER 
   
           
                     GEL  
                    PVDF MEMBRANE  
             
  
          BLOTTING PAPER  
           
          GAUZE   
          ANODE  
  
 
2.3.5.3 Probing for Histagged proteins 
Once the membrane was been blocked for non specific binding in milk-PBS-
solution, (2 hrs or overnight) to decrease any background activity, the membrane 
was probed for the primary antibody, left overnight (or for 2 hrs) at 4 ° C in 5 % 
non-fat milk in PBS, containing 1/1000 primary antibody (mouse anti-his 
monoclonal antibody, Novagen), with constant gentle agitation.  
 
After washing the membrane with PBS and three times with Tris-NaCl wash buffer 
(50 mM Tris-HCl pH7.5, 150 mm NaCl), the membrane was incubated with the 
secondary antibody, goat anti-mouse IgG alkaline phosphatase conjugate, for 1 hr at 
room temperature at a working dilution of 1:5,000 in 5 % non-fat milk in 50 mM 
Tris, 150 mM NaCl.  
 
The membrane was again washed with Tris-NaCl buffer thoroughly before proteins 
were visualised by incubating the membrane with one tablet of Sigma Fast 
BCIP/NBT (5-Brom-4-choro-3-indolyl phosphate / nitroblue tetrazolium), dissolved 
in 10 ml of water, a substrate for alkaline phosphate. The colour, a dense blue, was 
allowed to develop and then stopped by washing in water. They were then allowed 
to dry and stored in away from light. 
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2.4     Isolation and production of tetrapyrroles 
2.4.1 UltraViolet-Visible Spectroscopy 
All UV-Vis spectra were recorded on a Varian Cary 50 Bio UV-Vis 
spectrophotometer over a range of 300 – 650 nm. 
 
2.4.2 Production of precorrin-2 and sirohydrochlorin in situ from cell 
extracts 
In situ production of precorrin-2 and sirohydrochlorin was performed under a 
nitrogen atmosphere, in a glove box (Belle Technology) with less than 2 ppm 
oxygen. This can be can be performed by synthesising from either ALA, or PBG 
available commercially (Sigma). 
 
This was achieved by incubating the crude soluble extract of recombinant E. coli 
strains over-producing the enzymes required for the transformation of ALA into PC-
2 or SHC (donated by Dr Helen Leech). The reaction mixture was incubated as 
follows: 10.0 mg ALA in a total volume of 40 ml of 50 mM Tris-HCl buffer, pH 8.0, 
containing 5 mg of ALA-dehydratase (HemB, B. megatarium), 5 mg of purified 
PBG deaminase (HemC, B. megatarium), 1 mg purified uroporphyrinogen III 
synthase (HemD, B. megatarium), 5 mg of purified UIII methyltransferase (CobA, 
Ps. denitrificans) and 10 mg of SAM.  If proceeding from PBG, this is done by 
incubating 2.5 mg PBG in a total volume of 40 ml of 50 mM Tris-HCl buffer, pH 
8.0, containing 5 mg of purified PBG deaminase (HemC, B. megatarium), 1 mg 
purified uroporphyrinogen III synthase (HemD, B. megatarium), 5 mg of purified 
UIII methyltransferase (CobA) and 10 mg of SAM. All powdered substances e.g. 
SAM, ALA, or PBG were suspended in 1 ml 50 mM Tris-HCl buffer, pH 8.0, just 
prior to addition and added to a total volume of 40 ml. The reaction mixture is then 
freeze thawed with liquid nitrogen, under vacuum to eliminated any air and left 
overnight under a strictly anaerobic environment at 22 °C to allow it to reach 
completion.  Sirohydrochlorin was generated using the same enzyme cocktail as 
described above, except that 5 mg of PC-2 dehydrogenase (SirC, B. megatarium) 
and 13 mg of NAD+ were added to the incubation.  
 
Prior to use, the mixture is filtered (2 μm) and the UV-Vis spectrum recorded to 
estimate PC-2 or SHC concentration. 
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2.4.3 Production of Precorrin-2 and sirohydrochlorin from purified 
proteins 
This method of production of PC-2 and SHC gives a much higher yield and purer 
form of the substrate. For the production of PC-2, pETcocoABCD (hemB, hemC, 
hemD, cobA) is used and for SHC, pETcocoABCDC (hemB, hemC, hemD, cobA, 
sirC) is used.  
Essentially both methods are identical except for the addition of NAD+ to the 
reaction mixture. Each plasmid is transformed into BL21* DE3 pLysS and plated on 
to LB-agar plates with ampicillin and 0.2 % glucose. A colony is used to inoculate a 
10 ml LB starter culture, which is then used to inoculate 1L of LB and grown at 37 
°C until an OD of 0.2 at which point a final concentration of 0.02 % Arabinose was 
added to the culture. This was further incubated at 37 °C until an OD of 0.6 (2 hrs) 
when the culture was induced with a final concentration of 0.4mM IPTG and left 
overnight at 16 °C. Cells were harvested by centrifugation and resuspended in 10 ml 
50 mM Tris-HCl buffer, pH 8.0. This was divided into four 2.5 ml aliquots, each 
being sufficient for the purpose and stored at –20 °C. 
Pellets were defrosted as required, sonicated, centrifuged and the soluble cell extract 
applied to a metal chelate (Ni) column. Proteins were eluted at 400 mM imidazole 
into 1ml fractions and pooled. Purified protein was taken into the anaerobic glove 
box and passed through a pD10 column to remove any oxygen. 10 mg ALA, 5 mg 
SAM and 10 mg NAD+ were taken into the glove box in powder form. The ALA 
and SAM were each dissolved in 50 mM Tris HCl pH 8.0, 0.1M NaCl to 500 μl and 
combined to give a final total volume of 1 ml and the pH adjusted to pH 8 using 
KOH (10 μl). The NAD+ was dissolved in 50 mM Tris HCl pH 8.0, 0.1M NaCl to 1 
ml. Once the proteins were passed through a pD10 column they were used quickly to 
make the following reaction mixtures: 
  For PC-2    For SHC 
  3 ml buffer 50 mM Tris HCl pH 8.0, 0.1M NaCl 
  1 ml ABCD    1 ml ABCDC 
       1 ml ALA (10 mg) + SAM (5 mg) in 50 mM Tris HCl, 0.1M NaCl (above) 
       1ml NAD+ at 10 mg/ml 
The mixture is left on a warmed heat block (turned off) overnight. There is no need 
to filter the mixture prior to use but the UV-Vis spectrum is used to estimate PC-2 or 
SHC concentration. 
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2.4.4 Production of haem d1 and intermediates 
Two methods were employed in the production of possible intermediates in the 
haem d1 pathway. Primarily, in vivo accumulation was attempted with the expression 
of multigene plasmids constructed in Table 2.4, both within E. coli and Ps. 
aeruginosa. Secondly, these same plasmids were expressed and reacted to pre-made 
PC-2 and SHC under anaerobic conditions. 
 
2.4.4.1 In vivo accumulation of intermediates 
Plasmids containing nir gene combinations of interest were transformed into E. coli 
and Ps. aeruginosa as appropriate and subsequently used to inoculate 1 L of LB and 
grown at 37 °C for 6-8 hrs until the OD reached 0.6. At this point, 0.4 mM IPTG in 
E. coli and 1 mM IPTG in Ps. Aeruginosa was added, as well as the addition of ALA 
(10 mg/ml) and SAM (10 mg/ml). The cultures were then incubated overnight and 
harvested by centrifugation. The media was kept as this stage and the pellets were 
resuspended in 50 mM Tris HCl pH 8.0, 0.1M NaCl and sonicated for 30 sec on, 30 
sec off three times at an amplitude of 10 μm. The resultant soluble cell extract and 
media was applied to a DEAE sephacel column or RP18 column aerobically or 
anaerobically. The columns were then washed as outlined for the type of column in 
Section 2.4.6 and Section 2.4.7, and any accumulated compounds were analysed by 
a UV-Vis spectrophotometer (HP-352 photodiode array). 
 
2.4.4.2 In vitro accumulation of intermediates 
PC-2 and SHC were synthesised anaerobically as described in Section 2.4.2 and 
Section 2.4.3. Accordingly the nir genes singularly or combinations thereof were 
expressed in either E. coli or Ps. aeruginosa.  The single expressed genes were 
purified if they were tagged, in a buffer as appropriate to the stability of the protein. 
Alternatively if they were not tagged or the multigene plasmids were being 
expressed, the pellet was resuspended in 50 mM Tris HCl pH 8.0, 0.1M NaCl and 
the soluble fraction used after sonication.  The purified protein or soluble cell extract 
was taken into the anaerobic glove box and passed through a pD10 column to 
remove any oxygen from the preparation. Accordingly, each condition as described 
in Chapter 5 was incubated with PC-2 or SHC overnight at 30 °C with or without 
potential cofactors as detailed below. The resultant mixture was applied to a DEAE 
sephacel column or RP18 column, which had been pre-equilibrated the same buffer 
in an anaerobic glove box. The columns were then washed as outlined for the type of 
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column in Section 2.4.6 and Section 2.4.7, and any accumulated compounds were 
analysed by a UV-Vis spectrophotometer (HP-352 photodiode array). 
 
  10 mg/ml NAD+ 
  10 mg/ml NADP 
  10 mg/ml NADPH 
  10 mg/ml SAM 
  1 mM Ferrous (FeII) Sulphate 
  1 mM Sodium Dithionate 
 
Each potential cofactor was taken into the anaerobic glove box in powder form and 
dissolved in 50 mM Tris-HCl pH 8.0, 0.1M NaCl to 6 ml.  
 
2.4.5 In vitro sirohydrochlorin coupled SUMT assay 
The assay was performed using purified SUMT, and a cocktail of HemB, HemC, 
HemD, and SirC. The SUMT (NirE or CobA) was overproduced and purified by 
metal chelate chromatography separately. A plasmid containing all four genes 
HemB, HemC, HemD, and SirC, pET14b-BCDC, was similarly overexpressed and 
the resultant overproduced recombinant proteins were purified in the same fashion 
and eluted at 400 mM imidazole. These were both passed through a pD10 column in 
the anaerobic glove box to remove any oxygen changing the buffer to 50 mM Tris 
HCl pH 8.0, 0.1 M NaCl. 20 mg ALA, 20 mg SAM and 26 mg NAD+ were taken 
into the glove box in powder form and each dissolved in 50 mM Tris-HCl pH 8.0, 
0.1M NaCl to 1 ml.  
 
All Proteins and cofactors were added in excess, except for the SUMT, to a total 
volume of 1 ml in a cuvette in 50 mM Tris-HCl buffer, 100 mM NaCl, pH 8.0, 
buffer. This allowed the reaction to be followed anaerobically by UV-Vis 
spectroscopy. A total of 20 µg ALA, 20 µg SAM, 26 µg NAD+, 200 µg BDCD was 
added to the reaction mixture. The SUMT was added last, incubated at room 
temperature and the reaction was followed at 5-minute intervals over a total of 60 
minutes. At each interval a UV-Vis scan was taken and the absorbance at 376 nm 
was followed to monitor the generation of SHC since SHC has an absorption 
maxima at 376 nm. The concentration of SUMT and the presence of the cofactors 
was varied in the reaction and monitored by UV-Vis spectroscopy. The specific 
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activity was calculated using the extinction coefficient of SHC as 2.4 x 105 M-1cm-1, 
using the equation below: 
 
Specific activity (nmoles/min/mg) = initial rate    x109 
        εSHC x enz mass (g) 
 
Initial rate (abs/min)=   Δ abs  
      ΔTime (min) 
 
2.4.6 Reverse Phase chromatography separation of pigments  
The resultant soluble cell extract was subject to reverse-phase chromatography that 
uses a non-polar stationary phase. Previously most chromatography was done with 
hydrophilic surface chemistry and had a stronger affinity for polar compounds but 
here polar compounds are eluted first while non-polar compounds are retained - 
hence “reversed phase” 
 
Approximately 3 g of RP-18 (particle size 5 μm )is charged with 10ml hexane, 
enough to make a 2 cm column, allowing it to be poured into a column. It is then 
washed with one column volume of 95 % analar ethanol, one column volume of 
ddH2O, and then soluble cell extract is applied to the column. Half a column volume 
of ddH2O is applied and the flowthrough collected. Any pigments or accumulated 
compounds were eluted at 25 % ethanol and collected and analysed by a UV-Vis 
spectrophotometer (HP-352 photodiode array). 
 
2.4.7 Ion exchange chromatography separation of pigments – DEAE 
Sephacyl  
DEAE Sephacyl is a weak anion exchanger based on beaded cellulose. The ion 
exchange group is diethylaminoethyl, which remains charged and maintains 
consistently high capacity over the entire working range, pH 2–9.  
 
The resultant soluble cell extract was applied to a DEAE sephacel column pre-
equilibrated the same buffer in an anaerobic glove box. The columns were then 
washed with two column volumes of the same buffer and any accumulated 
compounds were eluted, by application of 50 mM Tris HCl pH8.0 with 2 M NaCl 
and analysed by a UV-Vis spectrophotometer (HP-352 photodiode array). 
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2.5   Crystallography - Hanging drop method 
Crystallisation trials were carried out using the hanging drop vapour diffusion 
method (McPherson 1976) . Recombinant protein was purified on a metal chelate 
(Ni) column and by FPLC on a seize exclusion column as detailed previously. The 
protein was further concentrated using vivaspin columns (Vivascience). Each 
reservoir of a 24-well crystallisation plate was filled with 500 μl of the buffers from 
Hampton Research Crystal Screen ITM and Crystal Screen IITM. 2 μl of concentrated 
protein samples were mixed with 2 μl of reservoir buffer on a cover slip. The cover 
slip was inverted, placed over the well of the same buffer that was sealed with the 
silicone grease. All the crystallisation trials were carried out at 18 °C or s 
appropriate in a controlled temperature room. 
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3. Characterisation of NirE – a S-Adenosyl-L-methionine uroporphyrinogen 
methyltransferase (SUMT) 
 
3.1. Introduction 
Haem d1 belongs to a family of tetrapyrroles that include vitamin B12, haem, 
chlorophyll and sirohaem, all of which branch from the first macrocyclic 
intermediate uroporphyrinogen III (UIII) (Chapter 1, Figure 1.2). From this point the 
pathway diverges to form the various tetrapyrroles, where decarboxylation of its 
acetate groups directs flux toward haem and chlorophyll synthesis, whereas 
methylation of the UIII macrocycle initiates synthesis toward sirohaem, vitamin B12, 
and haem d1. The UIII macrocycle is shown in Chapter 1, Figure 1.1. 
 
S-Adenosyl-L-methionine uroporphyrinogen III methyltransferase (SUMT) defines a 
group of enzymes that catalyse the methylation of the UIII to produce precorrin-2 
(PC-2, also known as dihydrosirohydrochlorin). Sirohaem, vitamin B12, coenzyme 
F430 and haem d1 all require this reaction as part of their synthesis and so are derived 
from PC-2. Thus, SUMT enzymes are also positioned at a key branch point in the 
synthesis of modified tetrapyrroles directing flux towards these molecules and 
portray some interesting regulatory features. 
 
All SUMT enzymes utilise S-adenosyl-L-methionine (SAM) as the methyl donor to 
insert two methyl groups onto the UIII macrocycle to yield PC-2, by the subsequent 
methylation of UIII at the base of the acetate side chains at positions C2 and C7 to 
produce PC-2. This reaction proceeds via a mono-methylated intermediate precorrin-
1 (PC-1) with the concomitant release of the product S-adenosyl-L-homocysteine 
(SAH). Precorrin-1 is in turn methylated to produce the bis-methylated PC-2 (Figure 
1.19) (Warren, Stolowich et al. 1990). 
 
There exist a plethora of SUMTs that have been discovered in different organisms 
and plants that perform this transformation; these are summarised in Figure 3.1. The 
most well known and well studied is CobA, which is associated with cobalamin 
biosynthesis. This was the first SUMT to be characterised from Ps. denitrificans in 
1989 (Blanche, Debussche et al. 1989). Since then orthologues have been identified 
in B. megatarium as SirA (Raux, Leech et al. 2003), E. coli as CysGA (Warren, 
Roessner et al. 1990), CorA in M. ivanovii (Blanche, Robin et al. 1991) and as 
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UROM Anacystis nidulans R2 (also called Synechococcus sp. PCC7942) (Jones, 
Jenkins et al. 1994) and Met1P in S. cerevisiae (Raux, McVeigh et al. 1999). 
SUMTs also exist in plants as UPM1p in Arabdopsis Thaliana (Leustek, Smith et al. 
1997) and ZmSUMT1 in maize (Sakakibara, Takei et al. 1996). NirE is also 
postulated to be part of the SUMT family. It has been found in Ps. aeruginosa 
(Kawasaki, Arai et al. 1997) and in Pa. denitrificans (Chang and Wu 1986). At 
present, there exists little information on NirE and this chapter reveals new findings. 
 
Figure 3.1: SUMTs and their associated downstream enzymes – a 
diagrammatic representation. 
Outline of the various organism and plant SUMTs transforming UIII to PC-2. The 
majority are involved in sirohaem synthesis. B. subtilis YlnD, YlnE, YlnF are 
renamed SirA, SirB, and SirC respectively to reflect their role in sirohaem synthesis. 
 
  NirE    NirF,D,L,G,H,J 
       UIII        PC-2       HAEM d1 
               (Ps. aeruginosa, Ps. stutzeri, Ps. denitrificans, Pa. denitrificans) 
 
  CobA                       Cob..n   
       UIII        PC-2    VITAMIN B12 
                   (Ps. aeruginosa, Ps. stutzeri Ps. denitrificans) 
  
  CysGA                        CysGB 
       UIII        PC-2    SIROHAEM 
        (E. coli, S. enterica, Ps. denitrificans, Ps. aeruginosa) 
 
  Met1P    Met8P 
       UIII        PC-2    SIROHAEM 
                         (Saccharomyces cerevisiae) 
 
  SirA      SirB, SirC                      (Bacillus megaterium) 
       UIII        PC-2    SIROHEAM 
  YlnD (SirA)       YlnE, YlnF (SirB, SirC)         (Bacillus subtilis) 
 
  
  UPM1p                           (At-SirB) 
       UIII        PC-2    SIROHAEM 
                      (Arabdopsis Thaliana) 
  ZmSUMT1              ? 
       UIII        PC-2    SIROHAEM 
                                              (maize) 
 
  CorA               ? 
       UIII        PC-2      (Methanobacterium ivanovii) 
 
  UROM                            ? 
      UIII           PC-2        SIROHAEM 
                        (Anacystis nidulans R2 (Synechococcus sp)) 
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CobA from Ps. denitrificans is responsible for the C2 and C7 corrin ring 
methylations in the conversion of UIII into PC-2 in the aerobic and anaerobic 
pathways to cobalamin of some thirty enzymes (Blanche, Debussche et al. 1989). 
Sirohaem synthesis is much less complicated than cobalamin requiring only CysG, a 
unique multifunctional enzyme encompassing all the properties to transform UIII 
into sirohaem, in both E. coli and S. enterica (Peakman, Crouzet et al. 1990; Warren, 
Roessner et al. 1990; Wu, Siegel et al. 1991). E. coli and S. enterica CysG have 90 
% homology to each other and have two functional domains; CysGB performing 
dehydrogenation and ferrochelatase activity and CysGA which mediates SUMT 
activity (Warren, Bolt et al. 1994).  
As opposed to the fused multifunctional CysG, B. subtilis and B. megaterium use 
three proteins for the conversion of UIII into sirohaem present in a distinct gene 
cluster. SirA is confirmed to confer SUMT activity; SirC is a PC-2 dehydrogenase 
and SirB a ferrochelatase completing the sirohaem pathway (Johansson and 
Hederstedt 1999; Leech, Raux-Deery et al. 2002; Raux, Leech et al. 2003).  
The enzymes identified for the transformation of UIII into sirohaem in S. cerevisiae 
are Met1p and Met8p. (Hansen, Muldbjerg et al. 1997; Raux, McVeigh et al. 1999). 
Met1p is similar to CysGA conferring SUMT activity and Met8p is a bifunctional 
enzyme with NAD+ dependent PC-2 dehydrogenase and ferrochelatase activity. 
Thus, the roles of Met1p and Met8p are considered to be isofunctional with CysG 
(Raux, McVeigh et al. 1999). MET1p from S. cerevisiae and SirA from Bacilli, 
which function independently, are homologous to CysGA (Warren, Bolt et al. 1994; 
Raux, McVeigh et al. 1999). MET8p and SirC also display similarity to CysGB, but 
SirB has no sequence identity with CysGB, suggesting CysG is somewhat unique in 
that the gene fusion event that created this trifunctional enzyme (Warren, Roessner 
et al. 1990; Warren, Bolt et al. 1994). Although E. coli does not produce vitamin 
B12, S. enterica, does make vitamin B12 anaerobically, suggesting CysG in S. 
enterica is common to both pathways (Raux, McVeigh et al. 1999).  
UPM1p from A. thaliana is identified as an SUMT as part of the sirohaem 
biosynthetic pathway in plants and shown to be ~40kDa with ~43% homology to E. 
coli CysGA. The search for a sirohydrochlorin dehydrogenase continues as it is the 
only missing component of the sirohaem pathway in A. thaliana (Leustek, Smith et 
al. 1997; Raux-Deery, Leech et al. 2005). ZmSUMT1 was isolated and identified to 
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be a SUMT. Its characterisation revealed it to be homodimeric with a molecular 
mass of 52 kDa by gel-filtration chromatography. It displays about 50% similarity to 
the E. coli CysGA SUMT. (Sakakibara, Takei et al. 1996; Fan, Wang et al. 2006).   
 
Resolving the topology of CobA from Ps. Denitrificans (Vevodova, Graham et al. 
2004), has given great insight in to the structure function relationship of SUMT 
activity. It is a homodimer with a subunit mass of 29 kDa and a low catalytic 
efficiency (38/h) (Blanche, Debussche et al. 1989). The position of the SAH binding 
site in CobA is the same in CysG from S. enterica (Stroupe, Leech et al. 2003), also 
a homodimer. A total of nineteen conserved residues have been attributed to 
SAH/SAM binding, including the glycine rich nucleotide binding region denoted by 
GXGXG (GAGPGD) (Vevodova, Graham et al. 2004). The structure of the CysGA 
domain resembles the structure of CbiF, also a homodimer, a cobalt-precorrin-4 
methyltransferase enzyme from B. megaterium in the anaerobic cobalamin pathway 
(Schubert, Wilson et al. 1998), and is concomitant with other cobalamin biosynthetic 
methyltransferases (Frank, Deery et al. 2007). 
 
Substrate inhibition of CobA from B. megaterium and Ps. denitrificans is observed 
at UIII concentrations above 2 μM, values below those found intracellularly 
indicating a regulatory role in SUMT activity and flux through the cobalamin 
pathway by way of feedback inhibition. CobA was also found to be sensitive to S-
adenosyl-L-homocysteine (SAH) but not to any other vitamin B12 intermediates, 
providing another regulatory mechanism. (Blanche, Debussche et al. 1989; Crouzet, 
Cauchois et al. 1990).  B. megatarium SirA was observed to have substrate 
inhibition with UIII concentrations ([UIII]) above 0.5 μM. However, it was desirable 
to obtain an SUMT that does not exhibit substrate inhibition to allow greater flux 
through these pathways. Such a SUMT was found in a methanogen called M. 
ivanovii which did not display substrate inhibition until a [UIII] close to 20 μM was 
reached (Blanche, Robin et al. 1991). It is perceived that since methanogens require 
such high levels of coenzyme F430 that inhibition does not occur at low UIII 
substrate concentrations. Therefore in comparison, SUMT substrate inhibition as 
observed in B. megaterium and Ps. denitrificans can be attributed to the lower 
requirement of cobalamin in these organisms (Robin, Blanche et al. 1991; Fan, 
Wang et al. 2006). 
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The nirE gene was first discovered in Pa. denitrificans, downstream of nirS (de 
Boer, Reijnders et al. 1994). It has since been found in Ps. aeruginosa (Kawasaki, 
Arai et al. 1997) and in Ps. stutzeri (Palmedo, Seither et al. 1995).  Vollack et al 
1998, used Southern hybridisation to probe for denitrification genes in Ps. 
aeruginosa and found two signals for nirE. Further analysis revealed that one 
persisted more and was part of the nir gene cluster (Vollack, Xie et al. 1998). The 
signal not associated with the nir cluster is presumably another SUMT, CobA or 
CysG. This demonstrates the importance of enzyme multiplicity as a factor for tight 
regulation of flux towards the biosynthesis of different tetrapyrroles in Ps. 
aeruginosa. 
 
NirE has been reported to be a SUMT of the haem d1 pathway on the basis of 
sequence similarity to well the characterised SUMTs discussed previously. However 
the activity of NirE has never been demonstrated to transform UIII to PC-2 
experimentally. Only from mutational and complementation studies, has it been 
shown that nirE is essential for haem d1 biosynthesis. Palmedo et al used mutational 
analysis in Ps. stutzeri to show that if any one or all nir genes are defective it results 
in an inactive semi apoform of cytochrome cd1, lacking haem d1 but containing 
haem c (Palmedo, Seither et al. 1995). Kawasaki et al showed the same in Ps. 
aeruginosa by mutational analysis as well as complementation, both indicating nirE 
is essential for haem d1 biosynthesis (Kawasaki, Arai et al. 1997). 
 
The connection of haem d1 to the tetrapyrrole biosynthetic pathway was established 
by the unique stereo-specificity and origins of the macrocycle and its peripheral 
groups. The source of the methyl groups at C2 and C7 is SAM and implicates C-
methylation as part of the route to haem d1 (Yap-Bondoc, Bondoc et al. 1990). 
Experiments using labelled ALA showed the haem d1 macrocycle is derived form 
ALA, including the carbonyls at C3 and C8 except for the methyls at C2 and C7 
(Matthews 1993). The exact stereo-specificity of the methyl groups on haem d1 was 
found to be exactly the same as vitamin B12, sirohaem and its intermediates, in the 
absolute configuration of 2R, 7R. This further implicates that methylation occurs as 
part of the haem d1 pathway consistent with the transformation of UIII to PC-2 
(Micklefield 1997).  
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Thus, methylation of UIII forming PC-2 is common to all these pathways differing 
in the enzyme utilised within the organism as well as the pathway. Indeed there 
exists an evolutionary advantage to have more than one SUMT in a single organism, 
as increased levels of substrate, and different levels of substrate inhibition for each 
SUMT allows tight regulation of tetrapyrrole biosynthesis. The presence of NirE 
may pose some advantage or specificity in its activity and is as yet to be discovered. 
 
In this chapter, nirE is cloned, overexpressed and the resultant recombinant protein 
purified and characterised from two different systems; the first overproduces NirE 
heterologously in E. coli and the second uses Ps. aeruginosa for the overproduction 
of NirE homologously. The roles of a number of residues are discussed with respect 
to their conservation across the family of SUMTs. NirE is shown for the first time to 
be a functionally active enzyme, performing the transformation from UIII to PC-2, 
both in vivo and in vitro as part of the haem d1 pathway. 
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RESULTS AND DISCUSSION 
 
3.2. Sequence identity of NirE to various SUMTs  
Sequence identity of NirE from Pseudomonads to CobA of Ps. denitrificans is 
documented in the region of 45.1 % with 56.8 % identity to CysG from E. coli and 
57.6 % to CysG from S. enterica (Palmedo, Seither et al. 1995; Kawasaki, Arai et al. 
1997).  
 
Since CobA is well characterised, NirE has been aligned with CobA showing a 
similarity of 50.3 % and an amino acid identity of 37.3 %, shown in Figure 3.2. The 
aligned nucleotide sequences of CobA from Ps. denitrificans (843 base pairs) with 
NirE from Ps. aeruginosa (839 base pairs) an identity of 56.0 %. The similarity of 
NirE to the well-characterised SUMT enzymes is shown in a multiple alignment 
(Figure 3.3). One can see there are 31 completely conserved amino acid residues 
across the various SUMTs. A highly conserved SAM binding site is evident in NirE 
as with the other SUMTs with a GXGXG region, highlighted by the green box in 
Figure 3.3. The sequence identity of these SUMT enzymes to NirE and relative to 
each other has been summarised in Table 4.1, on the bases of pair wise alignments 
using ClustalW. Clearly they have a high degree of similarity and identity to each 
other portraying an average sequence identity of 45 %. The lowest with Met1p at 30 
% and the highest being with NirE from Ps.  stutzeri at 63 %. 
 
The alignment of NirE with CysG has been performed with the CysGA C-terminal 
domain, as CysGB shows no sequence similarity to NirE (or MET8p-data not 
shown). This predicts NirE has a sole function as a S-adenosyl-L-methionine 
uroporphyrinogen UIII methyltransferase, as opposed to the multifunctional CysG 
enzyme. On the basis of the inferences made above with the similarity of NirE to 
other SUMT enzymes and the structural topology of CobA, CysG and CbiF being 
that of a homodimer, one may also predict that NirE will also be homodimeric.  
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Figure 3.2:  Alignment of NirE, Ps. aeruginosa with CobA. Ps. denitrificans  
 
The aligned sequences of CobA from (280 AA) with NirE from (279 AA) show a 
similarity of 50.3 % (154/306 AA) and identity of 37.3 % (114/306 AA). 
 
 
CobAPs.denitr   1          MIDDLFAGLPALEKGSVWLVGAGPGDPGLLTLHAANALRQA     41 
                           ::|   ...||   |||.||||||||||||||.|...|:|| 
NirEPs.aerugi   1 MNTTVIPPSLLD---VDFPA---GSVALVGAGPGDPGLLTLRAWALLQQA     44 
 
CobAPs.denitr  42 DVIVHDALVNEDCLKLARPGAVLEFAGKRGGKPSPKQRDISLRLVELARA     91 
                  :|:|:|.||..:.:.|........:.|||.|..|..|.:|:..||.|||. 
NirEPs.aerugi  45 EVVVYDRLVARELIALLPESCQRIYVGKRCGHHSLPQEEINELLVRLARQ     94 
 
CobAPs.denitr  92 GNRVLRLKGGDPFVFGRGGEEALTLVEHQVPFRIVPGITAGIGGLAYAGI    141 
                  ..||:||||||||:||||.||...|:|..|..::|||:||..|...|||| 
NirEPs.aerugi  95 QRRVVRLKGGDPFIFGRGAEELERLLEAGVDCQVVPGVTAASGCSTYAGI    144 
 
CobAPs.denitr 142 PVTHREVNHAVTFLTGH-DSSGLVPDRINWQGIASGSPVIVMYMAMKHIG    190 
                  |:|||::..:.||:||| .:.|.:.  ::|.|:|.|...:|.||.:.::. 
NirEPs.aerugi 145 PLTHRDLAQSCTFVTGHLQNDGRLD--LDWAGLARGKQTLVFYMGLGNLA    192 
 
CobAPs.denitr 191 AITANLIAGGRSPDEPVAFVCNAATPQQAVLETTLARAEADVAAAGLEPP    240 
                  .|.|.|:..|.:.|.|.|.|.......|.|....||...|......|:|| 
NirEPs.aerugi 193 EIAARLVEHGLASDTPAALVSQGTQAGQQVTRGALAELPALARRYQLKPP    242 
 
CobAPs.denitr 241 AIVVVGEVVRLRAALDWIGALDGRKLAADPFANRILRNPA              280 
                  .::|||:||.|                   ||.|.:.:|:           
NirEPs.aerugi 243 TLIVVGQVVAL-------------------FAERAMAHPSYLGAGSPVSR    273 
 
NirEPs.aerugi 274 EAVACA 279
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Figure 3.3: Multiple sequence alignment of known characterised SUMT enzymes  
NirE Ps. aeruginosa (279), NirE Ps. stutzeri (278), SUMT Pa. denitrificans (287) were aligned with CobA Ps. denitrificans (280), SirA B. 
megatarium (259), SirA (YlnD) B. Subtilis (257), CorA M. ivanovii (231), Met1p S. cerevisiae (593), A. thaliana (369), ZmSUMT1 maize (423), 
CysGA S. enterica (242), CysGA E.coli (255). Sequence identities are evident by the darker coloured boxes, the conserved SAM binding site is 
shown by the green box (GXGXG). The first portion of the alignment is shown here and the second portion on the next page. 
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Figure 3.3 continued. The second portion of the alignment, with the latter half of the protein sequences. 
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Table 3.1: A summary of SUMT amino acid homology 
The values represented here are derived from alignments using ClustalW (Figure 3.3) and are given as percentage amino acid sequence identity.  
    
% ZmSUMT maize  
UPM1p 
A.thal   
Met1p
S. cere
CorA 
M.ivan 
SirA 
B. subt 
SirA 
B. meg 
CysGA 
S. typhi 
CysGA  
E. coli 
CobA 
Ps. deni 
    NirE 
Ps. stut  
NirE 
Pa. den 
NirE Ps. aeru 43 42 30 45 40 42 55 52 41 63 46 
NirE Pa. den 40 40 29 38 36 37 46 43 37 43  
NirE Ps. stutz 44 43 31 41 42 41 56 54 39   
CobA Ps. den 38 36 30 40 41 41 44 41    
CysGA E. coli 48 48 35 41 47 48 92     
CysGA S. typhi 50 49 35 39 45 48      
SirA B. meg 45 44 29 46 62       
SirA B. subt 44 41 31 43        
CorA M. ivan 44 44 28         
Met1p S.cere 34 35          
UPM1p A.thal 67           
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3.3. The overproduction of NirE 
3.3.1. Cloning and expression of nirE in E.coli 
Primers designed to Ps. aeruginosa nirE were constructed to introduce suitable 
restriction sites, NdeI (TGC ATA TGA ACA CTA CCG TGA TTC CG) and BamHI (TCG 
GAT CCG ATC AGG CGC ATG CGA C), at the 5` and 3` termini of the nirE gene 
respectively.  Introduction of these sites allows in frame cloning in to the pET14b 
(ampR) expression vector allowing the encoded protein to be produced as a N-
terminal poly-Histidine tagged fusion protein, conveniently allowing protein 
overproduction and affinity purification by metal chelate chromatography 
 
Amplification of nirE was performed by PCR using the respective designed primers 
and HotStarTaq DNA polymerase (Qiagen). Conditions for the amplification can be 
found in Section 2.2.8.1.1. The PCR product of predicted size was separated by 
agarose gel electrophoresis, extracted and cloned into pGEMT-Easy (pVP01); nirE 
was then subcloned into pET14b expression vector (pVP02) using the NdeI, BamHI 
restriction sites, behind a poly-histidine encoding sequence, under the control of a 
T7 promoter. Refer to Chapter 2, Section 2.2 for protocols. 
 
To facilitate recombinant protein overproduction, the pET14b-nirE plasmid was 
transformed into E. coli BL21 (DE3) pLysS strains, in which the T7 polymerase is 
induced by the addition of IPTG, to a final concentration of 0.4 mM in cultures 
grown in LB medium at 37 C (plus antibiotics) with aeration. Cultures were further 
incubated at 37 C or 16 C with aeration, before harvesting by centrifugation (10 
000 x g, 4 C). The bacterial pellets were primarily resuspended in binding buffer (5 
mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 8.0) before protein extraction and 
purification (Section 2.3.3). 
 
3.3.2. Cloning and expression of nirE in Ps. aeruginosa 
Since the pET14b T7 promoter is not recognised by Ps. aeruginosa pUCP19-NcoI, 
under the control of a lac promoter, was used as compatible plasmid for expression 
in Ps. aeruginosa (Chuanchuen, Narasaki et al. 2002). nirE was subcloned into 
pUCP19-NcoI (pVP17), from pET14b using the restriction sites NcoI and BamHI, 
sub-cloning the gene with the Histag to allow recombinant protein purification. 
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To facilitate recombinant protein overproduction, the pUCP19-Nco-nirE (pVP17) 
plasmid was transformed into wild type Ps. aeruginosa (PAO1), in which the lac 
promoter is induced by the addition of IPTG. A final concentration of 1 mM IPTG 
was added in cultures grown in LB or SLB medium at 37 C (plus carb 500 mg/l) 
with aeration. Cultures were further incubated at 16 C with aeration, before 
harvesting by centrifugation (10 000 x g, 4 C). Anaerobic cultures were grown in 
the same way but on a nitrate-containing medium (25 mM) with mineral oil to 
deplete oxygen and without aeration. The bacterial pellets were resuspended in 
binding buffer (5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 8.0) before 
protein extraction and purification as detailed in Section 2.3.3. 
 
3.3.3. Purification of recombinant NirE from E. coli and Ps. aeruginosa. 
Overproduced recombinant NirE from E. coli and Ps. aeruginosa was purified as 
described in the pET system manual (Novagen). Typically, prior to purification, the 
crude cell fractions were sonicated and centrifuged (10 000 x g, 4C). The resultant 
supernatants containing soluble protein were then loaded onto separate charged His-
Bind columns. The columns were washed with binding buffer, and wash buffers of 
increasing imidazole concentration (50 mM then 100 mM), before eluting the 
protein at 400 mM imidazole. The presence of protein in the fractions was detected 
by the BioRad protein assay and protein integraty was verified by SDS-PAGE. 
 
3.3.4. SDS Analysis of recombinant NirE from E. coli and Ps. aeruginosa 
SDS-PAGE gels containing 12 % polyacrylamide were used to analyse purified 
NirE, providing sufficient resolution for NirE that is predicted to be 31.9 kDa.  
 
NirE was purified to homogeneity and is soluble in both E. coli (44 mg/L) and Ps. 
aeruginosa (34.5 mg/L) in 50 mM Tris pH8, 0.5M NaCl. Protein integrity was 
verified by SDS-PAGE of the final eluted fractions from both organisms. The gene 
for nirE is 839 bases therefore the protein is predicted to be 29.7 kDa. With the His-
tag we see this at 31.9 kDa on the SDS-PAGE gels in Figure 3.5 and 3.6. The yield 
of protein obtained by incubation at 37 C (32 mg/L) after the addition of IPTG was 
less than that obtained at 16 C (44 mg/L). Subsequent experiments were performed 
by incubation at the lower temperature. The yield was lower in Ps. aeruginosa and 
to enhance overproduction, nirE was overexpressed in Ps. aeruginosa grown on 
Super LB broth, and was compared that grown on LB, to provide more nutrient 
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media as induction for long periods is not possible in this organism due to the 
production of pyocyanin (Whooley 1982). Pyocyanin is a toxic product produced 
when growth factors are limiting for the organism and thus is a limiting factor in the 
overproduction of proteins in Ps. aeruginosa.  
 
Each culture was grown for the same time, induced and harvested and purified 
together in exactly the same manner for comparison. However, this made no 
significant difference to NirE yields with both producing approximately 30-34 
mg/L of NirE as observed in Figure 3.7. Further analysis of NirE by gel filtration 
chromatography shows that NirE exists as a homodimer in its native form, as 
predicted. Interestingly, the concentrated NirE fractions exhibited red/ burgundy 
hues. The UV-Vis spectrum of this is shown in Figure 3.8 and is consistent with the 
presence of trimethylpyrrocorphin, a product of the overmethylation of UIII 
observed in the soluble cell extract of other SUMTs, such as CysG (Warren, 
Stolowich et al. 1990). It appears that NirE uniquely retains this even through 
purification, being quite tightly bound whereas other SUMTs do not exhibit this 
phenomenon. Other properties exhibited by this pigment are discussed in section 
3.35.  
 
 
Figure 3.4:  The structure of pyocyanin 
Pyocyanin is a phenazine pigment produced by Ps. aeruginosa, when growth 
factors are limiting, and is responsible for the production of reactive oxygen species 
(Whooley 1982). 
 
 
N+
N
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Figure 3.5: SDS-PAGE of NirE from E.coli.    
Lane 1 contains the molecular mass marker as indicated (kDa). Lanes 2, 3,and 4 
represent each 2 ml NirE protein fraction eluted from the His-bind column, which is 
clearly evident by bands at 31.9 kDa (NirE is 29.7 kDa plus N - terminal poly 
histidines at 2.2 kDa). These results are from 1L cultures grown at 37 °C and 
induced for protein expression at 16 °C, overnight. NirE = 44 mg/L. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: SDS-PAGE of NirE from Ps. aeruginosa.    
Lanes 1, 2 and 3 represent each 2 ml NirE protein fraction eluted from the His-bind 
column, which is clearly evident by bands at 31.9 kDa (NirE is 29.7 kDa plus N - 
terminal poly histidines at 2.2 kDa). Lane 4 contains the molecular mass marker as 
indicated (kDa). These results are from 1L cultures grown at 37 °C and induced for 
protein expression at 16 °C, overnight. NirE = 34.5 mg/L. 
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Figure 3.7: SDS-PAGE of NirE from Ps. aeruginosa 
Lanes 1, 2 and 3 represent each 2 ml NirE protein fraction eluted from the His-bind 
column of NirE overproduced in LB. Lane 4 contains the molecular mass marker as 
indicated (kDa). Lanes 5, 6, 7 represent each 2 ml NirE protein fraction eluted from 
the His-bind column of NirE overproduced in SLB. These results are from 1L 
cultures grown at 37 °C and induced for protein expression at 16 °C, overnight. We 
can see that there is no significant difference in the amount of protein produced in 
LB or SLB. NirE 30-34 mg/L for both LB and SLB 
 
 
Figure 3.8: UV-VIS Spectra of NirE with porphyrinoid material 
Concentrated NirE fractions have red / burgundy hues. The UV-Vis spectrum is 
consistent with the presence of trimethylpyrrocorphin with absorbance maxima at 
354 nm. This is a product of the overmethylation of UIII, normally observed in the 
soluble cell extract of other SUMTs, but here it is tightly bound to purified NirE. 
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3.3.5. The accumulation of a red pigment, trimethylpyrrocorphin 
A property common to SUMT activity is the accumulation of a red pigment due to 
the presence of a mixture of porphyrinoid material mainly trimethylpyrrocorphin 
(Figure 3.9). This is observed when CobA, CysG, Met1p, ZmSUMT1 and UPM1p 
are overexpressed as recombinant proteins in E. coli and has absorbance maxima at 
354nm (Warren, Stolowich et al. 1990; Raux, McVeigh et al. 1999; Fan, Wang et 
al. 2006). NMR analysis shows it to be a result of overmethylation of PC-2 by 
addition of a third SAM-derived methyl group at position C-12. When illuminated 
by UV light, cells and the isolated cell fractions also fluoresce a characteristic 
bright pink / red colour.  There is no physiological role for it and no implication for 
this material in the biosynthesis of tetrapyrroles. It is likely to be an artifact of non-
physiological conditions that would otherwise not occur in vivo (Warren, Bolt et al. 
1994). This property means that SUMT enzyme activity can be easily detected. 
Additionally, cobA or cysG genes can be employed in a wide range of cell types as 
a fluorescence-based method for the selection of recombinant plasmids as the 
replacement or disruption of these genes with other fragments of DNA results in 
loss of enzymatic activity and nonfluorescent cells. Thus inserts are detected in 
clones lacking fluorescence (Roessner and Scott 1995; Roessner 2002). 
Interestingly, the red pigment was not observed with CorA suggesting greater flux 
through the pathway (Robin, Blanche et al. 1991; Fan, Wang et al. 2006). 
 
In the case of NirE it was noted that cells cloned with nirE exhibit fluorescence 
under UV light, as shown in Figure 3.10. During purification, isolated cell fractions, 
especially the supernatant containing soluble NirE prior to purification was a deep 
red/brown colour and exhibited bright red / pink coloured fluorescent activity under 
a UV trans-illuminator. This has been shown in Figure 3.11, where the dark colour 
of the supernatant is clearly visible on both the column and the eppendorf with 
red/pink fluorescence when illuminated by UV light. This is consistent with the 
SUMT activity predicted for NirE, indicating the presence of porphyrinoid 
pigments. The group of Layer et al recently analysed this pigment and confirmed 
that it is indeed trimethylpyrrocorphin (FEBS Journal, 2009, in press). Further, the 
presence of this pigment still bound to concentrated NirE may suggest a greater flux 
through the haem d1 pathway, and a lack of inhibition of NirE by substrate (UIII) or 
product (SAH). These characteristics being attributed to most SUMT isolates 
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further suggest NirE is an active UIII methyltransferase and performs methylation 
of UIII to PC-2 in vivo. 
 
Figure 3.9: The structure of trimethylpyrrocorphin 
SUMT enzymes sequentially methylate UIII at C2 and C7 yeilding PC-2. Further 
incubation of SUMT enzymes with PC-2 and SAM result in an additional 
methylation at C12 to produce 2,7,12 - trimethylpyrrocorphin, a non-physiological 
product. 
 
 
Figure 3.10: NirE cells containing trimethylpyrrocorphin fluoresce red under 
UV light.  
NirE pET14b transformed into BL21 (DE3) pLysS, plated with amp and IPTG and 
incubated at 37 °C. When illuminated by UV light the fluorescent red colour can be 
clearly seen in clones with nirE, a phenomena characteristic of cobA and most 
SUMT enzymes (Warren, Stolowich et al. 1990), indicating NirE is a SUMT. 
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Figure 3.11: The characteristic red pigment of SUMTs shown by NirE.  
In A, the metal chelate column has been changed from blue to brown by the 
addition of the supernatant from cells overproducing NirE. In B, the red pigment is 
clearly visible in the supernatant and in C, the UV fluorescence of 
trimethylpyrrocorphin is shown. These entire characteristics are attributed to 
SUMTs and signify that NirE is a SUMT. 
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3.4. Complementation of Salmonella enterica cysG metH mutant 
strains by Ps. aeruginosa NirE 
 To investigate the role played by NirE in the tetrapyrrole biosynthetic pathway, a 
plasmid containing nirE (pVP16) was used to complement a S. enterica cysG metH 
mutant (Table 2.1, provided by Dr Deery). S. enterica cysG metE (AR3612) is a 
CysG cysteine auxotrophic strain, unable to produce sirohaem or synthesise 
cysteine as shown in Chapter 1. It is deficient only in its methyltransferase activity 
having no CysGA activity but retaining CysGB activity as the host contains a gene 
having the same phenotype as cysGB (cbiK) (Raux, Lanois et al. 1996). S. enterica 
metE cells are reliant upon their alternative B12-dependent methionine synthase, 
encoded by metH, for the biosynthesis of methionine. Therefore it lacks the ability 
to catalyse the transformation of UIII to PC-2. 
  
On the basis of complementation with cysG mutants from E. coli (cysG 302Δa) and 
S. enterica (cysG metE AR3612), MET1p was shown to confer SUMT activity, as it 
was able to complement the cysteine auxotrophy of the S. enterica mutant, but not 
the E. coli strain. It has been shown that S. enterica cysG mutants are blocked in 
cobalamin and sirohaem synthesis thus implicating its role in both, as opposed to P. 
denitrificans cobA mutants that retain less than 2 % of their parent activity. They 
continue to grow on minimal media without cysteine, suggesting Ps. denitrificans 
does make sirohaem via another SUMT, CysG, and the presence of more than one 
SUMT. This S. enterica mutant is deficient in only its CysGA whereas the E. coli 
strain is deficient in all CysG. Furthermore, using a different strain, it was shown 
that ZmSUMT1 and UPM1p were able to complement E. coli CysGA mutants by 
overcoming cysteine autotrophy on minimal media. (Crouzet, Cauchois et al. 1990) 
 
Complementation studies were conducted by transforming into S. enterica cysG 
metE (AR3612) competent cells. The resultant colonies were then restreaked on to 
minimal media plates made with 50 μg/ml of both methionine and cysteine; with 
cysteine and without methionine; without cysteine and with methionine; without 
cysteine and methionine; plus antibiotics as appropriate. The plates were then 
incubated at 37 oC for 24-48 hrs, until bacterial colonies were evident in the plates. 
The results have been summarised in Table 3.2. 
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nirEpUCPNde (pVP16) was used to confirm its ability to complement SUMT 
activity; nirFpUCPNde (pVP18) was used to check for any methyltransferase 
activity as it has been reported that NirF has 21 % sequence identity to NirE in the 
N-terminal 100 amino acids, but the aligned SAM binding site of NirE (GAGPG) is 
different in NirF (LRGSG) (Kawasaki, Arai et al. 1997);  nirFDLGHJpUCPNde 
(pVP63)  was used to confirm again that NirE is the only SUMT of this operon; 
pUCPNde and cobA respectively acted as negative and positive control.  
 
The results obtained show for the first time that nirE is able to complement the 
cysteine auxotrophy of the S. enterica mutant (cysG metE AR3612) by its capacity 
to grow in the absence of exogenous cysteine. Thus it is able to complement the 
lack of CysGA in the sirohaem and vitamin B12 pathways and confers UIII 
methyltransferase activity in the transformation of UIII to PC-2. Additionally, the 
requirement of NirE for methionine to perform this reaction is also evident by the 
lack of growth in the absence of both methionine and cysteine as it is unable to 
overcome this. As predicted cobA gave similar results to nirE; pUCPNde, 
nirFDLGHJ and nirF were unable to complement the cysteine auxotrophy of the S. 
enterica mutant. This confirms that nirF confers no methyltransferase activity and 
that nirE is the only SUMT as part of the nir operon. 
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Table 3.2: Summary of results obtained from complementation of S. enterica 
cysG metE (AR3612) 
Complementation was performed using nirE, cobA, nirF and nirFDLGHJ. +++ 
indicates good growth and normal colony size after 24 hrs; ++  indicates slow cell 
growth and small colonies after 24 hrs but normal cell size after 48 hrs; + indicates 
very poor cell growth and small colony size after 48 hrs; - indicates a negative 
response, no colonies 
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cobA 
pET14b 
nirE 
pUCPNde 
pUCPNde 
nirF 
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3.5. Biochemical complementation of NirE 
NirE, thus far, was able to complement the S. enterica cysG metH mutant. It was 
able to restore sirohaem and vitamin B12 biosynthesis in this strain, but there 
remained ambiguity as to whether it would be possible to synthesise experimentally 
PC-2 in vitro with NirE and thereafter SHC using SirC. It is predicted that NirE is 
able to synthesise PC-2 with the same stereo-regio specificity as the sirohaem, or 
vitamin B12 pathways, that is then converted to SHC. The production of both PC-2 
and SHC under anaerobic conditions is fully characterised and been performed 
using CobA (Leech, Raux-Deery et al. 2002; Raux, Leech et al. 2003). The first 
point of interest was to see if NirE could make both PC-2 and SHC in situ from 
soluble crude cell extracts of the enzymes required to make PC-2 and SHC, in the 
same way that CobA is able to do so. On the basis of this, a SHC coupled assay can 
be used to look at the activity of NirE in the presence or absence of defined co-
factors and substrates. 
 
The production of PC-2 and SHC can be monitored by marked differences in the 
spectra of the two compounds and their distinctive colouring; PC-2 is yellow and 
exhibits a broad spectrum, with no distinct absorption maxima; SHC is purple and 
has UV-Vis absorption maxima at 376 and 590 nm. The differences arise due to the 
increased level of conjugation in SHC, around the macrocyclic ring by the addition 
of a double bond. This appearance of SHC in the transformation of PC-2 to SHC 
can therefore be easily followed by spectroscopy as shown in Figure 3.12 by the 
increase in absorbance at 376 nm. 
 
3.5.1. Production of PC-2 and SHC in situ using NirE   
PC-2 and SHC were produced from ALA, using CobA and NirE under a nitrogen 
atmosphere, in a glove box with less than 2 ppm oxygen as described in Section 
2.4.2. The resultant UV-Vis spectra for PC- 2 and SHC produced with CobA are 
shown in Figure 3.13. PC-2 and SHC produced with NirE is shown in Figures 3.14 
and 3.15 respectively. Briefly, crude soluble cell extracts containing overproduced 
HemB, HemC, HemD and either CobA or NirE, were added to 10.0 mg ALA and 
10 mg of SAM, in a total volume of 40 ml of 50 mM Tris-HCl buffer, pH 8.0.  
Sirohydrochlorin was generated using the same enzyme cocktail as above for PC-2 
but included SirC and 13 mg of NAD+. The reaction mixture was left overnight at 
22 °C to allow it to reach completion, and the resulting tetrapyrroles filtered before 
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spectroscopic analysis. It was notable that whilst CobA was seen to turn over a 
small amount of the substrate after an hour, NirE had not, and took longer to 
begin turning over the substrate. Also, the spectra for NirE PC-2 and SHC can be 
seen to have a great deal of precipitation, even after filtration presumably due to the 
presence of NirE and its relative instability. Furthermore, when left for a further 24 
hrs, PC-2 was turning slightly orange and an UV-Vis scan of the filtered reaction 
mixture showed that PC-2 was slowly being oxidized due to its high sensitivity to 
oxygen. SHC was seen to be turning slightly blue after 24 hrs; again an UV-Vis 
scan showed that it too had a less well-defined spectrum. Therefore, we report here 
for the first time the formation of PC-2 and SHC with the use of NirE as a SUMT in 
the reaction.  
 
Figure 3.12: Spectra showing the transformation of PC-2 to SHC by CobA. 
The conversion of PC-2 to SHC was followed by UV-Vis spectroscopy over time. 
PC-2 is shown as the thick yellow band, mostly at the bottom and SHC is shown by 
the thick purple spectra, mainly at the top. The generation of SHC is seen by the 
increase in the absorption maxima at 376 nm and 590 nm shown by the arrows, 
characteristic of SHC 
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Figure 3.13: In situ production of PC-2 and SHC with CobA. 
UV-Vis spectra from incubation of CobA with soluble crude cell extracts of the 
enzymes required for the synthesis of PC-2 and SHC from ALA. Typical spectra 
obtained for PC-2 is seen in yellow with a band 350 nm to 430 nm. Spectra 
characteristic of SHC is shown in purple, with absorption maxima at 376nm and 
590 nm (also at 388 nm and 400 nm). As expected, the mixtures were yellow and 
purple for PC-2 and SHC respectively.  
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Figure 3.14: In situ production of PC-2 with NirE. 
UV-Vis spectra obtained from incubation of NirE with the soluble crude cell 
extracts of the enzymes required for the synthesis of PC-2. The spectra for PC-2 can 
be seen with a band at 350 to 430nm. The solution was observed to be yellow, as 
expected, indicating that NirE is able to make PC-2. In inset picture shows the 
colour of PC-2 after filtration.  
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Figure 3.15: In situ production of SHC with NirE. 
The UV-Vis spectra below are obtained from incubation of NirE along with the 
soluble crude cell extracts of the enzymes required for the synthesis of SHC. The 
spectrum for SHC is shown in purple with absorption maxima at 376 nm and 590 
nm. The solution was observed to be purple, as expected, indicating that NirE is 
also able to make SHC. The inset picture shows the colour of SHC after filtration. 
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3.6. SHC coupled NirE assay 
It has now been shown that NirE is able to make PC-2 and SHC in situ. This can be 
utilised to look at the activity of NirE in the presence or absence of SAM and 
NAD+, and with or without NirE under strictly anaerobic conditions. This will give 
us an indication of the dependency of the transformation on NirE our SUMT and 
further the dependency of NirE on co-factors, mainly SAM.  
 
SHC was used as an indicator of SUMT activity instead of PC-2. The reasons for 
coupling SUMT activity to SHC are many. SHC is less sensitive to oxygen than 
PC-2 that is very sensitive to an oxygen concentration of greater than 2 ppm, 
monitoring PC-2 will be more difficult as it may spontaneously oxidise. SHC is 
more easily monitored by UV-Vis spectroscopy as the spectra for SHC is more 
defined than that of PC-2, as seen in Figure 3.12. 
 
The assay was performed using purified NirE, and HemB, HemC, HemD, and SirC. 
NirE was overproduced and purified separately, as before. A plasmid containing all 
four genes required to produce SHC from ALA, hemB, hemC, hemD, and sirC, 
pET14b-BCDC, was similarly overexpressed and the resultant overproduced 
recombinant proteins were purified in the same fashion. All proteins and cofactors 
were added in excess, except for NirE, which was added last. The reaction was 
followed at timed intervals and the change in absorbance at 376 nm was followed to 
monitor the generation of SHC since SHC has an absorption maximum at 376 nm. 
The concentration of NirE was varied at 9 µg/ml and 4.5 µg/ml total in the reaction. 
The effect on the absence of NirE, SAM and of NAD+ was also monitored 
similarly. The specific activity was calculated using the extinction coefficient of 
SHC as 2.4 x 105 M-1cm-1. For a protocol see Section 2.4.5. 
 
From the data obtained by the SHC coupled assay it is clear that NirE is performing 
the transformation of UIII to PC-2. The presence of SAM, NAD+ and HemB, 
HemC, HemD and SirC along with a defined concentrations of NirE catalyses the 
formation of SHC from ALA, as shown in Figure 3.16.  The assay was performed 
with a NirE concentration of 2.25 µg/ml, 4.5 µg/ml and 9 µg/ml. The calculated 
turnover rate at 2.25 µg/ml NirE is 24/h (data not shown); at 4.5 µg/ml NirE is 27/h 
and at 9 µg/ml NirE is 40/h showing a concentration dependent effect on the speed 
of the reaction as expected, seen in Figure 3.17. The absence of NirE halts the 
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reaction indicating a reliance on NirE for SUMT activity in the assay, as no colour 
change is observed. All subsequent reactions were performed with 4.5 µg/ml NirE. 
 
The absence of SAM from the reaction demonstrates NirE is dependent on SAM to 
perform this reaction as with other SUMT enzymes. Omitting SAM from the 
reaction mixture does not form SHC because the substrate for this reaction PC-2 is 
not being formed by the methylation of UIII by NirE, this is shown in Figure 3.18.  
 
The absence of NAD+ from the reaction mixture also inhibits SHC production, but 
in this case we clearly have the formation of PC-2 by NirE. The reaction cannot 
proceed further from PC-2 to SHC as SirC activity is perturbed by the lack of 
NAD+. The formation of PC-2 is shown in Figure 3.19, and the yellow colour of 
PC-2 is seen also. 
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Figure 3.16: UV-Vis Spectra showing the in vitro generation of SHC by NirE  
NirE is able to make SHC in vitro, under anaerobic conditions. The reaction 
conditions remained as stated with the exception of the NirE concentration. In (A) 
NirE is added to a final concentration of 9 µg/ml and in (B) NirE is added to a final 
concentration of 4.5 µg/ml. Each spectrum denotes a wavelength scan at 5 min 
intervals. The arrows show the direction of change in the spectra. The picture inset 
shows SHC formed by NirE, as the solution changes from clear to purple. 
A. 9.0 µg NirE 
 
B. 4.5 µg NirE  
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Figure 3.17: The rate of generation of SHC by NirE 
The rate of formation of SHC by NirE is shown at NirE concentrations of 9 µg/ml 
and 4.5 µg/ml as well the absence of NirE. The absorbance at 376 nm was followed 
over time plotted below. The specific activity was calculated accordingly. The 
reaction is dependent on NirE to transform UIII to PC-2 as the absence NirE results 
in the inhibition of SHC formation.  
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Figure 3.18: UV-Vis Spectra of reaction mixture without SAM  
The reaction conditions remained as stated with the concentration of NirE at 4.5 
µg/ml with the exception of there being no SAM added. SHC is not formed and the 
resultant UV–Vis spectra, show no NirE activity (inset) indicating that NirE is a 
SAM dependent UIII methyltransferase. The small observed increase is likely due 
to precipitation as the incubation turned slightly cloudy. The solution remained 
colourless, as is UIII. 
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Figure 3.19: UV-Vis Spectra of reaction mixture without NAD+ 
The reaction conditions remain as stated with the concentration of NirE at 4.5 µg/ml 
with the exception of there being no NAD+ added. As SirC is NAD+ dependent 
SHC is not formed and the resultant UV–Vis spectra, shows no NirE activity 
(inset). After a period of time the cuvette turned yellow indicating the presence of 
PC-2 from the picture and from its spectra. This confirms that NirE is able to 
synthesise PC-2 but since there is no NAD, SirC is unable to take the reaction to 
completion.  
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3.7. Conclusion 
NirE is well documented to be an S-adenosyl-L-methionine Uroporphyrinogen III 
methyltransferase in literature, but it has never been shown experimentally to 
perform the transformation of UIII to PC-2. Initially, nirE was cloned to allow 
expression in both E. coli and Ps. aeruginosa. Then it was investigated for 
complementation of a S. enterica cysG metH knockout strain. The next point of 
interest was to biochemically complement CobA in the pathway to SHC via PC-2 
under anaerobic conditions. It was investigated if NirE can perform the same 
reaction using crude cell extracts as has been performed on many occasions by 
CobA. The dependency of NirE on cofactors was also investigated with a SHC 
coupled SUMT assay. 
  
This thesis shows for the first time that NirE exhibits the same characteristics 
during purification that are attributed to other SUMT enzymes such as CobA and 
CysGA (Warren, Stolowich et al. 1990).  The supernatant was deep red in colour 
and exhibited fluorescent activity under a UV trans-illuminator indicating the 
presence of tetrapyrrole pigments, including trimethylpyrrocorphin (Figure 3.9). 
NirE is unique however in that it remains tightly bound to the porphyrinoid even 
through purification and may suggest a greater flux through the haem d1 pathway, 
and a lack of inhibition of NirE by substrate (UIII) or product (SAH). From the 
observed characteristics of NirE in the purification process, we can implicate NirE 
as our Uroporphyrinogen III methyltransferase, catalysing the first step, the 
transformation of UIII to PC-2.   
 
Since Ps. aeruginosa does not recognise the T7 promoter, a new system was 
formulated to facilitate recombinant protein overproduction in Ps. aeruginosa. It 
was expected that NirE would be well overproduced in this organism as it is being 
homologously expressed, and the vector contains a weaker promoter. It was 
expressed, but not as well as in E. coli and likely to be due to the tight regulation of 
the expression of these genes in Ps. aeruginosa. Therefore, despite sharing 
similarities with other SUMT enzymes, nirE expression is tightly regulated and 
evolved to respond to different regulatory signals than those of the sirohaem and 
haem b pathways. The nir gene operons in Ps. aeruginosa and Ps. stutzeri have 
been shown to have recognition motifs for the anaerobic regulator ANR in their 
promoter regions (Arai, Igarashi et al. 1994). In Pa. denitrificans the nir cluster is 
Vina Parmar                                                         Chapter 3: Characterisation of NirE – a SUMT: page 130 
130 
under the control of a NNR transcriptional activator which responds to NO (Van 
Spanning, De Boer et al. 1995; Saunders, Houben et al. 1999). Conversely, the 
sirohaem pathway is regulated by nitrogen and is independent of oxygen. Thus, the 
expression of nirE is clearly a well-regulated process in Ps. aeruginosa. 
 
NirE is also shown for the first time to complement CysGA activity in a S. enterica 
cysG metH mutant. This strain transformed with nirE from Ps. aeruginosa was able 
to restore sirohaem and methionine biosynthesis and thus complement the cysteine 
and methionine auxotrophy. This implies the role of NirE is of SUMT activity and 
the transformation of UIII to PC-2 and is able to complement the sirohaem and 
cobalamin pathways. Additionally, nirF was also postulated to be a 
methyltransferase having 21% 100 amino acid identity to NirE at the N-terminal 
(Kawasaki, Arai et al. 1997), this did not complement the mutant strain as 
expected, since there is no SAM binding site with NirF. The same result was 
observed with a nirFDLGHJ plasmid transformed into the complementation strain, 
indicating that nirE is the only one of the operon conferring SUMT activity in the 
pathway. 
 
The formation of PC-2 and SHC by NirE is shown for the first time by incubation 
of the soluble extract with the proteins required for the synthesis of PC-2 and SHC, 
with NirE. Furthermore, the activity of NirE in our SHC coupled assay also 
indicates that NirE is performing the transformation of UIII to PC-2. The absence 
of NirE halts the reaction and the absence of SAM from the reaction demonstrates 
NirE is dependent on SAM to perform this reaction as predicted. The absence of 
SAM in the reaction mixture does not form SHC because the substrate for this 
reaction, PC-2 is not being formed. The absence of NAD+ from the reaction 
mixture also does not produce SHC as SirC activity is NAD+ dependent, but in this 
case we clearly have the formation of PC-2 by NirE. We can also say with 
confidence that the origin of the methyl groups at C2 and C7 is S-adenosyl-L-
methionine, and that the reaction is likely to proceed via precorrin-1 as in the case 
of CobA in the vitamin B12 pathway and other SUMT enzymes. 
 
Therefore, in summary we have shown for the first time that NirE is indeed a 
functionally active S-adenosyl-L-methionine UIII methyltransferase, transforming 
UIII to PC-2. As predicted, chromatographic analysis of NirE by gel filtration 
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proves it is a homodimer with a subunit mass of 29 kDa, consistent with the 
topology of CobA, CysG and CbiF. It portrays all the defined characteristics that 
are attributed to similar SUMTs such as the accumulation of porphyrinoid material. 
It is SAM dependent, and able to generate PC-2 complementing the pathways for 
vitamin B12 and sirohaem, providing the substrate for the generation of SHC. This 
suggests that SHC is may be a part of the pathway to haem d1, but as yet no 
candidate from the nir operon has been identified for this dehydrogenation reaction 
and warrants further investigation.  
 
Thus, the first step in the haem d1 pathway is the consecutive SAM dependent 
methylation of C2 and C7 from UIII to PC-2. The remaining steps performed by 
NirF, NirD, NirL, NirG, NirH, and NirJ to haem d1 are as yet unknown (Figure 
3.20). 
 
Figure 3.20: The first step of haem d1 biosynthesis 
In this chapter, NirE is confirmed to catalyse the first step in the methylation of UIII 
at C2 and C7 to form PC-2. It is unclear if the pathway then proceeds via SHC or 
from PC-2 to haem d1, with NirF, NirD, NirL, NirG, NirH, and NirJ. 
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4. Optimisation of production and stabilisation of proteins involved in haem d1 
synthesis 
 
4.1. Introduction 
Haem d1 is a unique tetrapyrrole found only in bacterial dissimilatory nitrite 
reductase, acting as the active centre for nitrite reduction. Whilst there exists a lot of 
literature on the enzyme for which it is a co-factor, the biosynthesis of haem d1 still 
remains poorly understood. This chapter looks at the overproduced recombinant 
proteins implicated in haem d1 biosynthesis in both E. coli and in Ps. aeruginosa, in 
an effort to understand the roles played by the individual components of the 
pathway. The previous chapter details NirE and the confirmation of SUMT activity 
in the transformation of UIII to PC-2. The remaining genes were cloned into 
appropriate vectors to allow their encoded products to be overproduced in both 
organisms. This study highlights the difficulties in overproduction of these proteins 
and furthermore the challenges incurred in stabilisation of these proteins, as well as 
the formulation of a new homologous expression system in Ps. aeruginosa.  
 
Mutation and complementation analysis of the nir genes necessitated a requirement 
of nirE, nirJ, nirH, nirG, nirL, nirD and nirF for haem d1 biogenesis (Kawasaki, 
Arai et al. 1995; Palmedo, Seither et al. 1995; Kawasaki, Arai et al. 1997). These 
are well known to exist as part of operons close to the genes required for the 
assembly of cytochrome cd1, and additionally form part of the denitrification gene 
cluster implicating their role in denitrification, as detailed in Chapter 1. 
 
In Ps. aeruginosa, nirCFDLGHJEN are found in one locus downstream of nirS and 
are hypothesised to encode the entire set of proteins required for the formation of 
haem d1 (Figure 4.1) (Kawasaki, Arai et al. 1995; Kawasaki, Arai et al. 1997). In 
Ps. stutzeri the same genes for haem d1 biosynthesis are located over two loci, 
nirJEN and nirCFDLGH, which lie upstream and downstream of the structural gene 
nirS, respectively (Palmedo, Seither et al. 1995). 
 
In Pa. denitrificans, the presence of nirECFD downstream of nirS (the structural 
gene for cytochrome cytochrome cd1), has been well documented (de Boer, 
Reijnders et al. 1994). In this study, our analysis of the sequence downstream of this 
(courtesy of Prof Ferguson, Oxford) has identified a cluster containing the gene 
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order of nirECFDLGHJN.  It is proposed that NirF of Pa. denitrificans, is a fusion 
of NirF and NirD, the first 350 residues showing 53.1 % identity to NirF from Ps. 
stutzeri and the latter showing 50.6% identity to NirD from Ps. stutzeri (de Boer, 
Reijnders et al. 1994; Palmedo, Seither et al. 1995).  However, our analysis of the 
Pa. denitrificans nir operon demonstrates this to be wrong. Whilst, the NirF protein 
sequence shown in the paper starts correctly, the latter 20 residues are incorrect and 
are derived from an erroneous frameshift. This frameshift is in the same reading 
frame as NirD, thus, it was presumed that NirF is a fusion of NirF and NirD because 
a termination of NirF was not detected. Consequently this assumption has no basis 
and may be ignored. Nevertheless, further analysis in this study, revealed that the 
separate open reading frames for nirD and nirL observed in Ps. aeruginosa and Ps. 
stutzeri are fused into a single open reading frame in Pa. denitrificans. Therefore, in 
Pa. denitrificans NirD and NirL are fused into a single protein. Pa. denitrificans is 
unique in comparison as it makes so much nitrite reductase that the periplasm 
preparation itself is brown. This is particularly useful as the level of haem d1 
synthesis and the required enzymes may also be high. 
The presence of a haem d1 like operon has recently been proposed in heliobacteria 
(Heliobacillus mobilus and Heliophilium fasciatum) by bioinformatic analysis 
(Xiong, Bauer et al. 2007). This is said to contain NirD, NirL, two forms of NirJ 
(NirJ1 and NirJ2) and CysGA and CysGB as well as the genes for the production of 
UIII from ALA. It has been hypothesised that CysGA acts as an SUMT to yield PC-
2 and CysGB yields SHC, and that only NirJ is involved in decarboxylation and then 
CysGB is involved further in ferrochelation in the synthesis of haem d1. The validity 
of this hypothesis is debatable as not all of the transformations from UIII to haem d1 
are explained. It does not take into account the formation of an acrylate at C17 nor 
the conversion of the propionates to oxo groups at C3 and C8. NirD and NirL are 
proposed to not be involved in the transformation of UIII to haem d1 but only in 
transcriptional regulation and DNA binding. As already mentioned, nirF, D, L, G, 
H, J, E, are essential to the pathway, thus if the genes for haem d1 were present as 
hypothesised by Xiong (NirJ1 and NirJ2; CysGA and CysGB), the insertional 
mutations of nirD and nirL would have no effect on haem d1 synthesis. It is very 
likely that the presence of these genes are for that of an alternative pathway for 
haem previously observed in D. vulgaris, whereby UIII is methylated instead of 
decarboxylated (Ishida, Yu et al. 1998). This pathway has also been identified in M. 
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barkeri, where a cluster of genes with the enzymes encoding for UIII (hemA, B, C, 
D) and genes with similarity to nirE, D, and J have been found, but the late haem 
genes are missing. Methylation occurs as part of the haem pathway therefore it is 
presumed that the synthesis of haem employs similar enzymes with as the Nir 
pathway (Buchenau, Kahnt et al. 2006). This is likely to be the case in this pathway 
observed in Heliobacteria.  Therefore this theory has no basis in the d1 pathway as 
they are based on bioinformatic analysis and manipulation only, they are not 
experimentally derived. Moreover, heliobacteria contain bacteriochlorophyll and 
have no indication of a requiring an alternative respiratory nitrogen metabolism 
pathway such as one requiring haem d1.  
 
 
Figure 4.1: The haem d1 operon.  
Illustration of the nir operon from Ps. aeruginosa, Ps. stutzeri and Pa. denitrificans. 
Block arrows show the direction of transcription and homologues are shown in the 
same colour. The genes have not been drawn to scale. Nir X and I are shown to be 
involved in transcriptional regulation of the operon. This study reveals that Pa. 
denitrificans has an operon similar to that observed in Ps. aeruginosa except that 
nirE resides at the start of the operon preceding nirC as opposed to the end of the 
operon. Additionally, nirD and nirL are observed to be fused Pa. denitrificans. 
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RESULTS AND DISCUSSION. 
 
4.2. Approaches employed in the analysis of NirF, NirD, NirL, NirG, NirH 
and NirJ 
NirF, D, L, G, H, J were subject to various methods of investigation to aid in the 
understanding of their role in the haem d1 pathway. Bioinformatic analysis 
highlighted the ambiguity that exists for each of the Nir proteins and thus the need 
for investigation of protein structure and function. This would enable an 
understanding of the reactions they may catalyse in the synthesis of haem d1. The 
different methods employed are discussed here first before examination of the 
results obtained 
 
4.2.1. Analysis of rare codons within the nir genes 
The level of rare codon usage was checked for nirF, nirD, nirL, nirG, nirH, and 
nirJ to eliminate any problems in the expression of these genes. Each organism 
carries it own bias in the usage of the 61 available codons. When the mRNA of 
heterologous genes are overexpressed in E. coli, differences in codon usage can 
impede translation due to the demand of one or more tRNA that maybe rare or 
lacking. Examination of codon usage in E. coli reveals the underepresentation of 
AGA, AGG, CGA, CGG, GGA, AUA, CUA and CCC. 
The number of these rare codons in the genes were calculated and found to be 
minimal and are summarised in Table 4.1. Therefore, expression of these genes 
within a host carrying these rare codons is not required, as it would have no 
implication on protein production. 
Table 4.1: Tabulation of rare codon usage for each nir gene 
Table showing percentage of rare codons calculated for each gene, by checking for 
AGA, AGG, CGA, CGG, GGA, AUA, CUA and CCC rare codons in E. coli, and 
represented as a percentage of the total codons. The level of rare codons is low and 
the use of a host with these codons would not affect protein production. 
 
 
Gene nirF nirD nirL nirG nirH nirJ 
Rare 
codon 
usage 
3 % 2.6 % 2.3 % 0 % 1.2 % 3.6 % 
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4.2.2. Cloning and heterologous overproduction of proteins in E. coli 
PCR primers were designed for each of the genes nirF, nirD, nirL, nirG, nirH, and 
nirJ as detailed in Chapter 2, Table 2.8. All nir genes were amplified by PCR using 
the respective designed primers. These were constructed to introduce suitable 
restriction sites, NdeI and BamHI, at the 5` and 3` termini of each nir gene 
respectively. Introduction of these sites allows in frame cloning into the pET14b 
(ampR) expression vector (via pGEMT-Easy) permitting the encoded protein to be 
produced as a N-terminal poly-Histidine tagged fusion protein, thereby facilitating 
rapid purification by metal chelate chromatography. 
To facilitate protein overproduction, the pET14b-nir gene plasmid constructs were 
individually transformed into E. coli BL21 pLysS (DE3, chlorR) strains in which the 
T7 polymerase is induced by the addition of IPTG, to a final concentration of 0.4 
mM in cultures grown in LB medium at 37 C (plus ampicillin 100 mg/l and 
Chloramphenicol 34 mg/l) with aeration. Cultures were further incubated as 
appropriate at 37 C or 16 C with aeration, before harvesting by centrifugation (10 
000 x g, 4 C). The bacterial pellets were resuspended in binding buffer (5 mM 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 8.0).  Proteins were purified as 
described in the pET system manual (Novagen). Typically, prior to purification, the 
crude cell fractions were sonicated and centrifuged (10 000 x g, 4 C). The resultant 
supernatants containing soluble protein were then loaded onto separate charged His-
Bind columns. The columns were washed with binding buffer, and wash buffers of 
increasing imidazole concentration (50 mM then 100 mM), before eluting the 
protein in elution buffer (400 mM imidazole). The presence of protein in the 
fractions was detected by the Biorad protein assay and SDS-PAGE analysis. 
 
4.2.2.1. Protease inhibitors 
Primary analysis of overproduction in E. coli showed the Nir Proteins were quite 
unstable and prone to degradation. As a result all subsequent purifications were 
performed in the presence of EDTA free protease inhibitors added to the cell 
fraction prior to sonication. This allowed for protein integraty of the Nir proteins 
from enzymes and proteases present within the cell. The effect of including protease 
inhibitors is most evident for NirF, shown in Figure 4.16B (p.160). 
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4.2.3. Control of expression by control of [IPTG] within a host strain 
Since, the overproduction was observed to be very high in all the Nir proteins, but 
the amount of soluble protein low, this implied that the level of overproduction 
within the cell might be too high to withstand. Thus, controlling the level of 
overproduction may in turn increase the solubility of the encoded proteins. This is 
facilitated by controlling the concentration of IPTG, which in turn requires 
transformation into a cell line that allows controlled levels of expression, unlike 
BL21 pLysS (DE3 chlorR), which has maximal expression levels.  
Tuner pLaci (chlorR) enables adjustable levels of protein expression throughout all 
cells in a culture. They are lacYZ deletion mutants of BL21, where the lac permease 
(lacY) deletion allows a constant level of entry of IPTG into all the cells, producing 
a concentration-dependent and homogeneous level of induction. In this manner the 
final concentration of IPTG induction was decreased four-fold to 0.1 mM and ten-
fold to 0.04 mM, from 0.4 mM. The resultant samples for each NirF, NirD, NirL, 
NirG, NirH, and NirJ at both levels of decreased induction were purified and 
analysed by SDS-PAGE. 
 
4.2.4. Cloning & homologous overproduction of proteins in Ps. aeruginosa 
A new strategy was employed to overcome the lack of solubility and stability of the 
proteins, as observed in E. coli, by the overproduction of the recombinant proteins 
in their native organism, Ps. aeruginosa. Since Ps. aeruginosa does not recognise 
the T7 promoter, a new system was formulated to facilitate recombinant protein 
overproduction in Ps. aeruginosa. Various plasmids were screened for 
transformation efficiency in Ps. aeruginosa and for suitable multiple cloning sites. 
The plasmid most compatible in both cases was pUCP19-Nco / Nde a Escherichia-
Pseudomonas shuttle vector for recombinant protein overexpression in 
Pseudomonas (Cronin and McIntire 1999). 
All the genes nirF, nirD, nirL, nirG, nirH, and nirJ genes were successfully 
individually subcloned into pUCP19-NcoI (carbR), from pET14b using the 
restriction sites NcoI and BamHI. This allowed both the gene and His-tag to be 
subcloned into pUCP19-NcoI and allowing protein overproduction and purification 
by metal chelate chromatography. 
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 To facilitate protein overproduction, plasmid constructs were individually 
transformed into wild type Ps. aeruginosa (PAO1), in which the lac promoter is 
induced by the addition of IPTG, to a final concentration of 1 mM in cultures grown 
in LB medium at 37 C (plus carb 500 mg/l) with aeration. Cultures were further 
incubated at room temperature with aeration, before harvesting by centrifugation 
(10 000 x g, 4 C). Anaerobic cultures were grown in the same way without 
aeration and on a nitrate-containing medium (25 mM) with mineral oil to deplete 
oxygen. The bacterial pellets were resuspended in binding buffer (5 mM imidazole, 
0.5 M NaCl, 20 mM Tris-HCl pH 8.0). The resultant homologously expressed 
recombinant proteins were then purified by metal chelate chromatography. The 
presence of protein in the fractions was detected by the BioRad protein assay and 
protein integrity checked by SDS-PAGE or western blotting. 
 
4.2.5. Protein stabilisation screen  
In an effort to stabilise the Nir proteins to obtain a sufficient level for further 
characterisation, various buffers were screened for each protein. All previous 
investigations were performed in 50 mM Tris pH8, 0.5M NaCl, but the proteins 
were observed to be unstable. The pI was also taken into account for each protein 
(see appendix). The buffers used in the stabilisation screen included 50 mM Tris 
pH8.0; 50 mM CHES pH10, 9.5, 9.0; 50 mM MES pH6.5, 6.0; 50 mM Hepes 
pH8.5, 8.0, 7.5; 50 mM sodium phosphate pH 8.5, 8.0; 50 mM potassium phosphate 
pH8.5, 8.0, each with 0.5M NaCl. The same buffers were screened again at 50 mM 
concentration but at a salt concentration of 0.1M, then each buffer at 20 mM 
concentration with 0.5M or 0.1M salt. 
Primarily, proteins from 4 x 1L growths for each protein were purified using ice-
cold buffers and eluted on ice in 50 mM Tris pH8, 0.5M NaCl. The fractions 
containing the desired protein were then pooled and buffer exchange was performed 
on a pD10 column eluting the protein into the buffer being tested. This was 
performed in batches of 6 of the same protein in different buffers. Firstly, screening 
was performed for the following buffers: 50 mM Tris pH 8.0, 50 mM CHES pH 9.5, 
50 mM MES pH 6.5, 50 mM Hepes pH 8.0, 50 mM sodium phosphate pH 8.5, 50 
mM potassium phosphate pH 8.0 each with 0.5M NaCl. The protein solutions were 
each then concentrated in 2ml vivaspin columns. The protein was deemed stable in 
a buffer if one was able to sufficiently concentrate it without the protein 
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precipitating out of solution.  If a protein was found to be more stable in a particular 
buffer, then the buffer was further used to screen for further stability at different pH 
or NaCl concentration if applicable. If no stabilisation was observed the same 
buffers at 50 mM were used to screen for stability again but at a lower 0.1M salt 
concentration and further at a lower, 20mM buffer concentration and varying NaCl 
concentrations of 0.5 mM and 0.1 mM. 
 
 
Each of these approaches was applied to NirF, NirD, NirL, NirG, NirH, and NirJ. 
The results obtained for each protein are discussed next. 
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4.3. NirD, NirL, NirG, NirH 
4.3.1. Bioinformatic analysis 
The functions of NirD, NirL, NirG and NirH are to date unknown, as is their 
structure and any reactions they may catalyse in the haem d1 pathway. Comparison 
of these proteins to those of known structure and function provides very limited 
information. A similarity of NirD, NirL, NirG and NirH is observed only to a 
family of leucine responsive protein (LRP) transcriptional regulators (Figure 4.2). 
Therefore the functions of NirD, L, G, H are somewhat ambiguous and remain to be 
characterised. 
 
Indeed, high levels of identity between NirD and NirG (Figure 4.3A, 41 %) and 
NirL and NirH (Figure 4.3B, 33 %) may suggest the catalysis of symmetrical 
reactions, such as decarboxylation of C12 and C18 or elimination of propionic side 
chains or oxidation at C3 and C8. Furthermore, they may form a multimeric and 
multifunctional enzyme complex in the form of a αβα`β` unit, as they are proposed 
in the nirD locus of Ps. stutzeri (nirDLGH) (Palmedo, Seither et al. 1995). The 
similarity of NirD and NirG, which are composed of 150 (17 kDa) and 147 (16.5 
kDa) amino acids respectively, and of NirH and NirL being 171 (19.6 kDa) and 174 
(20.2 kDa) respectively, also supports this view. The degree of identity that exists 
within all four proteins (Figure 4.3C), suggests that these may have arisen as result 
of gene duplication events. Identity between NirD, NirL, NirG and NirH of Ps. 
aeruginosa with those from Ps. stutzeri is in the region of 60 % to 72 % and 39 % 
to 62 % for Pa. denitrifications (Table 4.2). This indicates a high degree of 
conservation of these proteins amongst species and may be indicative of the 
evolution of a highly specialised role. In heliobacteria only NirD and NirL are 
found and proposed by the author to regulate the transcription expression of nir 
genes only (Xiong, Bauer et al. 2007). However, it is also well documented that 
FNR-like transcriptional regulators mediate transcription regulation of the nir 
operon. Consequently no clear function can be assigned to these proteins and there 
remains ambiguity in their roles as part of the haem d1 pathway. 
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Figure 4.2: Sequence alignment of NirD, NirL, NirG, NirH to LRP from E. coli  
The similarity of NirD, NirL, NirG and NirH to a Leucine Responsive Protein 
(LRP) transcriptional regulator from E. coli is shown. The asterisks show identical 
amino acids, dots those belonging to the same group. 
                    
Table 4.2: Comparison of the amino acid sequences from NirF, NirD, NirL, 
NirG, NirH and NirJ sequences of Ps. aeruginosa (PAO) with Ps. stutzeri and 
Pa. denitrificans, using Clustal W. 
 
 
% Amino acid identity with 
PAO 
NirF 
PAO 
NirD 
PAO 
NirL 
PAO 
NirG 
PAO 
NirH 
PAO 
NirJ 
Ps. stutzeri - NirF 67.3 - - - - - 
Pa. denitrificans - NirF 55.4 - - - - - 
Ps. stutzeri - NirD - 68.5 - - - - 
Pa. denitrificans - NirD - 49.3 - - - - 
Ps. stutzeri - NirL - - 60.4 - - - 
Pa. denitrificans - NirL - - 39.3 - - - 
Ps. stutzeri - NirG - -  63.9 - - 
Pa. denitrificans - NirG - - - 45.5 - - 
Ps. stutzeri - NirH - - - - 71.3 - 
Pa. denitrificans - NirH - - - - 62.2 - 
Ps. stutzeri - NirJ - - - - - 62.7 
Pa. denitrificans - NirJ - - - - - 47.4 
NirD      ------------------------MDDLSRRLLARYQKGLPICAEPYRRMAETLGCSEAE 36 
NirG      ------------------------MDEFDRRLLNRLQHGLPLEPHPYALLAAELDCREED 36 
NirL      -----------------MNPVEPLAAPQRQHLRYLLEQGLPLASRPYRVLAERIGAGEDE 43 
NirH      ----------------MSACISPSDALLARRLIELTQAGLPLVADPWAWIAAQLRLSEAE 44 
LRP_Ecoli -------------MVDSKKRPGKDLDRIDRNILNELQKDGRISN---VELSKRVGLSPTP 57 
                                       :.:    : .  :       ::  :    
NirD      VLERLRRLEADGALSRVGPVLRHQRAG--ASTLAALAVPE---ERLQRVAERISQYAEVN 91 
NirG      ILRRLDDLLDDGTLTRFGPLFDIEPLGG-AFTLAAMSVPE---ARFEEIAALLAGWPQVA 92 
NirL      VLEQVRRWDEDGLFRRFGVILHHRALGYTANAMLVLDVAD---AEVDAVGRALAHETIVS 100 
NirH      TLALLKRLRDAGVIRRIAAVPNHYRLGYRHNGMTVWDVAD---ERIERLGRLVGGLSFVS 101 
LRP_Ecoli CLERVRRLERQGFIQGYTALLNPHYLDASLLVFVEITLNRGAPDVFEQFNTAVQKLEEIQ 117 
           *  :      * :     :      .     :    :       .: .   :     :  
 
NirD      HNYQR-----EHRYNLWFVLTAGDRAQLDRVLAEIAA--------DTGLQPLDLPMQEAY 138 
NirG      HNYRR-----EHALNMWLVVACDSPAEVAETLARLER--------ESGLAVLDLPKEATY 139 
NirL      LCYRRPRRLPMWPYNLFCMIHGRERGEVERQIEALLERHALRQTPHRWLFSLRAYKQCGG 160 
NirH      HCYRRPRHLPQWRYNLFAMVHGRSEAEIEGYRQQIRLLLGEDCRADEMLVSSRILKKTG- 160 
LRP_Ecoli ECHLVSG-DFDYLLKTRVPDMSAYRKLLGETLLRLPG--------VNDTRTYVVMEEVKQ 168 
            :           :            :      :                     :    
 
NirD      CIDLAFPLEASR-- 150 
NirG      HVGLHFPL------ 147 
NirL      RYTAPPADLERRHG 174 
NirH      ---LRLAQKEERPC 171 
LRP Ecoli SNRLVIKTR----- 177
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Figure 4.3: Sequence alignments of NirD, NirL, NirG, NirH. 
Alignments of NirD with NirG from Ps. aeruginosa (PAO) shows 47 % identity 
(A) and NirH with NirL from Ps. aeruginosa shows 33 % identity (B). Alignment 
of NirD, NirL, NirG, and NirH  (C) shows the degree of identity that exists between 
them, suggesting that these may have arisen as result of gene duplication events. 
The asterisks show identical amino acids, dots those belonging to the same group.  
(A) 
 
     (B) 
 
 
    (C) 
                               
 
 
NirD      MDDLSRRLLARYQKGLPICAEPYRRMAETLGCSEAEVLERLRRLEADGALSRVGPVLRHQ 60 
NirG      MDEFDRRLLNRLQHGLPLEPHPYALLAAELDCREEDILRRLDDLLDDGTLTRFGPLFDIE 60 
          **::.**** * *:***: ..**  :*  *.* * ::*.**  *  **:*:*.**::  : 
 
NirD      RAG-ASTLAALAVPEERLQRVAERISQYAEVNHNYQREHRYNLWFVLTAGDRAQLDRVLA 119 
NirG      PLGGAFTLAAMSVPEARFEEIAALLAGWPQVAHNYRREHALNMWLVVACDSPAEVAETLA 120 
          * * ****::*** *::.:*  :: :.:* ***:***  *:*:*::... *:: ..** 
 
NirD      EIAADTGLQPLDLPMQEAYCIDLAFPLEASR 150 
NirG      RLERESGLAVLDLPKEATYHVGLHFPL---- 147 
          .:  ::**  **** : :* :.* ***     
NirL      -MNPVEPLAAPQRQHLRYLLEQGLPLASRPYRVLAERIGAGEDEVLEQVRRWDEDGLFRR 59 
NirH      MSACISPSDALLARRLIELTQAGLPLVADPWAWIAAQLRLSEAETLALLKRLRDAGVIRR 60 
              :.*  *   ::*  * : ****.: *:  :* ::  .* *.*  ::*  : *::** 
 
NirL      FGVILHHRALGYTANAMLVLDVADAEVDAVGRALAHETIVSLCYRRPRRLPMWPYNLFCM 119 
NirH      IAAVPNHYRLGYRHNGMTVWDVADERIERLGRLVGGLSFVSHCYRRPRHLPQWRYNLFAM 120 
          :..: :*  ***  *.* * **** .:: :** :.  ::** ******:** * ****.* 
 
NirL      IHGRERGEVERQIEALLERHALRQTPHRWLFSLRAYKQCGGRYTAPPADLERRHG 174 
NirH      VHGRSEAEIEGYRQQIRLLLGEDCRADEMLVSSRILKKTG----LRLAQKEERPC 171 
          :***...*:*   : :    .    ... *.* *  *: *       *: *.*   
 
NirL      -MNPVEPLAAPQRQHLRYLLEQGLPLASRPYRVLAERIGAGEDEVLEQVRRWDEDGLFRR 59 
NirH      MSACISPSDALLARRLIELTQAGLPLVADPWAWIAAQLRLSEAETLALLKRLRDAGVIRR 60 
NirD      --------MDDLSRRLLARYQKGLPICAEPYRRMAETLGCSEAEVLERLRRLEADGALSR 52 
NirG      --------MDEFDRRLLNRLQHGLPLEPHPYALLAAELDCREEDILRRLDDLLDDGTLTR 52 
                       ::*    : ***: . *:  :*  :   * : *  :      * : * 
 
NirL      FGVILHHRALGYTANAMLVLDVADAEVDAVGRALAHETIVSLCYRRPRRLPMWPYNLFCM 119 
NirH      IAAVPNHYRLGYRHNGMTVWDVADERIERLGRLVGGLSFVSHCYRRPRHLPQWRYNLFAM 120 
NirD      VGPVLRHQRAG--ASTLAALAVPEERLQRVAERISQYAEVNHNYQR-----EHRYNLWFV 105 
NirG      FGPLFDIEPLGG-AFTLAAMSVPEARFEEIAALLAGWPQVAHNYRR-----EHALNMWLV 106 
          .. :      *     : .  *.: ..: :.  :.  . *   *:*         *:: : 
 
NirL      IHGRERGEVERQIEALLERHALRQTPHRWLFSLRAYKQCGGRYTAPPADLERRHG 174 
NirH      VHGRSEAEIEGYRQQIRLLLGEDCRADEMLVSSRILKKTG----LRLAQKEERPC 171 
NirD      LTAGDRAQLDRVLAEIAADTGLQPLDLPMQEAYCIDLAFP---------LEASR- 150 
NirG      VACDSPAEVAETLARLERESGLAVLDLPKEATYHVGLHFP---------L----- 147 
          :   . .::      :    .          : 
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4.3.2. Optimisation of overproduction 
4.3.2.1. Overproduction in E. coli 
The genes nirD, nirL, nirG and nirH, from Ps. aeruginosa, were successfully 
cloned into the pET14b expression vector without mutations, behind a 
polyhistidine-encoding region. The encoded proteins were therefore produced as N-
terminal His-tagged fusion proteins in E. coli, and purified by metal chelate 
chromatography.  
All NirD, NirL, NirG, and NirH, were detected on SDS-PAGE and shown to be 
purified after elution at 400 mM imidazole from the His-bind column. Notably, 
NirD is overproduced and purified together with an unknown protein, presumably a 
host encoded chaperone protein (Figure 4.7). Therefore, all the proteins whilst only 
being soluble to a certain degree, required screening for optimisation of conditions 
for maximal expression. 
The first attempt towards increasing solubility was to change the conditions during 
induction to 16 C, instead of 37 C. The length of induction was also varied from 3 
hours to overnight. A greater degree of solubility is observed for NirD, NirL, NirG, 
and NirH with induction of protein overproduction at 16 C overnight as opposed to 
induction at 16 C for 3 hours or 37 C. The difference in yield is summarised in 
Table 4.3. The SDS-PAGE results are shown for NirL (Figure 4.4) and NirD 
(Figure 4.7), are representative of those obtained for NirG and NirH.  
Induction at 16 C overnight gives a sufficient yield of protein if performed on a 
large scale. However, it was not possible to sufficiently concentrate the eluted 
proteins because of their instability in solution. Analytical gel filtration of NirL, 
NirG, and NirH without concentrating them revealed that they were unstable and 
could not be sufficiently purified to homogeneity being present mostly as 
aggregates (Figure 4.5), even in the presence of protease inhibitors. NirD (Figure 
4.8) could not be separated from the co-eluted protein indicting a very tight 
complex, discussed later. Since NirD, NirL, NirG, and NirH all behave in a similar 
fashion, it suggests that perhaps these proteins need to be coproduced as a 
multimeric and thus multifunctional complex of NirDLGH as has been reported for 
Ps. stutzeri (Palmedo, Seither et al. 1995). They may then only be sufficiently 
soluble and stable for further investigation. 
 
Vina Parmar           Chapter 4: Optimisation of production and stabilisation of haem d1 proteins: page 145 
145 
 
NirL + Histag = 22.4 kDa 
Figure 4.4: SDS-PAGE gels of incubation at 37 °C and 16 °C for NirL.   
NirL is shown to represent the difference in solubility revealed when cultures where 
induced for overproduction at the two temperatures. Similar results were obtained 
for NirD, NirH and NirG. The first lane is the protein marker. Lane 1 the 
supernatant. Lanes 2, 3, 4, 5 are washes with binding buffer of increasing imidazole 
concentration (0 mM, 5 mM, 50 mM and 100 mM respectively). Lanes 6, 7, 8, 9 
represent the purified protein eluted with 400 mM imidazole. These results reveal 
the greater solubility of the protein NirL when induced at the lower temperature, 16 
°C overnight. 
 
NirL at 37°C              1         2          3          4          5            6           7           8          9                 
 
             29 
               24 
            
             20 
 
 
         NirL at 16°C                                           
                            29 
                                         24 
                
                                  20 
 
 
Table 4.3: Comparison of soluble protein yields from NirD, NirL, NirG and 
NirH from 1L cultures incubated at 37 °C and 16 °C. 
 
Temp NirD NirL NirG NirH 
37 °C 8.47 mg 10.95 mg 8.74 mg 9.85 mg 
16 °C 15.65 mg 12.67 mg 13.01 mg 11.56 mg 
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Figure 4.5: Gel filtration elution profiles of NirL, NirG and NirH 
NirL, NirG and NirH were analysed by gel filtration chromatography, without 
concentrating the sample eluted from metal chelate column. The elution profiles 
shown indicate that NirL, NirG and NirH are unstable the majority being present as 
aggregated protein (A) or broken peptides (B)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A)  
(A)  
(A) 
(B)  
 NirL
NirH Nir G
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The majority of the protein was observed to be present in the cell debris fraction 
after sonication. Therefore, the level of overproduction was high but the amount of 
soluble protein was low in comparison. Thus, adjusting the levels of protein 
expression by using Tuner cells may in turn increase the amount of soluble protein, 
such that they are less likely to be drawn in to inclusion bodies. The final 
concentration of IPTG induction was decreased four-fold to 0.1 mM and ten-fold to 
0.04 mM, from 0.4 mM, and cell fractions analysed by SDS-PAGE.  The results 
showed no change in the yield of soluble NirD, NirL, NirG and NirH at either 
decreased concentration of IPTG, even in the event of reduced overproduction 
(Figure 4.6).   
 
Figure 4.6: SDS-PAGE of NirL at 0.1mM IPTG 0.04mM IPTG in Tuner Cells 
NirL is representative of the results obtained for NirD, NirG and NirH. A decrease 
in the level of expression is observed with a decrease in [IPTG], seen in lanes 1, but 
no increase in solubility is observed for NirG, NirH or NirL, at either levels of 
IPTG induction. M represents the protein marker, 1 is the total crude cell extract, 2 
is the pellet after lysis, 3 the supernatant, lanes 4, 5, 6, and 7 are washes with 
binding buffer of increasing imidazole concentration (0 mM, 5 mM, 50 mM and 
100 mM respectively), lanes 8, 9, 10, 11 are the 2 ml protein fractions eluted with 
400 mM imidazole. 
 
0.1mM IPTG    1        2       3      4       5        6       7       8        9       10      11       M     
                
29  
                                                        24 
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                       24
  
                                     20  
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NirD purification by metal chelate chromatography revealed that NirD has great 
affinity to a protein of size 22 kDa. A change in the conditions and incubation did 
not alter the level of this co-expressed protein as seen in Figure 4.7. As with NirL, 
NirG and NirH, NirD incubation at 16 °C gives a greater amount of soluble protein. 
Purification was repeated in the presence of protease inhibitors, and concentrations 
of imidazole in the washes prior to elution were changed, but this extra protein 
remained firmly associated with NirD. Furthermore, they cannot be separated from 
each other even by FPLC as is evident elution profile and the SDS-PAGE gel of 
these fractions in Figure 4.8. This indicates that they are tightly bound together with 
the concentration of both being proportional to each other, suggesting a tight 
complex. Further analysis of this co-expressed protein by MALDI revealed the 
protein being co-expressed is NirD itself from Ps. aeruginosa, having on average a 
62 % - 87 % match. It is interesting that this protein is not the size of NirD that is 
19kDa with a His-tag, and is approximately 3 kDa larger at 22 kDa, thus we do not 
have a typical homodimer. The protein at 22 kDa may be suggestive of some form 
of post-translational modification of NirD, and it is notable that it remains very 
tightly bound to the original NirD at 19 kDa. It is also suggestive of the preference 
of these proteins to co-exist as larger molecules and indeed as the NirDLGH 
complex previously hypothesised. Consequently, co-crystallation of this tightly 
bound complex of NirD would be invaluable in identification of structure, stability 
and function.              
 
Figure 4.7 SDS-PAGE gel of NirD incubated at 37 °C and 16 °C  
NirD is clearly overproduced at 19.21 kDa with a host encoded protein that is ~22 
kDa. Lanes 1, 2, 3, represent purified NirD eluted with 400 mM imidazole from 
cultures incubated at 37 °C. Lane M is protein marker. Lanes 5, 6, 7 are of purified 
NirD incubated at 16 °C. Clearly the yield of soluble protein is greater at 16 °C. 
                  
                                   
                      1          2          3                M             5        6        7
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Figure 4.8: NirD gel filtration elution profile and SDS-PAGE of eluted 
fractions.   
Gel filtration was not able to separate the two NirD proteins of different size at 19 
kDa and 22 kDa (A). Any other contaminants were successfully removed. The yield 
of the co-expressed 22 kDa NirD seems to be proportional to the yield of NirD at 19 
kDa as seen in the SDS-PAGE of the eluted fractions (B). M is the protein size 
marker and A1 to A9 are the 1 ml fractions from the gel filtration column 
represented in the elution profile. 
 
(A). NirD elution profile 
 
 
 
(B). SDS-PAGE of the corresponding fractions from gel filtration. 
A1 to A9 corresponds to the fractions eluted from the gel filtration column as per 
the elution profile above. 
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Vina Parmar           Chapter 4: Optimisation of production and stabilisation of haem d1 proteins: page 150 
150 
4.3.2.2. Overproduction in Ps. aeruginosa 
Attempts were made to overcome the lack of solubility and stability of NirD, NirL, 
NirG and NirH, when overproduced in E. coli, by the overproduction of the 
recombinant proteins in their native organism, Ps. aeruginosa. All nirD, nirL, nirG 
and nirH, were individually subcloned into pUCP19-NcoI, from pET14b using the 
restriction sites NcoI and BamHI. This allowed transfer of both the gene and the 
encoded His-tag into pUCP19-NcoI and thus recombinant protein overproduction in 
Ps. aeruginosa and purification by metal chelate chromatography. The presence of 
protein from 1L cultures of Ps. aeruginosa grown aerobically or anaerobically and 
purified was analysed by SDS-PAGE and western blotting. 
The level of overproduction of recombinant NirD, NirL, NirG, NirH in Ps. 
aeruginosa was observed to be very low under both aerobic and anaerobic 
conditions. This was not clearly detectable on SDS-PAGE gels, thus western 
blotting towards the His-tag was performed. The resultant western blots for NirG 
and NirH, (Figure 4.9), are shown but the same result was observed for NirL and 
despite similar efforts as performed in E. coli, to change the incubation temperature, 
no dependency for temperature was observed. Anaerobiosis was hypothesised to 
increase the level of expression, as expression in the presence of nitrate and the 
absence of oxygen is shown to increase the expression of the nir genes (Filiatrault, 
Wagner et al. 2005). However, again no clear dependency on the presence or 
absence of oxygen was observed in comparison to aerobic overproduction in Ps. 
aeruginosa and aerobic overproduction in E. coli.   
Results obtained for NirD (Figure 4.9) were particularly intriguing; no extra band 
was observed for over production in Ps. aeruginosa as oppose to the extra NirD 
band observed at 22 kDa in E. coli. Therefore the presence of the extra NirD in E. 
coli maybe due to the overproduction of this protein in an organism that does not 
produce this normally and may be artifactual. Furthermore, NirD overproduced in 
E. coli was used as a control and western blotting displayed 2 bands for this sample. 
This indicates that it too is His-tagged, in addition to NirD at 19.2 kDa that was 
expected. It is certainly fascinating that these two remain tightly bound but are of 
different size. Since protein levels in Ps. aeruginosa are quite low to be able to 
obtain a sufficient amount of protein for analysis, this returns us to the expression of 
the nir genes in E. coli and to the investigation of the theory that NirD, NirL, NirG, 
NirH may exist together as a multimeric protein. 
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Figure 4.9: NirG, NirH and NirD western blots from overproduction in Ps. 
aeruginosa aerobically and anaerobically 
NirD, NirL, NirG, NirH are not clearly visible on SDS-PAGE but are seen on 
western blots by raising antibodies to the His-tag. NirH, NirG and NirD are shown: 
C is the control purified from E.coli. M is the protein marker. SN represents the 
supernatant and P the pellet after sonication. BB, WI, WII are washes with buffer 
of increasing imidazole (5 mM, 50 mM, 100 mM respectively). The numbered lanes 
represent purified protein eluted at 400 mM imidazole. These results reveal the 
lower level of overproduction in comparison to the controls, from E. coli. Similar 
results were obtained for NirL. There is no clear dependency on protein 
overproduction with aerobic or anaerobic growth. In some cases an extra band is 
seen but this band at ~40 kDa is also seen in the control (not shown). NirD = 19.21 
kDa, NirH = 21.78 kDa, NirG = 18.75 kDa. 
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4.3.2.3. Co-expression of NirD, NirL, NirG, and NirH. 
The complementarity of NirD, NirL, NirG, and NirH is well observed (Figure 4.3), 
as is the similarity of these proteins amongst denitrifying bacteria (Table 4.2). The 
similar behaviour of the overproduced proteins in this study and the partiality of 
these proteins to form complexes is suggestive that these proteins to prefer to exist 
as a complex. The presence of a complex of NirDLGH as a multimeric protein has 
been proposed before (Palmedo, Seither et al. 1995). However, it has not been 
proven experimentally. Therefore, the co-expression of these proteins together 
would be of great significance if they indeed form a complex. 
 
To investigate this possibility in both E. coli and Ps. aeruginosa, pET14b (pVP76) 
and pUCP-Nco (pVP73) were respectively constructed containing nirD, nirL, nirG 
and nirH, such that only nirD would be encoded with an N-terminal His-tag. 
Subsequent overexpression of this plasmid was performed in E. coli and Ps. 
aeruginosa as before, with subsequent purification by metal chelate 
chromatography. If NirD, NirL, NirG, and NirH indeed prefer to exist as a complex, 
purification on a His-bind column would enable NirD to also co-purify with NirL, 
NirG, and NirH. A higher similarity exists of NirD with NirG and it is predicted 
that NirD would have a greater affinity for NirG. 
 
Primarily, a small difference is observed from NirD and NirG overproduced alone 
in E. coli (BL21 DE3 pLysS) in comparison to NirDLGH overproduced together 
(Figure 4.10A), by SDS-PAGE analysis of the supernatant and pellet after 
sonication. Controls were performed with and without pET14b in E. coli. NirDLGH 
coproduced together showed additional bands in the region of 15-18 kDa that could 
be NirG (16.5 kDa) but no such bands corresponding to NirL (20.21 kDa) and NirH 
(19.58 kDa) could be clearly identified.  
 
Subsequent purification on a His-bind column revealed a small amount of protein is 
purified in comparison to NirG and NirD when overproduced on their own (Figure 
4.10B). Importantly, purification of NirDLGH shows no band for NirD expected at 
19.21 kDa but the 22 kDa band for NirD is seen, along with a band corresponding 
to the size of NirG (16.55 kDa), which is not seen when NirD is purified alone. This 
is notable since it suggests that NirD prefers to exist at the higher mass and further 
that NirD binds to NirG. This is the first time that this has been shown, and is in 
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accordance with previous reports of possible complex formation and the stated 
complementarity of NirD to NirG. An extra band is seen at ~23 kDa but does not 
correspond to the size of NirL or NirH and is also observed when NirD is purified 
alone and thus can be eliminated.  
However, SDS-PAGE analysis of NirDLGH, of the supernatant and pellet after 
sonication in comparison to the eluted fractions of purified protein reveals that NirD 
at a size of 19.21 kDa is drawn completely into the cell debris fraction (Figure 
4.10C). This may be a consequence of the higher 22 kDa form of NirD being bound 
to NirG instead of the 19.21 kDa NirD and may be indicative of some sort of 
stabilisation feature of the 22 kDa form. It must also be noted that a significantly 
smaller amount of these proteins are observed when coproduced in comparison to 
NirD and NirG alone. 
Similar results were obtained in JM109, by co expression of nirDLGHpUCPNco 
(data not shown). Co-expression in Ps. aeruginosa was not evident since the level 
of overproduction of NirD, NirL, NirG, and NirH on their own is low (data not 
shown). Therefore any co-production is more difficult to detect in Ps. aeruginosa. 
 
Figure 4.10: SDS-PAGE analysis of the co production of NirD, NirL, NirG and 
NirH in E. coli (BL21 DE3 pLysS) 
(A) SDS – PAGE analysis of the supernatant and pellet after sonication. NirD and 
NirG were overproduced alone and coproduced as part of NirDLGH. Controls were 
performed with and without pET14b in E. coli (BL21 DE3 pLysS). M is the protein 
marker. SN the supernatant and P is the pellet after sonication. 
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(B) SDS – PAGE analysis of the eluted fractions of NirD and NirG overproduced 
alone as well as NirDLGH overproduced together. Bands for NirD at 22 kDa and 
NirG at 16.55 kDa are evident in the lanes for NirDLGH co eluted at 400 mM 
imidazole from a His-bind column. 
 
 
 
 
    
 
 
                                               NirD        NirG        NirDLGH 
                                                19.21 kDa    18.75 kDa    (NirD = 22 kDa, NirG = 16.55 kDa) 
     
 
(C) SDS – PAGE analysis of the purification of NirDLGH. M is the protein marker. 
TCF is the total cell fraction. SN the supernatant and P is the pellet after sonication. 
BB, WI, WII are washes with buffer with increasing imidazole (5 mM, 50 mM, 
100 mM respectively). The numbered lanes represent purified protein eluted at 400 
mM imidazole where bands for NirD at 22 kDa and NirG at 16.55 kDa are evident. 
NirD at 19.21 kDa is seen in completely in the cell debris pellet.  
 
           M   TCF      P       SN      BB1  BB2   WI      WI      WII         2          3       M                                
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4.3.3. Stabilisation screen 
NirD, NirL, NirG and NirH, were all screened for stability in a variety of different 
buffers as detailed in Section 4.2.5. Protein stability was verified by SDS-PAGE 
analysis and gel filtration chromatography. 
NirG was the only protein found to be suitably stable in 50 mM Hepes, 0.1M NaCl. 
Whilst being purified in 50 mM Tris pH8, 0.5M NaCl, the average yield from 1L 
was 13 mg, however in Hepes a yield of 26 mg was achieved by suspension of the 
cell fraction and purification in Hepes. A marked difference in stability is observed 
both by SDS-PAGE and gel filtration analysis (Figure 4.11 and 4.12). Gel filtration 
chromatography further allowed the isolation of a tetramer (75 kDa) and a monomer 
of NirG (18.75 kDa) confirmed by native gel analysis (Figure 4.13A). The same 
native gel is run with NirG in the presence and absence of β-mercaptoethanol 
(Figure 4.13B), revealing that the tetramer is held together with disulphide bridges. 
Furthermore, observation of the SDS-PAGE gels always showed a band below that 
of NirG, which was predicted to be NirG without the His-tag. This band appears to 
increase quantity the older NirG is. Consequently, the His-tag was cleaved from 
NirG and run alongside a two-week-old sample of NirG, showing it is exactly the 
same size as cleaved NirG (data not shown). This was also the same size as the band 
obtained for NirG, when NirDLGH are co-expressed. It can be inferred that NirG is 
somewhat cleaving the His-tag and prefers to exist in the cleaved state. This His-tag 
free NirG was stable and was purified by gel filtration and used in subsequent 
investigations. Therefore, NirG was the only one of the Nir proteins purified to 
homogeneity allowing it to be investigated for crystal formation in structural 
studies. 
 
Figure 4.11: SDS-PAGE of NirG in HEPES  
The first lane is the marker. The other lanes represent each 2 ml fraction of NirG 
purified by metal chelate chromatography, from a 1L culture. NirG is more stable in 
50 mM Hepes, 0.1M NaCl, allowing a sufficient level of NirG to be obtained for 
further analysis. 
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Figure 4.12: Elution profile of NirG in HEPES 
NirG purified in HEPES has a markedly different elution profile in comparison to 
the elution profile for NirG in 50 mM Tris pH8, 0.5M NaCl (Figure 4.5). Here we 
see two forms of NirG being eluted, as a tetramer (T) and a monomer (M). These 
fractions were subsequently analysed on non-denaturing (native) gels. The inset is 
an SDS-PAGE gel of NirG from a His-bind column and fractions A8, A10 and A11 
from gel filtration. 
             
                         (M = A10 / A11) 
                             A8  A10  A11                                                               (T =A8) 
     
    
       
 
    
 
Figure 4.13: Non-denaturing (native) gels of NirG of the corresponding 
fractions from gel filtration chromatography 
A8 and A10/A11 correspond to the fractions eluted from the gel filtration column as 
per the elution profile above for the tetramer and monomer respectively. (A) a 
native gel of fractions A8, A10 and A11. (B) a native gel run with A8, A10 and A11 
in the presence (+) and absence (-) of β-mercaptoethanol as indicated, whose 
presence reveals that the tetramer is held by disulphide bonds. 
  
  (A)       A8  A10  A11        (B)       A10+  A8+    A10-  A8-  
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4.3.4. NirG crystallisation trials 
Of NirD, NirL, NirG and NirH, only NirG was purified to homogeneity and 
sufficient stability for investigation of crystal formation to deduce the structure from 
X-ray crystallography. This would enable us to obtain a precise description of the 
tertiary structure of NirG and allow comparison of NirG to proteins of known 
structure and similarity. This would make possible the assignment of a role and 
function for NirG. 
 
The hanging drop method vapour diffusion method was used to screen for optimal 
conditions for crystallisation. Optimal conditions for NirG crystals was obtained at 
60 % 2-methyl-2, 4-pentanediol (MPD), 0.1M Tris pH 8.5 and 0.2M ammonium 
phosphate after much analysis of various precipitant solutions. There was no 
dependency on temperature, as the screens were performed at 4C as well as 16C. 
The various crystal formations are shown in Figure 4.14. 
 
Unfortunately, analysis by Dr Brindley revealed these to be salt crystals and not 
protein crystals.  
 
Figure 4.14: Crystal formations in 60 % MPD, 0.1M Tris pH 8.5 and 0.2M 
ammonium phosphate. 
Pictures of the crystal formations obtained by screening for NirG with various 
conditions. These were later identified to be salt. 
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4.4. NirF 
Conflicting arguments exist regarding the precise role of NirF, a protein of 43.3 
kDa. Whilst Palmedo et al suggest the similarity of NirS and NirF (41 % nucleotide 
identity) indicate a scaffold role for a precursor of haem d1 or dehydrogenase 
activity with PC2 to yield SHC (Palmedo, Seither et al. 1995), other papers suggest 
a role in ferrochelation (Kawasaki, Arai et al. 1995). Indeed, a similarity to a 
cobalamin decarboxylase, CobT, also exists (Kawasaki, Arai et al. 1995; Zumft 
1997). It is believed to be translocated to the periplasm due to the presence of a 
signal in Pa. denitrificans NirF, but this is not clearly observed with NirF from Ps. 
aeruginosa and Ps. stutzeri. However, a high level of sequence similarity at an 
average of 55 % of NirF exists between the species suggesting they share a 
periplasmic location (Table 4.2) (Baker, Saunders et al. 1997). This diminishes the 
theory that NirF acts as a scaffold, as from our previous chapter, NirE is clearly a 
cytoplasmic protein and therefore if it were to act as a scaffold for the assembly of 
haem d1 it would not reside in the periplasm. 
Bioinformatic analysis shows little similarity to any proteins of known structure and 
function. The similarity of NirF to the d1 domain of cytochrome cd1 has implied a β- 
propeller domain structure (Baker, Saunders et al. 1997), and a role for binding 
haem d1. This also suggests that NirF may have evolved as a result of gene 
duplication, but it is unknown whether its necessity in haem d1 biosynthesis is by 
binding it in a β- propeller domain, or through the synthesis of intermediates. This 
remains to be elucidated through discovery of its structure and function attempted in 
this thesis. 
Furthermore, NirF has 21 % identity to NirE in the first 100 N-terminal residues, 
suggesting a similar methyltransferase role but the SAM binding site is somewhat 
different in NirF to NirE, suggesting a possible interaction with SAM (Figure 4.15). 
However, in Chapter 3, experiments with a S. enterica cysG metH mutant deficient 
only in its methyltransferase activity, with a plasmid containing NirF was not able 
to complement the cysteine auxotrophy of this mutant. Therefore we can say with 
confidence that NirF confers no such activity and NirE is the only SUMT of the nir 
operon. 
NirF was accordingly overproduced in E. coli, in the same way as NirD, NirL, 
NirG, and NirH in the previous section. An increase in the level of protein is 
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NirE  MNTTVIPPSLLDVDFPAGSVALVGAGPGDPGLLTLRAWALLQQAEVVVYDRLVARELIAL 60
NirF  MNLRPLAPLLLTLLAGCSQQPPL-RGSGDLGVLIERADGSVQILDGTAKTSLARVEGLGD 59
      **   :.* ** :   ... . :  *.** *:*  ** . :*  : ..   *.  * :.  
 
NirE  LPESCQRIYVGKRCGHHSLPQEEINELLVRLARQQRRVVR 100 
NirF  LSHASLVFSRDQRYAYVFGRDGGLTKLDLLAQRIDKRLIQ 119  
      *..:.  :  .:* .:    :  :.:* :   * ::*:::
observed with induction of protein overproduction at 16 C overnight (17.2 mg/L) 
in comparison to 37 C (9.3 mg/L). Though NirF was found to be soluble, it is 
highly unstable and rapidly degraded as observed by SDS-PAGE analysis (Figure 
4.16A). The addition of protease inhibitors markedly changes the stability of NirF 
(Figure 4.16B), but analysis of NirF by gel filtration chromatography shows it is 
mostly aggregated (Figure 4.17). Homologous expression of NirF in Ps. aeruginosa 
revealed the same results as observed with NirD, NirL, NirG, and NirH obtained 
aerobically and anaerobically. NirF is not well over produced aerobically and did 
not increase with the induction of anaerobiosis in Ps. aeruginosa (Figure 4.18). 
Decreasing the concentration of IPTG in Tuner cells to 0.1 mM and 0.04 mM did 
not alter the yield of soluble NirF (data not shown). NirF was also screened for 
stability in a variety of buffers as detailed in Section 4.2.5, but was to no avail, as 
was the addition of DTT (data not shown). Therefore, work is still required to 
overproduce NirF with a sufficient level of stability to allow for further 
characterisation. 
 
Figure 4.15: Comparison of sequences of NirF and NirE 
An alignment of NirF and NirE from Ps. aeruginosa shows a 21 % identity in the 
first 100 N-terminal residues. The asterisks show identical amino acids, dots those 
belonging to the same group, and the SAM binding site is shown in red.  
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Figure 4.16: SDS-PAGE analysis of NirF with induction at 16 C and 37 C 
and in the presence of protease inhibitors 
(A) Optimal protein yield was achieved from induction at 16 C overnight, in 
comparison to 37 C overnight. The SDS-PAGE shows the fractions eluted at 400 
mM imidazole. Cultures and samples were treated identically except for the 
different incubation temperature.  
 
 
 
 
 
 
(B) NirF is more stable and less prone to degradation in the presence of protease 
inhibitors, as shown by SDS-PAGE of eluted fractions from a His-bind column. 
 
 
 
 
 
 
Figure 4.17: Elution profile of NirF with gel filtration chromatography 
      The resultant elution profile of NirF shows it is eluted as aggregated protein. 
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45
30
NirF =45.5 kDa
Figure 4.18: NirF western blots from overproduction in Ps. aeruginosa 
aerobically and anaerobically 
NirF overproduction is not clearly visible on SDS-PAGE, therefore western blot 
analysis was performed by raising antibodies to the His-tag. C is the control 
purified from E.coli. M is the protein marker. SN represents the supernatant and P 
the pellet after sonication. BB, WI, WII are washes with buffer of increasing 
imidazole (5 mM, 50 mM, 100 mM respectively). The numbered lanes represent 
purified protein eluted at 400 mM imidazole. NirF has a lower level of 
overproduction in comparison to the control, from E. coli. No difference in protein 
level is observed with aerobic or anaerobic growth.  
     
NirF  AEROBIC                    C        M       P       SN   BB     WI   WII       2        3        4       
 
 
 
 
NirF      ANAEROBIC             C     M     P    SN      BB   WI   WII       2       3       4        5                               
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4.5. NirJ 
Bioinformatic analysis of the Ps. aeruginosa NirJ sequence (Figure 4.19) shows the 
presence of a conserved N-terminal motif for radical SAM enzymes. This motif, 
CXXXCXXC, predicts it to be a [4Fe-4S] protein, similar to that observed in 
MoaA, NifB, HemN and PqqE proteins for which a metal redox-binding site (Fe-S) 
is postulated. These are all believed to take part in the conversion of SAM to a 
radical form, being classified as part of the radical SAM protein family (Sofia, Chen 
et al. 2001). However, the functions of MoaA, NifB, and PqqE are largely unknown 
and cannot be used to ascertain the precise function of NirJ. It is notable that radical 
SAM enzymes are involved in anaerobic or oxygen independent mechanisms, 
which are otherwise performed aerobically with other proteins. Therefore, NirJ is 
likely to be involved in radical chemistry such that it may be the likely candidate to 
catalyse the introduction of the oxo groups on the haem d1 macrocycle, under 
anaerobiosis. HemN, a coproporphyrinogen III oxidase, is one such enzyme 
catalysing the anaerobic oxidative decarboxylation of coproporphyrinogen III to 
yield protoporphyrinogen IX in the haem biosynthetic pathway (Troup, Hungerer et 
al. 1995; Layer, Kervio et al. 2005). HemN converts the propionate side chains at 
C3 and C8 to the corresponding vinyl groups via a reduction of the Fe-S cluster, 
electron transfer to SAM, SAM cleavage, and formation of the deoxyadenosyl 
radical.  This radical is then presumed to abstract a hydrogen atom from the 
substrate propionate side chain, yielding 59-deoxyadenosine and a substrate radical. 
CO2 release and vinyl group formation produces protoporphyrinogen IX (Layer, 
Kervio et al. 2005). For many years the presence of an adenosyl radical has been 
presumed but has only been confirmed recently by work performed on Pa. 
pantotrophus NirJ (data unpublished, communication Dr Brindley). NirJ from Pa. 
pantotrophus is available at high concentrations and stable for further analysis. It 
was seen to contain iron sulphur centers and exhibited the characteristic brown 
appearance that his moiety endows the cells with. EPR investigations of NirJ 
resulted in the appearance of a radical signal, which is due to the presence of a 
deoxyadenosyl radical, confirming the mechanism of action of radical SAM 
enzymes. In the same vein, we may make the assumption that NirJ from Ps. 
aeruginosa will act similarly as it shares 47 % identity with Pa. pantotrophus NirJ. 
Therefore, it may also be inferred that NirJ, in a similar fashion to HemN, is 
involved in radical chemistry whereby the addition of the oxo groups at C3 and C8 
is facilitated. This however remains to be confirmed experimentally. 
Vina Parmar           Chapter 4: Optimisation of production and stabilisation of haem d1 proteins: page 163 
163 
Figure 4.19: Multiple sequence alignment of NirJ 
Multiple alignment of NirJ from Ps. aeruginosa (PAO) with NirJ Pa. pantotrophus 
(PAPANT), HemN from Ps. aeruginosa, HemN from E. coli and MoaA from Ps. 
aeruginosa. Asterisks show identical amino acids, dots belonging to the same 
group. The conserved radical SAM enzyme motif, CXXXCXXC, is shown in red. 
NirJ_PAO     ----MLRISHYLRSLTEDAPTPRRAG-----------------------GRRAPVVIWNL 33 
NirJ_PAPANT  -----------MHQLLDPSPPRRRSRP----------------------DAVRPVVIWNL 27 
HemN_PAO     -MLDTIRWDADLIRRYDLSGPRYTSYPTAVQFHEGIGPFDQLHALRDSRKAGHPLSLYVH 59 
HemN_E.coli  MSVQQIDWDLALIQKYNYSGPRYTSYPTALEFSEDFGEQAFLQAV--ARYPERPLSLYVH 58 
MoaA_PAO     -----------MTDWIDGQG------------------------------RQIDYLRLSV 19 
                            :    :                                           
 
NirJ_PAO     LRRCNLTCKHCYS-------TSADSDFRGELETAEILRGIDDLRAAGVRVLILSGGEP-- 84 
NirJ_PAPANT  TRSCNLKCRHCYT-------VSADRPFPGELSHDQAMAVLRDLSDFRIPALILSGGEP-- 78 
HemN_PAO     IPFCANICYYCACNKVITKDRGRSAPYLARLVREIEIVSRHLSREQVVEQLHFGGGTPTF 119
HemN_E.coli  IPFCHKLCYFCGCNKIVTRQQHKADQYLDALEQEIVHRAPLFAG-RHVSQLHWGGGTPTY 117
MoaA_PAO     TDRCDFRCVYCMA------EDMRFLPRQQVLTLEEIERVARLFVAGGVRKLRLTGGEP-- 71 
                *   * .*                   *                :  *   ** *   
 
NirJ_PAO     LMHPDLFEIAAHARQ------AGM-FVALSSNGTLIDEGNIQRVAEARFDYVGISLDGLR 137
NirJ_PAPANT  MSRFDFWELAEEARR------LDFRHLSLSTNGTKIDAGNVERLAGLGFDYVGISLDGIG 132
HemN_PAO     LSPGQLRELMSQLRTHLNLLDDDSGDYGIEIDPREADWSTMGLLRELGFNRVSLGVQDFD 179
HemN_E.coli  LNKAQISRLMKLLRENFQFNAD--AEISIEVDPREIELDVLDHLRAEGFNRLSMGVQDFN 175
MoaA_PAO     LVRPGIVGLCERLAALP-----GLRELCMTSNGSQLVR-YARPLYDAGLSRLNISLDTLD 125
             :    :  :                   :  :           :    :. :.:.:: :  
 
NirJ_PAO     ETHDRFRQKQGSFDAALAAMRLCREADIR---VGMRTTLTEENAAQLPALLDLMRELDVQ 194
NirJ_PAPANT  AVNDWFRGVEGAFDQALAGVRACKAQGVK---VGLRFTITEGNAHHLPAMLDLCRDEGVD 189
HemN_PAO     MEVQKAVNRMQTPEETRTIVEAARTLQYRSINLDLIYGLPKQTPDSFARTVDEVIALQPD 239
HemN_E.coli  KEVQRLVNREQDEEFIFALLNHAREIGFTSTNIDLIYGLPKQTPESFAFTLKRVAELNPD 235
MoaA_PAO     PLRFRAITRNGELDKVLAGIDAAQAAGFRRIKLNAVV-MKGRNADEVPALVDFAIARGLD 184
                          :   : :  .:        :.    :   ..  ..  :.       : 
 
NirJ_PAO     KFYLSHLNYSGR--GRRSRALDAHHRRTREALALLFERADQDIRQGR---DSDFVTGNND 249
NirJ_PAPANT  KFYLSHLVYAGR--GDKHRGEDTEHARTRRAMDLLIARAWQAVERGE---PLEVVTGNND 244
HemN_PAO     RLSVFNYAHLPERFMPQRRINADDLPSPGQKLEMLQRTTEQLAAAGYRYIGMDHFALPDD 299
HemN_E.coli  RLSVFNYAHLPTIFAAQRKIKDADLPSPQQKLDILQETIAFLTQSGYQFIGMDHFARPDD 295
MoaA_PAO     ISFIEEMP-----LGQVGRERGESFCSSDEVRALIAQRHALLDSAEQ-------SGGPAR 232
                : .            :        . .   ::                          
 
NirJ_PAO     ADAILLLDWLKRR-RPQQLARLCELLLDWGGNASGEGIANIDNTGEVHPDSYWWHHSVGN 308
NirJ_PAPANT  ADAVYFLRWAETRFAPAAVAHLRAHLQAWGGNSSGLGVGNIDPQGRVHPDTYWSDYTLGS 304
HemN_PAO     ELASAQEDGTLQRNFQGYTTHGHCDLVGLGVSAIS-QIGDLYSQNSSDINDYQTSLDNGQ 358
HemN_E.coli  ELAVAQREGVLHRNFQGYTTQGDTDLLGMGVSAIS-MIGDCYAQNQKELKQYYQQVDEQG 354
MoaA_PAO     YVRLVEHPQTRIGFISPHSHNFCATCNRLRLTVEGRLLLCLGHEHSLDLRALLRRHPLHD 292
                                 .          .  .  :         .             
 
NirJ_PAO     IRHQR------FADFWFERPDPLLLQLRQRPRPVVGRCSQCRWLDICNGNTRTRAWAG-G 361
NirJ_PAPANT  VKERP------FSAIWTG-DDPILATLRTRPRPLKGRCGACAYQAVCGGNTRIRALQLTG 357
HemN_PAO     LAIRRGLHCN-SDRVRRAVIQQLICHFELAFEDIETEFGIDFRSYFAELWPDLERFAADG 417
HemN_E.coli  NALWRGIALTRDDCIRRDVIKSLICNFRLDYAPIEKQWDLHFADYFAEDLKLLAPLAKDG 414
MoaA_PAO     G------------PLLEAIGEALQRKPARHEFSAAGEVQVLRFMNMSGG----------- 329
                           .     . :             .        ..              
 
NirJ_PAO         ELWGEDPGCYLSDQ---EIG-----LERIALHAV------------ 387 
NirJ_PAPANT      DPWAEDPACYLSGS---EIGAEGADLDRLAVTPFRGKSHDPAHRFL 400 
HemN_PAO         LIRLDAKGIDITSSGRLLVRSICMLFDRYLPSLNR-QRFSRVI--- 459 
HemN_E.coli      LVDVDEKGIQVTAKGRLLIRNICMCFDTYLRQKARMQQFSRV---- 456 
MoaA_PAO         ---------------------------------------------- 
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During the process of cloning nirJ, a database sequence error, R211R, was 
discovered in all sequencing projects when confirming the cloned nirJ was mutation 
free. This was observed as a change from CGC (Arg) to a database error of CGG 
(Arg).  
Overproduction of NirJ in E. coli shows it to be highly insoluble and no change in 
protein level is observed for NirJ with a change of conditions during induction to16 
C, instead of 37 C, as well as varying the length of induction from 3 hours to 
overnight.  The majority of NirJ remains in the cell debris fraction rather than the 
supernatant of the cell. The presence of a small amount of NirJ is observed in the 
eluted fractions off the His-bind column only by western blotting in both E. coli and 
Ps. aeruginosa (Figure 4.20). Controlling the level of expression by decreasing the 
concentration of IPTG in Tuner cells had no effect on the yield of soluble NirJ (data 
not shown). Again, NirJ was screened for solubility and stability in a number of 
buffers as detailed in Section 4.2.5, but no significant change was observed. NirJ 
was the least soluble of all the Nir proteins. In comparison to NirJ from Ps. 
aeruginosa, NirJ from Pa. pantotrophus is much more stable and soluble. 
Therefore, further examination is required to obtain NirJ from Ps. aeruginosa that is 
viable for further experimentation. 
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Figure 4.20: SDS-PAGE and western blot of NirJ in E. coli, BL21 DE3 pLysS 
and Ps. aeruginosa (aerobic and anaerobic) 
 (A) SDS-PAGE and western blot analysis of NirJ shows the majority of NirJ is 
found in the cell debris fraction. A small amount of NirJ is seen in the eluted 
fractions. M is the protein marker. SN represents the supernatant and P the pellet 
after sonication. BB, WI, WII are washes with buffer of increasing imidazole (5 
mM, 50 mM, 100 mM respectively). The numbered lanes represent purified protein 
eluted at 400 mM imidazole. NirJ is highly insoluble, the majority being drawn into 
the pellet. (B) No difference in protein level is observed with aerobic or anaerobic 
growth. NirJ is seen at 46.1 kDa. 
 
 
(A) NirJ AEROBIC –SDS-PAGE - BL21 DE3 pLysS      NirJ AEROBIC – WESTERN BLOT -BL21 DE3 pLysS           
           M    4        3       2    WII  WI   BB    BB   SN     P                              M     4       3       2    WII   WI  BB  BB   P    SN   M          
      
 
 
    (B) NirJ AEROBIC – WESTERN BLOT -PAO                            NirJ ANAEROBIC –  WESTERN BLOT-PAO       
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4.6. Conclusion 
All the potential haem d1 biosynthetic genes nirF, nirD, nirL, nirG, nirH, nirJ, 
from Ps. aeruginosa, were successfully cloned into pET14b. Preliminary attempts 
at overproducing the respective proteins in E.coli revealed them to be 
predominantly insoluble remaining largely in the cell pellet after cell lysis and 
centrifugation. Each was found to have varying degrees of solubility and stability. 
This was surprising it had been predicted that the Nir proteins should be 
hydrophilic and thus soluble, without membrane spanning domains (Palmedo, 
Seither et al. 1995). The instability of the Nir proteins also warranted the inclusion 
of protease inhibitors in subsequent investigations. However, NirJ was found to be 
predominantly insoluble being drawn completely in the cell debris fraction. A 
database error in the nucleotide sequence was also discovered (R211R) during 
sequecing of NirJ and alignment with the database sequence. Notably, NirD (19.21 
kDa) is co purified with another form of NirD (22 kDa) visible on SDS-PAGE, 
such that they form a very tight complex that cannot be separated by gel filtration. 
This is the first time that such results have been observed for NirD and may be 
suggestive of post translation modification and warrants further investigation.  
 
Co-expression of nirDLGH, where only NirD is His-tagged revealed that NirD is 
co-eluted with NirG. This was as predicted from the observed higher 
complementarity of NirD to NirG as oppose to NirH and NirL. This is the first time 
that NirD has been experimentally shown to have an affinity towards binding NirG. 
It has been well hypothesised that the complementarity of NirD, NirL, NirG and 
NirH is likely to form a multimeric and thus, a multifunctional enzyme (Palmedo, 
Seither et al. 1995). Therefore it may further be hypothesised that NirL will have 
and affinity towards binding NirH on the basis of the complementarity that they 
share. Further examination is required to see if they do indeed form a complex of 
NirDLGH together. 
 
In an attempt to optimise overproduction of the Nir proteins, the level of induction 
of IPTG was changed ten fold (0.04 mM) and four fold (0.1 mM) by growth in a 
cell line that allow homogeneous induction of cell in a culture (tuner cells). The 
results showed no change in the amount of protein that fell into inclusion bodies 
and controlling the level of expression by decreasing the concentration of IPTG had 
no effect on the level of soluble protein for NirF, NirD, NirL, NirG, NirH and NirJ. 
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A new system for protein expression in Ps. aeruginosa was formulated to overcome 
the problems with solubility and stability of the recombinant proteins when 
overproduced in E. coli. The level of overproduction of recombinant NirF, NirD, 
NirL, NirG, NirH and NirJ in Ps. aeruginosa was observed to be very low under 
both aerobic and anaerobic conditions and required detection by western blotting. 
No dependency on the presence or absence of oxygen was observed for 
overproduction in Ps. aeruginosa. This was unexpected as it was predicted that 
anaerobiosis increases the level of nir expression in response to the presence of 
nitrate and the absence of oxygen, the the level of overproduced protein was alos 
expected to be high (Filiatrault, Wagner et al. 2005).  
 
Since protein levels in Ps. aeruginosa were insufficient for further analysis, the 
overproduced recombinant proteins from E. coli were screened for stabilisation in a 
range of buffers. So far, NirG has been suitably stabilised. The gel filtration elution 
profile of NirG revealed the presence of a monomer and a tetramer. This study 
shows for the first time that NirG may indeed exist as a tetramer. This is 
particularly interesting as it implies that NirD, NirL, and NirH may also be bound to 
this tetramer to produce a larger multifunctional enzyme, or indeed it implies that 
NirD, NirL, and NirH with NirG is itself a tetramer, as proposed previously and 
NirG is displaying its preference to exist in this formation. This remains to be 
confirmed 
 
From Chapter 3, NirE catalyses the first step transforming UIII to PC-2. In this 
chapter, NirJ can be postulated to perform the anaerobic oxidative decarboxylation 
of the macrocycle by the removal of the propionates and the subsequent addition of 
the oxo- groups at C3 and C8 in a similar fashion to the reaction catalysed by 
HemN.  The scheme is summarised in Figure 4.21. It is unknown which of the 
remaining steps NirF, NirD, NirL, NirG and NirH perform to haem d1. 
 
Whilst assigments of role or function cannot be made for the all the Nir proteins, 
except for NirJ and NirE, this thesis further endeavours to optimise the stability of 
these proteins. This would be invaluable in allowing the proteins to be structurally 
characterised to give further insight into the function of these proteins and possible 
reactions they may catalyse on the pathway to haem d1. Thus enabling a precise 
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description of tertiary structures of the Nir proteins and further allow the 
comparison of the Nir proteins to those that are structurally similar with known 
function. This would make possible the assignment of roles and functions for the 
Nir proteins that to this point are still a mystery. 
 
Figure 4.21: The steps of haem d1 biosynthesis 
In Chapter 3, NirE is confirmed to catalyse the first step in the methylation of UIII 
at C2 and C7 to form PC-2. In this chapter NirJ can be postulated in the removal of 
the propionates and the subsequent addition of the oxo- groups at C3 and C8. The 
roles of NirF, NirD, NirL, NirG and NirH are still unclear. 
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CHAPTER 5 
                                             
 
A Synthetic Biology Approach Towards the 
Generation of Tetrapyrrole Intermediates of the 
Haem d1 Pathway, In Vivo and In Vitro  
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5. A synthetic biology approach towards the generation of tetrapyrrole 
intermediates of the haem d1 pathway, in vivo and in vitro. 
 
5.1. Introduction 
Haem d1 is a unique tetrapyrrole found only in bacterial dissimilatory nitrite 
reductases, acting as the active centre for nitrite reduction. It differs from other 
known porphyrins, such as haem b, being more saturated and characterised by the 
presence of two oxo groups at C3 and C8, methyl groups at C2 and C7 and an 
acrylate in the C17 peripheral group.  
 
All the genes necessary for haem d1 biosynthesis have been identified by mutational 
and complementation analysis in Ps. aeruginosa and Ps. stutzeri (Palmedo, Seither 
et al. 1995; Kawasaki, Arai et al. 1997). This thesis identifies a Pa. denitrificans 
operon containing exactly the same genes, but in a different order to Ps. aeruginosa 
and Ps. stutzeri, as detailed in Chapter 4. Interestingly, the genes for nirD and nirL 
are fused in Pa. denitrificans. Essentially the genes required for the production of 
haem d1 constitute nirF, nirD, nirL, nirG, nirH, nirJ, and nirE forming an operon. 
 
Thus far, a function has only been confirmed for NirE, as a SUMT catalysing the 
SAM dependent transformation of UIII to PC-2 as proven in Chapter 3. The rest of 
the pathway from PC-2 to haem d1 remains uncharacterised. To date no true 
intermediates have been isolated and as a result there exists a distinct lack of 
information as to how the aforementioned atypical substituents are introduced into 
the macrocycle. The most intriguing of which is the incorporation of oxygen onto 
the macrocycle under anaerobic conditions. In comparing their structures, shown in 
Figure 5.1A, the synthesis of haem d1 from PC-2 requires the decarboxylation of the 
acetate side chains at C12 and C18; loss of the propionic side chains at C3 and C8 
with subsequent oxidation at C3 and C8; dehydrogenation of the C17 propionate 
side chain to give the acrylate substituent and ferrochelation. 
Only one putative intermediate has been put forward, termed Compound 800 
(Figure 5.1B), after the unique mass of its methyl ester derivative, where cell 
extracts of Ps. aeruginosa with NirFDLGH and SUMT from D. vulgaris were 
incubated anaerobically with SAM and UIII (Youn, Liang et al. 2004). There is no 
inclusion of NirE, the preferred SUMT for this pathway, and also NirJ, which is 
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shown to be necessary for haem d1 biosynthesis (Palmedo, Seither et al. 1995; 
Kawasaki, Arai et al. 1997). Treatment of C800 with strong acid and heat results in 
haem d1, however these are non-physiological conditions that will not occur 
otherwise in vivo. C800 has some unusual substituents such as epoxide and 
sulfoxide moieties that have not previously been found in any tetrapyrrole 
intermediate. Therefore, it remains to be seen if C800 is a true intermediate or 
related to an intermediate in the pathway to haem d1. 
 
Figure 5.1: The pathway from UIII to haem d1 
A: The synthesis of haem d1 from UIII via PC-2 
The synthesis of haem d1 from PC-2 requires the decarboxylation of the acetate side 
chains at C12 and C18; loss of the propionic side chains at C3 and C8 with 
subsequent oxidation at C3 and C8; dehydrogenation of the C17 propionate side 
chain to give the acrylate substituent and ferrochelation 
 
B: The structure of Compound 800. 
The structure of C800 bears a resemblance to haem d1 in the southern half of the 
macrocycle, whereas the sulfoxide and epoxide moieties are in the norther half. 
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In light of the lack of any characterised intermediates available, this chapter 
explores the journey in the engineering of a strain to synthesis haem d1 de novo, and 
thus any intermediates in the pathway. This is performed in a number of ways. 
Primarily, bacteria were engineered with plasmids containing the nir genes in 
predefined arrangements and combinations, in the hope that these would produce 
haem d1 or any of the preceding intermediates in vivo. This was performed in both 
E. coli and Ps. aeruginosa in a number of ways. The next method used soluble cell 
extracts with predefined overproduced Nir proteins either singularly, or 
combinations thereof, to check for activity towards PC-2 and SHC, synthesised in 
vitro.  The presence of key cofactors was also varied. The data obtained are 
discussed herein. 
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RESULTS AND DISCUSSION 
  
5.2. In vivo accumulation of intermediates 
It was highly attractive to engineer a bacterial system with the nir operon to 
synthesise haem d1, and in this manner too, synthesise any intermediates in vivo by 
defining the genes or combinations thereof to be overexpressed. This would not 
only negate the problems of instability and the amount of soluble purified protein, 
but also show which reaction or reactions they may be catalysing in vivo in both E. 
coli and Ps. aeruginosa. This method of tetrapyrrole intermediate production has 
been performed with success before and given rise to previously uncharacterised 
intermediates in the vitamin B12 pathway (McGoldrick, Roessner et al. 2005).  
 
5.2.1. The expression of the operon in E.coli 
A plasmid containing the haem d1 operon cloned into pKK233.3 with nirFDLGHJE 
all in succession was kindly provided by Dr Raux-Deery. Preliminary attempts to 
overexpress the genes were unsuccessful. This was performed in a number of 
strains by transforming the plasmid into JM109, ER171 (CysG deleted strain) and 
CysG-247 (CysG deleted strain, but with CobA). These were then cultured in 1L 
volumes and grown with IPTG induction. Controls containing no plasmid were also 
grown at the same time and subject to the same conditions. The resultant cell extract 
and pellets obtained after sonication and centrifugation were then analysed for Nir 
protein over production by SDS PAGE, shown in Figure 5.2. The cell extract and 
the pellets exhibited no fluorescence indicative of no tetrapyrrole compounds 
except for those expressed in CysG-247, due to the presence of CobA. Analysis of 
the SDS-PAGE confirms this since there is no difference between the control and 
the strain expressing the plasmid. No proteins of predicted size for NirF, D, L, G, H, 
J or E is observed. This result is likely to be due to poor translation of the protein as 
no such factors were included in the cloning between the genes and they were 
cloned straight after each other. Therefore, the expression of the operon must 
include this. 
 
 
 
 
 
Vina Parmar           Chapter 5: Generation of tetrapyrrole intermediates in vivo and in vitro: page 174 
174 
 
Figure 5.2: SDS-PAGE of the haem d1 operon overexpressed in E. coli. 
An SDS-PAGE of the haem d1 operon expressed in JM109 alongside a control of 
JM109 only is shown. Clearly no difference can be seen between our control and 
the strain overexpressing the operon. Lane 1 is the marker, lane 2 control total cell 
fraction (CT), lane 3 the total cell fraction with the operon (OP T), lane 4 the 
control isolated supernatant (C supernatant), lane 5 isolated supernatant with the 
operon (OP SN), lane 6 the control cell pellet (C P) and lane 7 the cell pellet with 
the operon (OP SN). The results for overexpression in ER171 and CysG-247, 
showed no differerence from the controls either. 
 
 
 
 
 
 
 
 
5.2.2. Link and Lock cloning of nir genes into an operon 
The problems in expressing the operon were apparent, as we neither saw the 
accumulation of tetrapyrroles nor the overproduction of the Nir proteins. To 
overcome this, the operon was cloned with the incorporation of ribosome-binding 
sites (RBS) before each gene to allow for greater translation.  
The cloning of the nir operon was achieved by the Link and Lock method of 
cloning, whereby genes may be consecutively cloned in to a plasmid, in order, one 
after the other by utilising the ability of neoisoschizomer restriction enzymes to 
form compatible cohesive ends. These when ligated, do not generate the same 
restriction sites and therefore can be re-used in introducing other genes, under the 
proviso that they do not occur naturally within the genes or plasmid. 
In this study NheI (GCTAGC) and XbaI (TCTAGA) were used, both forming 
compatible cohesive ends that when ligated are no longer restrictable (Section 
2.2.12). These sites are not found within the nir genes or the plasmid, pUCPNde. 
Primers were designed for each of the genes nirE, nirJ, nirG, nirH, nirL, nirD and 
nirF, to introduce, NdeI and a RBS (AGGAG(A)) for the first gene, nirE or nirF, 
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      66 
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and then NheI and RBS at the 5` end for all other genes. XbaI and BamHI restriction 
sites were introduced at the 3` termini of all the nir genes. The introduction of these 
sites allowed Link and Lock cloning of the operon into the pUCPNde expression 
vector allowing the encoded proteins to be overproduced both within E. coli 
(JM109) and wild type Ps. aeruginosa (PAO1).  
The first gene in the sequence, for example nirE, was cloned into the plasmid using 
NdeI at the 5’end and XbaI – BamHI at the 3’end. The next gene and all subsequent 
genes, pre-restricted with NheI and BamHI, are then cloned consecutively into the 
plasmid that is prerestricted with XbaI and BamHI. The compatibility of XbaI and 
NheI allows ligation but these are no longer restrictable after ligation, therefore they 
can be reused to clone genes into the plasmid in subsequent steps. Please refer to 
Section 2.2.12 for a detailed account. The strategy is outlined in Figure 5.3. 
In this manner the entire nir operon was cloned into pUCPNde to allow 
overexpression and the formation of haem d1 in both E. coli and wild type Ps. 
aeruginosa. Accordingly a library of different constructs was created to allow the 
accumulation of intermediates in both organisms, these are listed in Table 5.1. Two 
sets of plasmids were created, the first starting with our first gene in the pathway 
nirE, with nirFDLGHJ in succession and the second starting with nirF, with 
nirDLGHJE in succession. The former allows for an increased level of substrate 
PC-2 as those genes closest to the promoter tend be better expressed. The latter to 
identify if they are required in the same order as in the Ps. aeruginosa operon, and 
thus a dependency on the presence of the other proteins NirFDLGHJ to be 
expressed first and subsequently a spontaneous reaction occurs as soon as NirE 
forms PC-2, though there may be less substrate than the former set. The operon is 
shown to be expressed in Figure 5.4 by SDS-PAGE analysis. 
Table 5.1: Plasmids constructed for the accumulation of haem d1 intermediates 
SET 1 SET 2 
nirE (pVP49) nirF (pVP58) 
nirEF (pVP50) nirFD (pVP59) 
nirEFD (pVP51) nirFDL (pVP60) 
nirEFDL (pVP52) nirFDLG (pVP61) 
nirEFDLG (pVP53) nirFDLGH (pVP62) 
nirEFDLGH (pVP54) nirFDLGHJ (pVP63) 
nirEFDLGHJ (pVP55) nirFDLGHJE (pVP65) 
Vina Parmar           Chapter 5: Generation of tetrapyrrole intermediates in vivo and in vitro: page 176 
176 
 Figure 5.3: Link and Lock method of cloning  
Diagrammatic representations of the link and lock method of cloning, for a detailed 
description, please see the text.  
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Figure 5.4: SDS – PAGE analysis of the expression of the operon constructed 
with ribosome binding sites (RBS) 
An SDS-PAGE of the haem d1 operon expressed in Ps. aeruginosa. Lanes 1 to 4 are 
of the pellet after sonication of NirFDLGH (1), NirEF (2), NirF (3), and NirE (4). 
Lane 5 is the marker. Lanes 5 to 9 are of the isolated supernatant after sonication, 
NirFDLGH (6), NirEF (7), NirF (8), and NirE (9). Lane 10 is the marker. The 
expression of the operon is evident by the presence of all the predicted proteins of 
correct size for each lane. NirE is 29 kDa, NirF is 44 kDa, NirD is 17 kDa, NirL is 
20.2 kDa, NirG is 16.5 kDa and NirH is 19.5 kDa. 
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5.2.3. Production, extraction and separation of accumulated tetrapyrroles 
Plasmids containing the nir gene operon or combinations thereof shown in Table 
5.1, were transformed into E. coli JM109 and Ps. aeruginosa wild type separately 
as outlined in Section 2.2.7. 1L cultures were grown either aerobically or 
anaerobically (with 25 mM sodium nitrate) as appropriate, with induction at 1 mM 
IPTG. At the same time ALA (10 mg/ml) and SAM (10 mg/ml) was added to the 
culture.  Supplementation of the culture with ALA is known to enhance the 
production of tetrapyrroles whereby they are secreted into the medium (Harris III 
1993). Thus we are able to isolate endogenous tetrapyrroles with ease if they are 
sufficiently produced. This method is well characterised in both E. coli and Ps. 
aeruginosa (Harris III 1993). The media was kept as this stage and the pellets were 
resuspended in 50 mM Tris-HCl pH 8.0 containing 0.1 M NaCl and sonicated for 
30 sec on, 30 sec off three times at an amplitude of 10 μn. The media showed no 
signs of tetrapyrrole accumulation therefore, the resultant soluble cell extract was 
NirD
NirH
NirL 
NirE
NirG
NirF 
Vina Parmar           Chapter 5: Generation of tetrapyrrole intermediates in vivo and in vitro: page 178 
178 
applied to RP-18 columns aerobically and anaerobically. The columns were then 
washed as outlined in Section 2.4.6, and any accumulated compounds were eluted 
at 25 % ethanol and analysed by a UV-Vis spectrophotometer. The same 
experiment was repeated, but with seperation on DEAE columns, but no difference 
was observed in the results. 
 
 
5.2.4. Results obtained from expression in E. coli JM109 
 
Figure 5.5: UV-Vis spectra of all isolated supernatants from E. coli prior to 
separation on RP-18 columns 
Overlayed UV-Vis scans of the isolated supernatants of overexpressed nir genes in 
pUCPNde containing nirE, nirEF, nirEFD, nirEFDL, nirEFDLG, nirEFDLGH, 
nirEFDLGHJ and controls JM109, JM109 with pUCPNde only. The inset shows 
the absorbance maxima for each.  
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Figure 5.6: UV-Vis spectra of all isolated fractions from E. coli after separation 
on RP-18 columns  
Overlayed UV-Vis scans of isolated fractions from RP18 columns at 25 % ethanol 
of over expressed nir genes in pUCPNde containing nirE, nirEF, nirEFD, 
nirEFDL, nirEFDLG, nirEFDLGH, nirEFDLGHJ and control JM109. The inset 
shows the absorbance maxima for each. 
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5.2.5. Results obtained from expression in Ps. aeruginosa  
Figure 5.7: UV-Vis spectra of all aerobically isolated supernatants from Ps. 
aeruginosa prior to separation on RP-18 columns 
Overlayed UV-Vis scans of the isolated supernatants of over expressed nir genes in 
pUCPNde containing nirEF, nirEFD, nirEFDL, nirEFDLG, nirEFDLGH, 
nirEFDLGHJ and control Ps. aeruginosa supernatant. No difference is observed. 
 
Figure 5.8: UV-Vis spectra of all aerobically isolated supernatants from Ps. 
aeruginosa after separation on RP-18 columns 
Overlayed UV-Vis scans of the isolated supernatants of over expressed nir genes in 
pUCPNde containing nirEF, nirEFD, nirEFDL, nirEFDLG, nirEFDLGH, 
nirEFDLGHJ and control Ps. aeruginosa supernatant. No difference is observed. 
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Figure 5.9: UV-Vis spectra of all anaerobically isolated supernatants from Ps. 
aeruginosa prior to separation on RP-18 columns 
Overlayed UV-Vis scans of the isolated supernatants of over expressed nir genes in 
pUCPNde containing nirEF, nirEFD, nirEFDL, nirEFDLG, nirEFDLGH, 
nirEFDLGHJ and control Ps. aeruginosa supernatant. No difference is observed. 
 
 
Figure 5.10: UV-Vis spectra of all anaerobically isolated supernatants from Ps. 
aeruginosa after separation on RP-18 columns 
Overlayed UV-Vis scans of the isolated supernatants of overexpressed nir genes in 
pUCPNde containing nirEF, nirEFD, nirEFDL, nirEFDLG, nirEFDLGH, 
nirEFDLGHJ and control Ps. aeruginosa supernatant. No difference is observed. 
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5.2.6. Discussion of data obtained from expression of the haem d1 operon in 
E. coli and Ps. aeruginosa  
It was hoped that expression of all the nir genes in E. coli would endow it with the 
ability to make haem d1 since it is not capable of producing it naturally. Similarly, 
the subsequent homologous expression of the plasmids in Ps. aeruginosa was 
expected to produce haem d1 more so. Preliminary analysis of the expression of the 
operon in E. coli and Ps. aeruginosa showed no evidence of haem d1 production. 
The spectrum of haem d1 is characterised by a soret band at 421 nm, and a band at 
608 nm with a weak band at 565 nm and of course has a green hue. No such bands 
or colours were eluted from the separation of supernatant of E. coli and Ps. 
aeruginosa expressing nirEFDLGHJ or nirFDLGHJE plasmids. No significant 
differences were observed in this analysis of the expression of nirF, nirFD, nirFDL, 
nirFDLG, nirFDLGH, nirFDLGHJ and nirFDLGHJE (data not shown) and for 
brevity the rest of the discussion is confined to the expression of plasmids 
beginning with nirE. 
 
The separation of the supernatants of Ps. aeruginosa expressing nirEFDLGHJ or 
nirFDLGHJE aerobically and anaerobically did not show or bind any substance at 
all. In fact, it was seen to flow completely through the column as was observed in 
the analysis of the expression of nirE, nirEF nirEFD, nirEFDL, nirEFDLG, 
nirEFDLGH, nirEFDLGHJ (Figure 5.8 and 5.10), aerobically and anaerobically 
respectively. This was unexpected, as the genes are being expressed in their native 
organism, and despite the low level of expression, as seen in Chapter 4, it was 
assumed that it would be sufficient to produce a small amount of haem d1 or any 
intermediates. Furthermore, the expression of the various plasmids under anaerobic 
conditions in Ps. aeruginosa was presumed to be more favourable for haem d1 or 
tetrapyrrole production. It is documented that the nir genes are up regulated almost 
16 fold in response to anaerobic conditions and in particular nitrate, at an optimal 
concentration of 25 mM (Carlson and Ingraham 1983; Filiatrault, Wagner et al. 
2005) Additionally, complete anaerobiosis is not required for expression of the 
denitrification cluster (Hartig and Zumft 1999). The results obtained may have 
arisen due to non-exacting conditions and higher requirement for substrates and 
cofactors that were limiting within Ps. aeruginosa. The expression of the nir genes 
was observed to be lower in Ps. aeruginosa than in E. coli in Chapter 4 and thus 
may be a limiting factor.  
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Interestingly, the UV-Vis spectra of each supernatant as shown in Figure 5.5, 
reveals no significant difference for nirEFDLGH, nirEFDLGHJ and nirE from the 
controls whereas nirEF, nirEFD, nirEFDL and nirEFDLG are showing additional 
peaks in the region of 375 nm ±1.01 nm. This is notable since it may be significant 
to the presence of SHC whose characteristic spectra shows absorbance maxima at 
376 nm and 590 nm. Subsequent separation with RP-18 revealed the presence of a 
pink band for all the separations except the control but in the case of the nirEFD, 
nirEFDL nirEFDLG, the band was slightly darker and the spectra showed a broad 
band with two peaks again in the region of 375 nm but less well defined (Figure 
5.6). If these are indeed preliminary data indicating the presence of SHC, it would 
be advantageous to express the same genes anaerobically and thus perform the 
separation anaerobically too. It must be noted that the presence of SHC may be a 
side reaction within the organism and not part of the haem d1 pathway as E. coli and 
Ps. aeruginosa posses the capability to produce it in vivo. Thus it would also be 
beneficial to see if this reaction occurs in vitro towards PC-2 and a Nir protein or 
proteins.  
 
Another strategy was explored whereby Pa. pantrophus nirJ was to be cloned in the 
place of Ps. aeruginosa nirJ as part of the multigene plasmids. NirJ from Ps. 
aeruginosa is predominantly insoluble in both E. coli and Ps. aeruginosa. In 
contrast, NirJ from Pa. pantrophus is significantly more soluble and well expressed 
in E. coli (data not published, courtesy of R. Zajicek, Oxford and A. Brindley, 
Kent). It is notable that Pa. denitrificans is unique in comparison as it makes so 
much NiR that the periplasm preparation is brown and thus, the level of haem d1 
synthesis and the enzymes may also be high. However, time was a limiting factor 
and this could not be completed, but NirJ from Pa. pantrophus was used in the 
production of intermediates in vitro, discussed next. 
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5.3. In vitro expression of Intermediates 
In vivo production of haem d1 and its intermediates has not been successful so far, 
presumably because of the resultant low steady state concentrations of the Nir 
proteins within the multigene plasmids. This limitation may be overcome in part by 
in vitro biosynthesis using soluble cell extracts with overproduced proteins and 
incubating these anaerobically with PC-2 or SHC, alongside probable cofactors. 
 
5.3.1. Production, extraction and separation of accumulated tetrapyrroles 
PC-2 and SHC were synthesised in situ as described in Section 2.4.2 using isolated 
soluble cell extracts containing the overproduced proteins supplemented with 
cofactors for synthesis from ALA (HemB, HemC, HemD, CobA without and with 
SirC respectively). Alternatively, the same purified proteins were incubated 
anaerobically with cofactors, in the glove box, generating PC-2 and SHC at higher 
concentrations, and in a purer form, as described in Section 2.4.3. The spectra for 
PC-2 and SHC synthesises by this method is shown in Figure 5.16. 
 
Accordingly the nir genes were singularly expressed in E. coli and the pellet 
resuspended in 50 mM Tris HCl pH 8.0, 0.1M NaCl. The soluble fractions with the 
Nir proteins were sonicated and buffer exchanged together in the anaerobic glove 
box or sonicated separately and buffer exchanged separately and combined in the 
reaction. This was to allow for any complex formation in case any Nir protein has 
an affinity to another. Each condition as listed in Table 5.2 was incubated with PC-
2 or SHC overnight at 30 °C with or without potential cofactors as appropriate 
(NAD+ / NADP / NADPH / SAM / FE II / NaDT). The resultant mixture was 
applied to a DEAE sephacel column, which had been pre-equilibrated the same 
buffer in an anaerobic glove box. The columns were then washed as outlined in 
Section 2.4.7, with increasing concentrations of NaCl, and any accumulated 
compounds were eluted at 1M NaCl and analysed by a UV-Vis spectrophotometer 
(HP-352 photodiode array). 
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Table 5.2: Summary of incubations of Nir proteins with PC-2 and SHC 
All incubations were performed as described in Section 2.4.4.2 in 50 mM Tris-HCl, 
pH 8.0, 0.1M NaCl in a total volume of 6 ml. This has been summarised in the table 
below. Where NirJ was used, it was a mixture of both NirJ from Pa. pantrophus as 
well as Ps. aeruginosa NirJ overproduced in E. coli. Reaction mixture contained 4.8 
ml of cell extract, 1 ml of substrate (PC-2 or SHC), 30 μl each of NAD+, NADP, 
NADPH (10 mg/ml suspension in 50 mM Tris-HCl, pH 8.0, 0.1M NaCl), 20 μl of 
iron and NaDT (at 1 mM, final concentration is 0.02 mM), made up to 6 ml with 50 
mM Tris-HCl, pH 8.0, 0.1M NaCl buffer. S = Nir proteins overproduced separately, 
and sonicated separately before combining in the reaction mixture; T = Nir proteins 
overproduced separately, and sonicated together before adding to the reaction 
mixture; All  = All cofactors NAD+ / NADP / NADPH / SAM / FE II / NaDT, 
unless otherwise specified. 
 
 REACTION  
Incubations with PC-2 and SHC produced in situ from cell extracts  
1. PC2 + FDLGHJ (T) E. coli + ALL 
2. SHC+ FDLGHJ (T) E. coli + ALL 
3. PC2 + FDLGHJ (S) E. coli + ALL 
4. SHC + FDLGHJ (S) E. coli + ALL 
Figure 5.11 
5. PC2 + FDLGHJ (T)  + Pa. pantrophus + ALL 
6. SHC + FDLGHJ (T) + Pa. pantrophus + ALL 
7. PC2 + FDLGHJ (S)  + Pa. pantrophus + ALL 
8. SHC + FDLGHJ (S)  + Pa. pantrophus + ALL 
9. PC2 + FDLGHJ (T) Ps. aeruginosa + ALL 
10 SHC + FDLGHJ (T) Ps. aeruginosa + ALL 
11 PC2 + FDLGHJ (S) Ps. aeruginosa + ALL 
12 SHC + FDLGHJ (S) Ps. aeruginosa + ALL 
Figure 5.12 
13 PC2 + BL21 DE3 pLysS + ALL 
14 SHC + BL21 DE3 pLysS + ALL 
15 PC2 + Ps. aeruginosa + ALL 
16 SHC + Ps. aeruginosa + ALL 
17 PC2 + Pa. pantrophus + ALL 
18 SHC + Pa. pantrophus + ALL 
Figure 5.13 
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Incubations of PC-2 with each overproduced Nir protein 
19 PC2 + F  
20 PC2 + F + NAD+ 
Figure 5.14A 
21 PC2 + F + ALL 
22 PC2 + D + ALL 
23 PC2 + L + ALL 
24 PC2 + G + ALL 
25 PC2 + H + ALL 
26 PC2 + J + ALL 
Figure 5.14B 
 
Incubations of SHC with each overproduced Nir protein 
27 SHC + F + ALL 
28 SHC + D + ALL 
29 SHC + L + ALL 
30 SHC + G + ALL 
31 SHC + H + ALL 
32 SHC + J + ALL 
Figure 5.15 
 
33 PC2 + FDLGHJ (T) + ALL (no pD10) 
34 SHC+ FDLGHJ (T) + ALL (no pD10) 
35 PC2 + FDLGHJ (T)  + Pa. pantrophus + ALL (no pD10) 
36 SHC + FDLGHJ (T)) + Pa. pantrophus + ALL (no pD10) 
37 PC2 + FDLGHJ (T) + Ps. aeruginosa + ALL (no pD10) 
38 SHC + FDLGHJ (T) + Ps. aeruginosa + ALL (no pD10) 
Data not shown 
 
Incubations with PC-2 and SHC produced from purified protein  
39 PC2 + FDLGHJ + ALL  
40 PC2 + FDLGHJ (S) + ALL – NO IRON  
41 PC2 + FDLGHJ (S) + ALL – NO NADP/NADPH 
Figure 5.17A & B 
42 SHC + FDLGHJ + ALL 
43 SHC + FDLGHJ (S) + ALL – NO IRON 
44 SHC + FDLGHJ (S) + ALL – NO NADP/NADPH 
Figure 5.18 
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5.3.2. Results obtained from incubation of Nir proteins with PC-2 and SHC 
produced in situ. 
 
Figure 5.11: UV-Vis spectra of NirF, D, L, G, H, J, incubated anaerobically 
with PC-2 and SHC with all cofactors.  
Overlayed spectra below show the UV-Vis scans of the resultant overnight 
incubations with PC-2 and SHC with isolated supernatants of overproduced NirF, 
D, L, G, H, J, proteins mixed together (T) and kept separately (S) prior to 
incubation. No difference is observed. 
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Figure 5.12: UV-Vis spectra of NirF, D, L, G, H, J incubated anaerobically 
with PC-2 and SHC, cell extracts of Ps. aeruginosa and Pa. pantrophus and all 
cofactors. 
Overlayed UV-Vis scans of the resultant overnight incubations with PC-2 and SHC 
with isolated supernatants of overproduced NirF, D, L, G, H, J, proteins mixed 
together (T) and kept separately (S) prior to incubation, with Ps. aeruginosa and 
Pa. pantrophus cell extract and all cofactors. No difference is observed from the 
two methods. 
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Figure 5.13: UV-Vis spectra of cell extracts of Ps. aeruginosa, E. coli and Pa. 
pantrophus incubated anaerobically with PC-2 and SHC and all cofactors (No 
Nir proteins). 
Overlayed UV-Vis scans of the resultant overnight incubations with PC-2 and SHC 
with all cofactors and isolated cell extract from E. coli and Ps. aeruginosa and Pa. 
pantotrophus as controls. 
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Figure 5.14: UV-Vis spectra of anaerobic incubations with PC-2 using cell 
extracts of each overproduced Nir protein separately.  
A shows data from incubation of NirF with PC-2 with and without the addition of 
NAD +. 
 
B shows the result of incubation with PC-2 of each Nir protein separately including 
all cofactors. No difference is observed between the proteins. 
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Figure 5.15: UV-Vis spectra of anaerobic incubations with SHC using cell 
extracts of each overproduced Nir protein separately. 
UV-Vis scans of the resultant overnight incubations with SHC of each Nir protein 
separately including all cofactors. No difference is observed between the proteins. 
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5.3.3. Results obtained from incubation of Nir proteins with PC-2 and SHC 
produced in vitro. 
 
Figure 5.16: UV-Vis spectra PC-2 and SHC produced from purified HemB, 
HemC, HemD, CobA ± SirC respectively (±NAD+) 
The resultant spectrum of PC-2 was diluted 1 in 10 and for SHC was diluted 1 in 
20. Evidently this method of production allows for high levels of substrate and 
eliminates any background activity that may be seen in the spectra of PC-2 and 
SHC produced from soluble cell extracts.  
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Figure 5.17: UV-Vis spectra of compounds eluted at 1M NaCl from anaerobic 
incubation of PC-2 with NirFDLGHJ with varying cofactors (39-41).  
Fractions eluted at 1M, are shown in graphs A and B, for each incubation, one with 
all cofactors, the next with all cofactors except iron and one with all cofactors 
except NADP/NAPH 
A shows the spectrum of fraction 1 eluted at 1M NaCl. This was yellow in colour 
and is PC-2, but in the process of oxidation to SHC. 
 
B is a pink fraction, eluted second, showing similarities to SHC, having absorbance 
maxima in the region of 376 nm and 590 nm. There was significantly less of this 
fraction than of that seen in graph A. Interestingly the absorbance maxima are in the 
region of 388 nm and 402 nm for the incubation without NADP/NADPH. 
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Figure 5.18: UV-Vis spectra of compounds eluted at 1M NaCl from the 
anaerobic incubation of SHC with NirFDLGHJ and all cofactors (42-44).  
Fractions eluted at 1M are shown. Incubation of SHC and NirF, D, L, G, H, J with 
all cofactors, all cofactors except iron and with all cofactors except NADP/NAPH 
shows separation of a purple colour, with the characteristics of SHC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vina Parmar           Chapter 5: Generation of tetrapyrrole intermediates in vivo and in vitro: page 195 
195 
5.3.4. Discussion of data obtained from incubation of cell extracts containing 
overproduced Nir proteins with PC-2 and SHC produced in situ or in vitro. 
Separation of the incubations as described in Table 5.2, showed no accumulation of 
haem d1 or any such new tetrapyrrole. Further analysis by the addition of Ps. 
aeruginosa and Pa. pantrophus cell extract to the incubation was performed to see 
if any factor present in these denitrifying organisms is required for the formation of 
haem d1 or its intermediates, since the proteins are being overproduced in E. coli. 
Other than the small differences expected between the organisms, shown in Figure 
5.12, no difference was observed between the Nir proteins with addition of new cell 
extracts (5-12) from the controls (13-18: Figure 5.13). The analysis of the 
separation again revealed no accumulation of haem d1 or new tetrapyrroles 
suggesting the presence of Ps. aeruginosa and Pa. pantrophus cell extract is not a 
necessity.  No significant difference is observed in the UV-Vis spectra when the Nir 
proteins are combined prior to sonication (T) or in the reaction mixture in the glove 
box (S) from the data obtained (1-4: Figure 5.11) again little difference is seen in 
comparison to the controls indicating this had no effect (13-18: Figure 5.13). 
 
It was anticipated that the incubations performed would result in haem d1 or a new 
tetrapyrrole within the pathway from PC-2. This was not the case, suggesting that 
either the conditions are not exacting for haem d1 production or that a significant 
factor was missing. The added cofactors are based upon the requirements that may 
or may not occur in the formation of haem d1. For example, if we have SHC as part 
of our pathway then previous work shows the dependence of dehydrogenase 
activity on NAD+. As present it is unknown whether the pathway to haem d1 is via 
SHC but the regio-specificity of the methyl groups on the haem d1 macrocycle is 
that same as that of SHC. Thus, the activity of each Nir proteins towards PC-2 was 
assessed with the addition of NAD+ incubated overnight. The results shown in 
Figure 5.14A revealed no single Nir protein produced SHC from PC-2 in the 
presence of NAD+, only NirF is shown as a representative spectra, as they showed 
no difference (19, 20); the incubation of each protein again with all the cofactors 
present with PC-2 similarly showed no SHC or any difference to each other as 
represented by Figure 5.14B (21-26).  
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Exactly the same reactions were performed this time with SHC instead of PC-2 only 
to show again that neither Nir protein was converting SHC into any newly derived 
tetrapyrrole (27-32: Figure 5.15). Even though two NirJ proteins from different 
organisms were present (Ps. aeruginosa and Pa. pantrophus) no change was 
observed. To rule out if buffer exchange of the cell extract was in someway having 
an effect the same incubations 1, 2, 5, 6, 9, 10 were repeated with out buffer 
exchange of the cell extracts (33-38, data not shown). Nothing was observed in the 
separation of the reaction mixtures again (data not shown) so this was not a factor.  
 
It was noted that in combining the entire cell extracts a certain amount of 
background activity was evident in the spectra. To reduce this, and also to increase 
the amount of substrate available, PC-2 and SHC were synthesised from ALA by 
using purified proteins HemB, HemC, HemD, CobA ± SirC respectively. This 
method does not require filtration prior to use. The spectra obtained from PC-2 and 
SHC synthesised in this way is shown in Figure 5.16 and illustrates the high 
concentration of substrate available for use. Accordingly the incubations as detailed 
in Table 5.2 (39-44) were performed, with NirF, D, L, G, H, and J sonicated 
together. 
 
The spectra obtained for the incubation of NirF, D, L, G, H, J, with a more 
concentrated amount of PC-2 and SHC substrate and thus less background activity 
showed no separation of haem d1. Interestingly, separation of incubations with PC-2 
isolated anaerobically (Figure 5.17B), show the presence of the same pink pigment 
observed in the expression of the operon or combination of nir genes in E. coli 
(Figure 5.6).  This again showed some resemblance to SHC showing similar 
absorbance maxima in the region of 376 nm. Evidently there is a very small amount 
of this material due to the scale of the spectra. A lack of iron in the reaction mixture 
revealed less of this material, but the absence of NADP or NADPH was seen to 
shift the absorbance maxima to 388 nm and 402 nm. This may be suggestive of 
some dependency on iron for this material and exertion of some effect by the 
cofactors. The fluorescence of this pigment when illuminated under UV light was 
pink for this material and addition of strong acid turned it colourless whilst the 
addition of strong base turned it yellow. This pigment was however not observed in 
the expression of the operon in Ps. aeruginosa indicating that it may be confined to 
E. coli and thus not a true intermediate of the haem d1 pathway.  
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Incubations with SHC again (Figure 5.18), showed no isolation of any new 
tetrapyrrole or indeed haem d1. Notably, the incubations with SHC and all the 
cofactors and without NADPH or NADP revealed the presence of a blue pigment 
exhibiting similarities to iron SHC (absorbance maxima at 412nm, data not shown), 
but since it was not observed in the incubation without iron, one may infer that one 
of the Nir proteins may be acting as a chelater of the exogenous iron to SHC and 
warrants further investigation. However, time was not a permitting factor and this 
investigation is confined to the future. 
 
 
5.4. Conclusions 
This chapter explores the attempts to generate haem d1. In doing so, it was hoped 
that this would also lead to the generation of intermediates in the haem d1 pathway. 
A number of methods were employed to synthesise these compounds both in vivo 
and in vitro under the assumption that a marked change in the spectral properties 
would be observed. 
 
Primarily, bacteria were engineered to overexpress the haem d1 operon, 
nirFDLGHJE or nirEFDLGHJ for the generation of haem d1 in vivo in both E. coli 
and Ps. aeruginosa.  Separation of the resultant cell extracts showed no 
accumulation of haem d1 in both organisms aerobically or anaerobically in Ps. 
aeruginosa. Further overexpression of nirE, nirEF nirEFD, nirEFDL, nirEFDLG, 
nirEFDLGH in Ps. aeruginosa did not exhibit or bind any substance at all when 
separated, and was observed to flow completely through the column. This was 
unexpected, as overexpression in Ps. aeruginosa was presumed to be more 
favourable for haem d1 or any intermediates. It is well documented that the 
expression of the nir genes is up regulated under anaerobic conditions and in 
particular with nitrate, at an optimal concentration of 25 mM (Carlson and 
Ingraham 1983; Filiatrault, Wagner et al. 2005). Such a result may be attributed to a 
higher requirement for substrates and a lower level of overproduction as observed 
in Chapter 4. 
 
It was anticipated that since in vivo production of haem d1 was to no avail that the in 
vitro incubation of soluble cell extracts containing the overproduced Nir proteins 
with PC-2 and SHC would be more productive. However, incubations performed 
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with PC-2 and SHC produced in situ, with all the Nir proteins together and 
singularly, revealed no such presence of haem d1 or any new tetrapyrroles, 
respectively.  It was notable that no Nir protein showed activity towards PC-2 in the 
presence of NAD+, since the haem d1 macrocycle shares the same regio-specificity 
in its methyl groups as that of SHC. It is unknown if the pathway to haem d1 
proceeds via SHC but the results obtained here indicate that it is unlikely as no Nir 
protein was able to convert PC-2 to SHC, and similarly no Nir protein showed 
activity towards SHC. This may be suggestive of a novel route for the synthesis of 
haem d1, from PC-2 but not via SHC. Such a route has been observed for protohaem 
synthesis in D. vulgaris, whereby instead of decarboxylation of UIII, as with the 
well-characterised aerobic haem pathway, UIII is methylated to form PC-2. 
Synthesis then proceeds from PC-2 by decarboxylation and deacetylation to form 
coproporphyrinogen III, which is part of the aerobic pathway, that is then converted 
to protoporphyrinogen IX (Ishida, Yu et al. 1998). Therefore, it is likely that the 
biosynthesis of haem d1 occurs via PC-2, but thereafter a completely different 
pathway is employed. 
 
Notably, overexpression of the multigene constructs in E. coli revealed the presence 
of a pink pigment with spectral similarities to SHC, with absorbance maxima in the 
region of 375 nm. This same pigment, though observed in small quantities, is 
observed when the Nir proteins are incubated with PC-2 at a high concentrations, 
but since it is not observed in Ps. aeruginosa, nor revealed when the proteins are 
singularly incubated with PC-2 or SHC, one may assume that this may be an 
artifactual result caused by non-exacting conditions in an organism that does not 
encode for these genes naturally.  It may therefore be advantageous to check for 
activity towards PC-2 and SHC with the purified forms of the Nir proteins as this 
would eliminate any such pigments within the supernatant and allow for isolation of 
intermediates without interference from endogenous factors. 
 
A blue pigment similar to that of iron SHC was observed when the Nir proteins 
were incubated with a high concentration of SHC and exogenous iron. This was not 
observed when iron was excluded from the reaction mixture and one may assume 
that the presence of one or more Nir proteins is able to chelate exogenous iron onto 
to SHC macrocycle. It would be highly desirable to check which of the Nir proteins 
or combinations thereof are able to chelate iron, or other metals, onto SHC, as this 
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would identify which enzyme is acting as a chelatase of the haem d1 pathway. 
Further investigations with metal free haem d1 would also be invaluable to check 
which Nir protein acts as a chelatase. Both experiments may allow differentiation of 
early or late chelation in the pathway. 
 
Therefore, in summary, no conclusive evidence has been obtained that the nir 
operon, nirFDLGHJE, is able to synthesise haem d1 either in vitro or in vivo. Some 
interesting observations are evident, but these all require further detailed 
examination. No large significant changes were evident and those that were 
observed were on a small scale, these are less amenable and require further analysis 
by more improved and sensitive apparatus, such as HPLC combined with MS.   
 
This chapter has provided some new an interesting data. It is the first concerted 
effort to engineer strains to produce haem d1 in vivo and further to synthesise 
intermediates in vitro by checking for activity towards well known tetrapyrrole 
precursors, PC-2 and SHC. It provides the framework for future studies on the 
synthesis of haem d1 and its intermediates and a valuable resource of multigene 
constructs to aid in its elucidation. 
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6. Conclusions 
The purpose of this PhD was to investigate the biosynthesis of a unique 
tetrapyrrole, haem d1, whose pathway is not yet fully characterised.  The elucidation 
of the pathway from UIII has posed a great challenge for over 20 years. This thesis 
has focused on many aspects of this pathway and explores many avenues to gain a 
deeper understanding of the biochemistry and molecular biology of such an 
important element of denitrification, and thus in nature. 
The distinct lack of information regarding any prerequisite intermediates in this 
pathway is reflected in the similar lack of understanding as to how the 
aforementioned atypical substituents are introduced to the macrocycle. The 
introduction of oxygen on the macrocycle is of particular interest as this is achieved 
under anaerobic conditions. Again, the scarcity in the information is compounded 
with a lack of similarity of the proposed enzymes to those of known structure and 
function.  
Confirmation that NirE is an active SUMT. 
In Chapter 3, it is shown for the first time that the previously proposed SUMT, 
NirE, is indeed able to catalyse the transformation of UIII to PC-2. Thus far, this 
had only been postulated on the basis of sequence similarity to the well-known 
SUMT enzymes, and had never been proven experimentally, until now. Mutational 
and complementation analysis (Palmedo, Seither et al. 1995; Kawasaki, Arai et al. 
1997), has showed NirE is necessary for haem d1 production suggesting that flux 
through the haem d1 pathway was tightly regulated by NirE, as SUMTs are branch 
point enzymes displaying feedback inhibition to both substrate and product. NirE 
was purified to homogeneity and found to be a homodimer by gel filtration analysis. 
It also displays the typical characteristics attributed to SUMT enzymes, such as the 
formation of a red pigment, trimethylpyrrocorphin, which fluoresces when 
illuminated by UV light. NirE is unique though, in that it remains tightly bound to 
this porphyrinoid through purification, suggestive of a lack of inhibition of activity. 
This is confirmed by recent findings by Layer et al, 2009 (FEBS Journal, in press), 
whose work revealed NirE substrate inhibition occurs above [UIII] of 17µM. This 
being much higher than CobA (2µM)(Blanche, Debussche et al. 1989), but is 
similar to that of CorA (20µM) (Blanche, Robin et al. 1991). This is suggestive of 
the high requirement of NirE to generate sufficient levels of substrate for anaerobic 
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respiration, and thus no inhibition at low [UIII] facilitates greater flux through the 
pathway.   
Optimisation of overproduction and stabilisation revealed NirG as a tetramer 
and a monomer, and that NirD associated to NirG. 
Chapter 4 explores the challenges posed in the optimisation of overproduction of 
NirF, NirD, NirL, NirG, NirH, and NirJ.  It is difficult to ascertain any information 
as to the reaction or reactions they may catalyse, as no similarity exists to proteins 
of known structure and function. A number of approaches were employed, whereby 
heterologous overproduction was successful, and a new system for homologous 
overexpression was formulated. However, homologous proteins were not 
overproduced to a sufficient level for further analysis and those overproduced 
heterologously were not stable. Introduction of all of these proteins into a 
stabilisation screen of various buffer conditions resulted in only NirG being suitably 
stabilised. Gel filtration analysis of NirG revealed for the first time, the presence of 
a tetramer as well as a monomer, revealing the preference of NirG to exist as part of 
a larger complex. It has long been proposed that NirD, NirL, NirG and NirH may 
exist as a complex. Therefore, it was predicted on the basis of the complementarity 
of NirD to NirG that co-overproduction of NirD, NirL, NirG and NirH with only 
NirD His-tagged would likely result in NirG being co-purified with NirD. Here we 
report for the first time that NirD does indeed bind NirG as they are co-purified 
together. In the same vein one would presume that NirL and NirH would be co-
purified together also but requires further investigation.  
No firm assignments can be made for the reactions these enzymes may catalyse. 
One can presume that NirDLGH performs the symmetrical changes to the 
macrocycle, such as decarboxylation at C12 and C18 and loss of propionic side 
chains at C3 and C8. The addition of oxygen to the macrocycle is likely to be 
performed by NirJ as similarity to HemN, an anaerobic oxidative decarboxylase, 
and radical SAM enzymes, suggest that NirJ is able to partake in the unique 
chemistry required to add oxygen on to the macrocycle. This leaves a putative 
assignment for NirF in ferrochelation.  The elucidation of these possible functions is 
highly desirable as is the resolution of their tertiary structure. Structural information 
would be invaluable in determining function by comparing to proteins of similar 
topology. Furthermore, this would aid elucidation of the reactions and thus 
intermediates they may catalyse. Only NirG was suitably stable to be entered into 
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crystal trials, but analysis of crystals obtained showed them to be salt. Therefore 
further refinement is required to stabilise the Nir proteins to enter them into 
structural studies. It is noteworthy that changing the type of tag used to purify these 
proteins may indeed aid in stabilisation, but time did not permit this. It would be 
highly desirable to do this and thus obtain Nir proteins that are sufficiently stable to 
be entered in various structural and functional studies. 
 
Attempts to generate haem d1 and it intermediates in vivo and in vitro require 
further refinement 
The pathway from PC-2 to haem d1 has only one proposed intermediate, C800 
(Youn, Liang et al. 2004), but it is unknown if it is indeed related in any way to the 
haem d1 pathway, either as a true intermediate or a derivative of an intermediate. Its 
ambiguity and unusual substituents, alongside the methods employed to connect 
this compound to the haem d1 pathway, leads to issue of the validity of such a 
material.  Therefore, the isolation of a true intermediate of this pathway is highly 
sought-after. Chapter 5 explores the various approaches used to synthesise haem d1 
and thus any intermediates in vivo and in vitro. E. coli and Ps aeruginosa were both 
engineered for the in vivo production of haem d1. This was achieved by the Link 
and Lock method of cloning where the nir operon was successively cloned into a 
single plasmid, by utilising the ability if neoisoschizomers to generate the same 
cohesive ends which when ligated do not form a restrictable site. These sites were 
then used to clone each gene consecutively into the plasmid to form the operon. 
However, no production of haem d1 or any such new tetrapyrrole was observed in 
either organism by overexpression of the operon, or combinations of the nir genes. 
This is attributed to the low steady state concentrations of the enzymes, revealed in 
Chapter 4. Consequently, an in vitro approach was employed to optimise the level 
of the proposed Nir enzymes and thus, haem d1 or tetrapyrrole production. 
In this approach, soluble cell extracts containing overproduced Nir proteins where 
checked for activity toward PC-2 and SHC, but again, no accumulation of haem d1 
was seen and further no activity of any singularly incubated protein was observed 
towards PC-2 or SHC. Interestingly, a small amount of a pink pigment was 
observed in E.coli overexpressing nirEFDLGHJ and nirFDLGHJE. This pink 
pigment was also observed in the incubation of the cell extracts of all the Nir 
proteins towards PC-2. This pigment displays some similarity to SHC but since it 
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was not observed in Ps. aerugonisa or in response to incubation with SHC, one may 
presume that it is a result of overproduction of proteins not native to E. coli. It may 
therefore be advantageous to check for activity towards PC-2 and SHC with the 
purified forms of the Nir proteins as this would eliminate any such pigments within 
the supernatant and allow for isolation of intermediates without interference from 
endogenous factors. 
The presence of a blue pigment was also seen in small quantity in the incubation of 
SHC with the Nir proteins and exogenous iron, but not in the absence of iron. This 
portrayed a spectrum similar to that of iron-SHC and may be indicative of iron 
chelation to SHC by one of the Nir proteins. It would be highly advantageous to 
investigate this further to check which of the Nir proteins or combinations thereof 
are able to chelate iron, or other metals, onto SHC, as this would identify which 
enzyme is acting as a chelatase of the haem d1 pathway. Investigations with metal 
free haem d1 would also be invaluable to check which Nir protein is able to chelate 
iron on to the haem d1 macrocycle. In this manner a candidate ferrochelatase may 
be identified. 
It was surprising that neither method was able to form haem d1 or accumulate any 
intermediates. It was presumed that the overexpression of the operon or 
combinations of nir genes in Ps. aeruginosa would be particularly amenable, since 
they are being overexpressed in their native organism. Clearly, there is a factor 
missing or the conditions were not exacting since even haem d1 is not formed, as it 
was assumed that a large change would be evident in the UV-Vis spectral 
properties. Therefore, it would be beneficial to use methods more sensitive to low 
levels of tetrapyrroles such as HPLC coupled to MS to detect any smaller changes 
that may have not been previously evident. Such a method would allow small 
steady state levels of the tetrapyrrole intermediates to be detected.  
It must also be considered that the nir operon is always preceded by nirC and is 
followed by nirN, both encoding for c-type cytochromes. It is was presumed that 
NirC may be involved in maturation of the d1 haem and but studies by Hasegawa et 
al, 2001 found this was not the case showing NirC to be an electron donor to nitrite 
reductase, therefore this was not used in our investigations. Similarly, NirN was 
also omitted from our investigation but in retrospect it would be interesting to co-
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express these with our nir operon to see if they exert any effect. Do they therefore 
play a role in haem d1 formation or stability or another effect?  
The Pa. pantotrophus nir operon could be utilised in a similar fashion to the 
investigations performed in this thesis, as these may be more amenable to further 
investigation. Clearly, the most insoluble protein from Ps aeruginosa was NirJ. In 
stark contrast, NirJ from Pa. pantotrophus was largely soluble and stable. This may 
be a reflection of the ease of which the remaining Nir enzymes from Pa. pantrophus 
may be used in the future and can be attributed to the higher level of haem d1 
production in this organism. Therefore the level of the enzymes and consequently 
any intermediates would be higher in this organism and elucidation of the pathway 
made possible. 
 
Can we predict the route of haem d1 synthesis on the basis of the well-
characterised haem pathways? 
The synthesis of haem d1 necessitates methylation (C2, C7), decarboxylation (C12, 
C18), loss of propionates (C3, C8), oxidation (C3, C8), dehydrogenation for 
acrylate formation (C17), and ferrochelation. This thesis confirms the methylation 
of UIII by NirE to form PC-2. It is unknown if the pathway to haem d1 proceeds 
from PC-2 via SHC as the haem d1 macrocycle shares the same regio-specificity in 
its methyl groups as that of SHC (and PC-2). No Nir enzyme can be assigned this 
role, as there is no similarity to known PC-2 dehydrogenase enzymes.  This thesis 
further illustrates that no Nir protein, or any combination of, showed activity 
towards PC-2 to generate SHC, in the presence of NAD+ and similarly no Nir 
protein showed activity towards SHC either. Therefore, on the basis of the data 
obtained within this study, one may presume that the synthesis of haem d1 proceeds 
via a completely separate and novel route, from PC-2 but not via SHC.  
After consideration of the available information on the well characterised haem 
pathways and of the steps required to synthesise haem d1, some parallel reactions 
are apparent and one can postulate a possible direction of synthesis for haem d1. A 
similarity is seen to a novel route for protohaem biosynthesis observed in D. 
vulgaris (Ishida, Yu et al. 1998) and M. barkeri (Buchenau, Kahnt et al. 2006), 
where the genes for UIII synthesis are present but the late haem genes are absent, 
despite the presence of cytochromes. This novel pathway proceeds from UIII, 
where instead of decarboxylation of the acetate side chains of UIII, as with the well-
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characterised aerobic haem pathway, UIII is methylated to form PC-2 (Ishida, Yu et 
al. 1998). This is parallel to the pathway for haem d1, which also methylates UIII, 
forming PC-2 but thereafter it does not proceed via SHC, as with the alternative 
route for synthesising haem. The possible route for haem d1 biogenesis is discussed 
but one must be mindful of the scarcity of information available on the proposed 
gene products. 
Synthesis of protohaem then proceeds from PC-2 by decarboxylation of the acetates 
at C12 and C18 to form 12,18 didecarboxyprecorrin-2. Since the synthesis of the 
haem d1 macrocycle also necessitates decarboxylation at C12 and C18 one may 
presume this would also be the route, shown in Figure 6.1. However, none of the 
proposed nir genes encodes for a decarboxylase enzyme. Although there exists 
some similarity of NirF to CobT, a decarboxylase of the cobalamin pathway, the 
assignment of a defined function to the Nir proteins remains vague.  
After decarboxylation at C12 and C18, the elimination of the acetate groups at C2 
and C7 forms coproporphyrinogen III (CPIII), returning to the more conventional 
route for haem synthesis. CPIII is then oxidatively decarboxylated to 
protoporphyrinogen IX (PP’gen IX), by HemN, which converts the propionate 
substituents at C3 and C8 to vinyl groups. This is achieved by the unique radical 
SAM chemistry that the Fe-S moiety bestows upon the enzyme. In Chapter 4, the 
evident similarity of HemN to NirJ can allow the inference that NirJ incorporates 
oxygen on to the haem d1 macrocycle in a similar fashion to HemN, and it is likely 
to be performed after decarboxylation at C12 and C18, and removal of the 
propionates at C3 and C8, shown in Figure 6.1. NirJ may of course be able to 
mediate the transformation of these propionates to oxygen on the macrocycle at C3 
and C8, similar to HemN, but the chemistry is different in that HemN forms vinyl 
groups not the keto groups of haem d1. It must also be stated that the C3 and C8 
keto groups are derived from the carboxylic acid group of the propionic acids side 
chains of the macrocycle (Matthews 1993) and not from another source, therefore it 
is likely that NirJ performs this transformation of the macrocycle. 
The pathway to protohaem is completed by the oxidation of PP’gen IX to 
protoporphyrin IX and chelation of iron. In the case of haem d1, the 
dehydrogenation of the C17 propionate to form the acrylate substituent and 
ferrochelation are required. Again, no Nir protein shows any similarity to proteins 
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that may undertake these reactions. One may return to the initial inferences, that 
NirDLGH may perform decarboxylation at C12 and C18 and remove the 
propionates at C3 and C8, thereby facilitating NirJ to oxidise the macrocycle at C3 
and C8, and NirF chelates iron. However, again, this theory also does not explain 
the formation an acrylate. Therefore, it can be presumed that one or more of the Nir 
proteins is multifunctional and is able to afford more than one of these 
transformations to the haem d1 macrocycle, or in fact are part of a larger multimeric 
complex able to partake in a number of reactions together with the substrate still 
bound. 
 
Figure 6.1: Schematic representation of the putative pathway to haem d1  
The possible pathway to haem d1 is shown here and discussed in detail in the text. It 
does not proceed via SHC, but from PC-2 being similar to a novel haem pathway.  
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In summary, the pathway for haem d1 proposed in this thesis and presented in 
Figure 6.1, is that of methylation of UIII at C2 and C7 to yield PC-2 by NirE. PC-2 
may then be decarboxylated at C12 and C18 to form 12,18 didecarboxyprecorrin-2, 
as found in the alternative haem pathway. It is unknown if decarboxylation is 
performed by NirF or a NirDLGH complex, but similarity of NirF to CobT lends to 
the possibility of NirF peforming this reaction. The removal of the propionates at 
C3 and C8, with subsequent anaerobic oxidation of the macrocycle is, expected to 
be facilitated by NirJ. It is unknown how further saturation of the macrocycle and 
ferrochelation is afforded as no single Nir enzyme has been identified to partake in 
these transformations. It may indeed be performed by the multimeric NirDLGH, 
bestowing a number of roles partaking in the transformation of the preceeding 
intermediates to haem d1. It is logical to presume that ferrochelation is the last step 
of the pathway, as found in the haem pathways characterised thus far, but again no 
assignment can be made as no similarity exists to known chelatases. This has been 
summarised in Table 6.1. 
Table 6.1: Summary of possible roles of the Nir Proteins 
A table summarising the possible reactions each of the Nir proteins are predicted to 
catalyse on the basis of the inferences made in this thesis 
Protein Reactions catalysed /Possible role 
NirF Decarboxylation of PC-2 to 12,18 -didecarboxy 
precorrin-2 
NirD NirL NirG NirH Multimeric complex performing saturation of 
macrocycle and ferrochelation  
NirJ Anearobic decarboxylation of 12,18 -
didecarboxy precorrin-2 
NirE SUMT- methylation of UIII to PC-2 
 
On the basis of the inferences made herein, it is apparent that all NirF, NirD, NirL, 
NirG, NirH, NirJ, NirE are required in the biogenesis of haem d1, each presumably 
imparting a specific role and thus transformation afforded to the macrocycle. This 
may be as a single enzyme or as part of a larger multimeric complex and is in 
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conjunction with previous genetic studies demonstrating their necessity. In contrast, 
the proposed haem d1 pathway in Heliobacter and the proposed intermediate, C800, 
both do not withstand their theories. In the former a wholly dissimilar pathway for 
haem d1 is proposed based entirely on bioinformatic analysis, in an organism that is 
not documented to require or form haem d1. Again, not all of the transformations 
are accounted for and further, the presence of some Nir proteins is excluded from 
the pathway and replaced by CysG. This would explain inclusion of SHC in their 
pathway, but the data represented in Chapter 4, clearly shows no Nir enzyme has 
activity towards PC-2 to form SHC. The proposed pathway appears to be a 
confusion of the alternative haem and sirohaem pathways, therefore it holds no 
bearing on haem d1 biosynthesis. In the latter, the formation of such an unusual 
intermediate is unlikely since the energy required to make haem d1 in this manner 
would not likely be favourable for anaerobic respiration, where a high demand for 
haem d1 occurs.  
Epilogue  
Despite the many different attempts made in this thesis to gain a deeper 
understanding of the mechanism of such a unique pathway, the biosynthesis of 
haem d1 still remains uncharacterised after 20 years of research. This project has 
focused on many aspects of this pathway, from the investigation of the proteins 
encoded by operon, nirF, nirD, nirL, nirG, nirH, nirJ and nirE in Ps. aeruginosa, to 
the possibility of generating haem d1 or any intermediates in vivo and in vitro. 
Whilst no firm assignments can be made for each protein some interesting results 
were obtained and similarly, the lack of activity towards PC-2 or SHC further lend 
to the hypothesis that haem d1 follows a completely separate and unique pathway. A 
possible route for the biogenesis of haem d1 has been proposed on the basis of 
possible common mechanisms for the synthesis of protohaem. Evidently, further 
investigation is required to elucidate the pathway for the synthesis of haem d1.  
Therefore, this thesis documents the first concerted effort to study the haem d1 
pathway in this manner and provides the framework for future studies on this 
molecule and its proposed enzymes. Consequently, it offers a valuable resource of 
single or multigene plasmid constructs and therefore potentially stable proteins and 
envisages a positive future for elucidation of the pathway for the future of haem d1 
research, which is clearly a highly desirable, but challenging prospect. 
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A: Summary of phenotypes conferred within bacterial strains or plasmids. 
F’  Host contains an F’ episome, with the stated features  
 
dcm   DNA cytosine methylase mutation  
Blocks methylation of cytosine  
 
DE3 Bacteriophage lambda carrying the gene for T7 RNA polymerase is 
integrated into the host genome. The DE3 designation means the strains 
contain the λ DE3 lysogen which carries the gene for T7 RNA 
polymerase under control of the lacUV5 promoter. IPTG is required to 
induce expression of the T7 RNA polymerase. 
 
endA1 DNA-specific endonuclease I mutation improves quality of plasmid 
DNA isolations. 
 
gal   Blocks catabolism of galactose. 
 
gyrA 96  DNA gyrase mutation Confers resistance to nalidixic acid. 
 
hsdR17 (rK–, mK+) Host DNA restriction and methylation system mutation: 
Restriction minus, modification positive or the E. coli K strain 
methylation system. Allows cloning without cleavage of 
transformed DNA by endogenous restriction endonucleases. 
DNA prepared from this strain can be used to transform rK+ E. 
coli strains. 
 
hsdS (rB–, mB–) Mutation of specificity determinant for host DNA restriction and 
methylation system. Restriction minus, modification minus for 
the E.coli B strain methylation system. Allows cloning without 
cleavage of transformed DNA by endogenous restriction 
endonucleases. DNA prepared from this strain is unmethylated 
by the hsdS 20 methylases 
 
lac   Lactose Promoter 
 
lacIq  Overproduction of the lac repressor protein. Leads to high levels of the 
lac repressor protein, inhibiting transcription from the lac promoter. 
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lacZM15  Partial deletion of -D-galactosidase gene. Allows complementation of 
-galactosidase activity by -complementation sequence in pGEM 
Vectors. Allows blue/white selection for recombinant colonies when 
plated on X-Gal. 
 
LysS   pLysS plasmid is integrated into the host genome. Strains carrying this 
plasmid will be tet resistant and produce T7 lysozyme, a natural 
inhibitor of T7 RNA polymerase, thus lowering background 
transcription of sequences under the control of the T7 RNA polymerase 
promoter 
 
ompT  Mutation of protease VII, an outer membrane protein. Reduces 
proteolysis of expressed proteins. 
 
proAB  Mutations in proline metabolism. Requires proline for growth in 
minimal media. 
 
recA1 Mutation in recombination; minimizes recombination of introduced 
DNA with host DNA, increasing stability of inserts. Inserts are more 
stable in recA 1 than recA 13 hosts. 
 
rel A1 ppGpp synthetase I mutation, a novel nucleotide guanosine 5′-
diphosphate-3′-diphosphate produced in response to starvation by relA 
ribosomal protein sensing uncharged tRNA. Allows RNA synthesis in 
the absence of protein synthesis. 
 
SupE44  Suppressor mutations. Suppresses amber (UAG) mutations. 
 
tac   Tryptophan and Lactose Hybrid Promoter  
 
traD 36  Transfer factor mutation.Prevents transfer of F′episome 
 
Thi Mutation in thiamine metabolism, Thiamine required for growth in 
minimal media. 
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B: Summary table of properties conferred by the nir genes and their encoded proteins: 
GENE FUNCTION PRIMARY LOCUS NAME
SWISS-
PROT/TrEMBL 
AC
NCBI ACC NO 
D84475.1 GENE LENGTH
RANGE ON P. 
Aeroginosa PA01 GC %
PROTEIN 
LENGTH   
PRT MW 
Da
PRT MW + 
Histag 
2.182kDa
THEORE
TICAL 
PRT PI
PROTEIN  
EXTINCTION 
CO-EFF
Nir E uroporphyrin-III c-methyltransferase- PA0510 P95417 BAA12682.1 839 573422 to 572586 72.16% 279 29654.11 31.83611 6.6 0.679
Nir J haem d 1 biosynthesis protein PA0511 P95416 BAA12681.1 1163 574596 to 573436 69.85% 387 43952.7 46.1347 6.9 1.369
Nir H haem d1 biosynthesis protein PA0512 P95415 BAA12680.1 515 575105 to 574593 69.20% 171 19581.73 21.76373 9.79 1.51
Nir G probable transcriptional regulator PA0513 P95414 BAA12679. 443  575523 to 575083 69.39% 147 16551.86 18.73386 4.71 0.939
Nir L haem d1 biosynthesis protein PA0514 P95413 BAA12678.1 524 576040 to 575519 71.07% 174 20210.2 22.3922 9.21 1.335
Nir D probable transcriptional regulator PA0515 P95412 BAA12677.1 452 576489 to 576040 70.00% 150 17017.36 19.19936 5.95 0.853
Nir F haem d1 biosynthesis protein PA0516 Q51480 AAG03905. 1178 577676 to 576501 69.05% 392 43338.02 45.5202 6.07 1.232
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